{"doc_id": 0, "doc": {"person_id": 115967211, "visit_occurrence_id": 51248592, "death_date": null, "visit_concept_name": "Case Management Visit", "visit_start_datetime": "2012-10-19 00:00:00", "visit_end_datetime": "2012-10-19 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2011-05-09 12:40:00", "patient_last_visit_date": "2015-02-18 00:00:00", "end_obs_date": "2013-10-19", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "recurrent", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 27, "cumulated_visit_num": 27, "cumulated_approximate_token_count": 12529, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-05-09 12:40:00, ended at 2011-05-09 19:32:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hematuria syndrome\n- Headache\n- Blepharitis\n- Posttraumatic stress disorder\n- Visual disturbance\n- Keratitis\n- Myopia\n\n### Drug\n- hypromellose 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day.\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 0.5 cm to both eyes 2 times a day. For 5 days in each eye\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-21 08:00:34, ended at 2011-05-21 09:57:57\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-29 12:55:00, ended at 2011-05-29 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Finding of head and neck region\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Disorder of brain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-31 00:00:00, ended at 2011-05-31 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm of uncertain behavior of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:01:04, ended at 2011-06-14 17:43:03\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- atomoxetine 40 MG Oral Capsule, through Oral route, presumably until 2011-07-26. Instructions: take 40 mg by mouth 2 times a day.\n- aripiprazole 2 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 2 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:40:28, ended at 2011-06-14 17:43:53\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-06-14, presumably until 2011-07-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth as directed. Take 2 tablets every morning and 1 tablet every afternoon\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-14 11:56:00, ended at 2011-06-14 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 76 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.03 (micro-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 12 (microgram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.60 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.15 (thousand per microliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 33 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-06-15 00:00:00, ended at 2011-06-15 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-15, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:44:00, ended at 2011-06-16 08:47:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n\n### Condition\n- Disorder of brain\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:48:00, ended at 2011-06-16 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-22 01:00:00, ended at 2011-06-22 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging guidance for needle placement (eg, for biopsy, needle aspiration, injection, or placement of localization device) radiological supervision and interpretation\n\n### Condition\n- Finding of head and neck region\n- Benign neoplasm of pituitary gland and craniopharyngeal duct\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-22 10:30:48, ended at 2011-06-22 17:57:17\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 10 mg by mouth every bedtime.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, presumably until 2011-07-26. Instructions: 2 Puffs by Inhalation route as needed.\n- clonazepam 1 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 1 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-06-23 06:05:00, ended at 2011-07-26 14:23:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Base deficit in Blood: 1.0 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 366 (picogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Prothrombin time (PT): N/A (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 39.0 (millimeter mercury column)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 94 (millimeter mercury column)\n- Oxygen [Partial pressure] in Blood: 51 (millimeter mercury column)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Osmolality of Serum or Plasma: 332 (milliosmole per kilogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Body height: 5' 2.992\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: N/A (second)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.12 (micro-international unit per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.00 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: N/A (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 46.6 (millimeter mercury column)\n- Erythrocyte sedimentation rate: 8 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 78.6 (microgram per milliliter)\n- Base excess in Blood by calculation: 9.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n- Osteoplasty of cranium with flap of bone\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Computer assisted surgery with MR/MRA\n- Evaluation of speech, language, voice, communication, and/or auditory processing\n- Insertion of endotracheal tube\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Percutaneous endoscopic gastrostomy\n- Occupational therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Other exploration and decompression of spinal canal\n- Evaluation of oral and pharyngeal swallowing function\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Collection of venous blood by venipuncture\n- Venous catheterization, not elsewhere classified\n- Partial excision of pituitary gland by transsphenoidal approach\n- Computed tomography, head or brain; without contrast material\n- Controlled ventilation procedure and therapy, initiation and management\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Arterial puncture, withdrawal of blood for diagnosis\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Insertion of catheter into artery\n- Continuous invasive mechanical ventilation for 96 consecutive hours or more\n\n### Condition\n- Asthma\n- Cachexia\n- Disorder of nasal cavity\n- Disorder of pituitary gland\n- Obesity\n- Blind or low vision - both eyes\n- Diabetes insipidus\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Atelectasis\n- Episodic mood disorder\n- Pleural effusion\n- Visual disturbance\n- Acute respiratory failure\n- Finding of head and neck region\n- Panhypopituitarism\n- Abnormal findings on diagnostic imaging of skull and head\n- Bipolar affective disorder, currently manic, severe, with psychosis\n- Disturbance of consciousness\n- Hyperosmolality and or hypernatremia\n- Lung field abnormal\n- Malnutrition (calorie)\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Pulmonary congestion and hypostasis\n- Acquired hypothyroidism\n- Fever\n- Homonymous hemianopia\n- Anxiety state\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n- Disorder of posterior pituitary\n- Blindness AND/OR vision impairment level\n- Pneumonitis due to inhaled substance\n- Tobacco dependence syndrome\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-07-14, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 3 Tabs by mouth every morning.\n- hydrocortisone 100 MG Injection, started on 2011-06-23, presumably until 2011-07-04\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-06-24, presumably until 2011-07-07\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-07-12, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n- desmopressin acetate 0.2 MG Oral Tablet, through Oral route, started on 2011-07-08, presumably until 2011-07-09\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-11-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 250 MG Oral Capsule, through Oral route, started on 2011-07-08, presumably until 2011-11-15, with intended 0 refill(s). Instructions: take 2 Caps by mouth every bedtime.\n- levothyroxine sodium 0.2 MG Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-05\n- olanzapine 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-06-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- acetaminophen 650 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2012-07-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 10 mg by mouth every bedtime.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-06-29, presumably until 2011-07-05\n- haloperidol 5 MG/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-05\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-24, presumably until 2011-06-30\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-07-18, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2011-06-24, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-01-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia.\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-07-01, presumably until 2011-07-06\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-07-16\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-07-07, presumably until 2011-07-21\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2011-07-03, presumably until 2011-07-03\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-06-29, presumably until 2011-07-22\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-06-28, presumably until 2011-06-30\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-06-23, presumably until 2011-06-23\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily before dinner.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-07-23\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- olanzapine 10 MG Injection, through Intramuscular route, started on 2011-06-24, presumably until 2011-06-30\n- hydrocortisone 20 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-13\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-06-30, presumably until 2011-07-03\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-07-01, presumably until 2011-07-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2011-07-15, presumably until 2011-07-15, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed.\n- 50 ML clindamycin 12 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-03\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-07-08\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-06-27\n- cefepime 2000 MG Injection, through Intravenous route, started on 2011-06-27, presumably until 2011-07-07\n- atomoxetine 40 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-27. Instructions: take 40 mg by mouth 2 times a day.\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-28\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- lorazepam 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- oxybutynin chloride 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-06-26, presumably until 2011-06-28\n- desmopressin acetate 0.004 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-23, presumably until 2011-07-06\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-04\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- clonazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24. Instructions: take 1 mg by mouth 3 times a day.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-07-05, presumably until 2011-07-06\n- midazolam 1 MG/ML Injectable Solution, started on 2011-06-30, presumably until 2011-06-30\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-11. Instructions: take 2 mg by mouth Every Day.\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2011-07-02, presumably until 2012-07-14, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every 2 hours.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2011-07-15\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-13 13:26:26, ended at 2011-08-13 14:48:05\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-13 17:32:00, ended at 2011-08-14 01:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.08 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.29 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Bipolar disorder\n- Neoplasm of uncertain behavior of pituitary gland\n- Visual disturbance\n- Postprocedural state finding\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-08-13, presumably until 2011-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:31, ended at 2011-09-13 12:56:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take  by mouth. 0.1 mg qhs, 0.05 mg in morning \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:48, ended at 2011-09-13 12:58:33\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 13:22:00, ended at 2011-09-13 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.4 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 34 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-15 10:10:00, ended at 2011-11-15 14:42:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of pituitary gland\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:56:54, ended at 2011-11-15 15:37:29\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route. Instructions: take  by mouth.\n- fluoxetine 20 MG Oral Capsule, through Oral route. Instructions: take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:57:10, ended at 2011-11-15 16:07:51\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-11-15 14:43:00, ended at 2011-11-16 15:45:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.23 (milli-international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 57.3 (millimeter mercury column)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Prothrombin time (PT): 12.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 39 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.0 (milliequivalent per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.24 (thousand per microliter)\n- Oxygen [Partial pressure] in Blood: 28 (millimeter mercury column)\n- Body height: 5' 3\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 57 (nanogram per deciliter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Insertion of temporary indwelling bladder catheter; simple (eg, Foley)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diagnostic interview and evaluation, not otherwise specified\n\n### Condition\n- Edema\n- Seizure\n- Anxiety state\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Psychotic disorder\n- Acquired hypothyroidism\n- Blind or low vision - both eyes\n- Dysthymia\n- Low blood pressure\n- Panhypopituitarism\n- Insomnia\n- Diabetes insipidus\n- Hyperlipidemia\n- Visual disturbance\n- Cough\n- Disorder of pituitary gland\n- Failure to thrive\n- Heteronymous bilateral visual field defects\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 3 Tabs by mouth every morning.\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2012-01-03, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 250 MG Extended Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Tab by mouth 2 times a day.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Cap by mouth 2 times a day.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth every bedtime.\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-01-03 10:16:11, ended at 2012-01-03 11:43:09\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take 100 mcg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-03 11:51:00, ended at 2012-01-03 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-17 14:02:05, ended at 2012-04-17 17:12:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Adrenal cortical hypofunction\n- Disorder of pituitary gland\n- Diabetes insipidus\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route. Instructions: take 0.1 mg by mouth as directed. 0.05 mg po qAM, 0.1 mg po qhs \n- hydrocortisone 10 MG Oral Tablet, through Oral route. Instructions: take 10 mg by mouth 2 times a day.  \n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, presumably until 2015-02-17. Instructions: take  by mouth.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-04-17 15:50:00, ended at 2012-04-18 12:30:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.78 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.35 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Prolactin [Mass/volume] in Serum or Plasma: <1 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: <0.01 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.2 (nanogram per deciliter)\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Hospital discharge day management; 30 minutes or less\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Blindness AND/OR vision impairment level\n- Diabetes insipidus\n- Disorder of nasal cavity\n- Disorder of visual pathways\n- Panhypopituitarism\n- Severe visual impairment\n- Essential hypertension\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-04-17, presumably until 2012-04-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Depressive disorder within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-05-09 12:40:00, ended at 2011-05-09 19:32:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hematuria syndrome\n- Headache\n- Blepharitis\n- Posttraumatic stress disorder\n- Visual disturbance\n- Keratitis\n- Myopia\n\n### Drug\n- hypromellose 2 MG/ML Ophthalmic Solution, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 1 Drop to both eyes 4 times a day.\n- erythromycin 0.005 MG/MG Ophthalmic Ointment, through Intraocular route, started on 2011-05-09, presumably until 2011-06-08, with intended 0 refill(s). Instructions: instill 0.5 cm to both eyes 2 times a day. For 5 days in each eye\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-05-21 08:00:34, ended at 2011-05-21 09:57:57\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Intraocular pressure of left eye: 14 (millimeter mercury column)\n- Intraocular pressure of right eye: 14 (millimeter mercury column)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-05-29 12:55:00, ended at 2011-05-29 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Finding of head and neck region\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Disorder of brain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-05-31 00:00:00, ended at 2011-05-31 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Neoplasm of uncertain behavior of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:01:04, ended at 2011-06-14 17:43:03\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- atomoxetine 40 MG Oral Capsule, through Oral route, presumably until 2011-07-26. Instructions: take 40 mg by mouth 2 times a day.\n- aripiprazole 2 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 2 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-14 09:40:28, ended at 2011-06-14 17:43:53\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-06-14, presumably until 2011-07-26, with intended 3 refill(s). Instructions: take 1 Tab by mouth as directed. Take 2 tablets every morning and 1 tablet every afternoon\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-14 11:56:00, ended at 2011-06-14 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Prolactin [Mass/volume] in Serum or Plasma: 76 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.03 (micro-international unit per milliliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Cortisol [Mass/volume] in Serum or Plasma: 12 (microgram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.1 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.60 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.52 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.15 (thousand per microliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 33 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 40 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- MCH [Entitic mass] by Automated count: 32.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 64.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Disorder of pituitary gland\n- Heteronymous bilateral visual field defects\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2011-06-15 00:00:00, ended at 2011-06-15 00:00:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-15, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:44:00, ended at 2011-06-16 08:47:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n\n### Condition\n- Disorder of brain\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-16 08:48:00, ended at 2011-06-16 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-06-22 01:00:00, ended at 2011-06-22 23:59:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance imaging guidance for needle placement (eg, for biopsy, needle aspiration, injection, or placement of localization device) radiological supervision and interpretation\n\n### Condition\n- Finding of head and neck region\n- Benign neoplasm of pituitary gland and craniopharyngeal duct\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-06-22 10:30:48, ended at 2011-06-22 17:57:17\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- simvastatin 10 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 10 mg by mouth every bedtime.\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, presumably until 2011-07-26. Instructions: 2 Puffs by Inhalation route as needed.\n- clonazepam 1 MG Oral Tablet, through Oral route, presumably until 2011-07-26. Instructions: take 1 mg by mouth 3 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2011-06-23 06:05:00, ended at 2011-07-26 14:23:00\nThe patient in this visit was 52 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Base deficit in Blood: 1.0 (millimole per liter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 366 (picogram per milliliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 288 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.3 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 34 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 138 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 91.5 (percent)\n- Prothrombin time (PT): N/A (second)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: <5 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 39.0 (millimeter mercury column)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 94 (millimeter mercury column)\n- Oxygen [Partial pressure] in Blood: 51 (millimeter mercury column)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 66 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- INR in Platelet poor plasma by Coagulation assay: N/A (ratio)\n- Osmolality of Serum or Plasma: 332 (milliosmole per kilogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Body height: 5' 2.992\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 98 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.4 (femtoliter)\n- Vancomycin [Mass/volume] in Serum or Plasma --trough: 7.8 (microgram per milliliter)\n- aPTT in Platelet poor plasma by Coagulation assay: N/A (second)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.23 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.46 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 35.5 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.15 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.12 (micro-international unit per milliliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.00 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.8 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: N/A (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 46.6 (millimeter mercury column)\n- Erythrocyte sedimentation rate: 8 (millimeter per hour)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.18 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.1 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Valproate [Mass/volume] in Serum or Plasma: 78.6 (microgram per milliliter)\n- Base excess in Blood by calculation: 9.0 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bicarbonate [Moles/volume] in Specimen: 32.3 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.6 (percent)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material, followed by contrast material(s) and further sections\n- Osteoplasty of cranium with flap of bone\n- Treatment of speech, language, voice, communication, and/or auditory processing disorder; individual\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s)\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Computer assisted surgery with MR/MRA\n- Evaluation of speech, language, voice, communication, and/or auditory processing\n- Insertion of endotracheal tube\n- Pathology consultation during surgery; first tissue block, with frozen section(s), single specimen\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Treatment of swallowing dysfunction and/or oral function for feeding\n- Percutaneous endoscopic gastrostomy\n- Occupational therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Other exploration and decompression of spinal canal\n- Evaluation of oral and pharyngeal swallowing function\n- Manipulation chest wall, such as cupping, percussing, and vibration to facilitate lung function; initial demonstration and/or evaluation\n- Collection of venous blood by venipuncture\n- Venous catheterization, not elsewhere classified\n- Partial excision of pituitary gland by transsphenoidal approach\n- Computed tomography, head or brain; without contrast material\n- Controlled ventilation procedure and therapy, initiation and management\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Duplex scan of extremity veins including responses to compression and other maneuvers; complete bilateral study\n- Insertion of peripherally inserted central venous catheter (PICC), without subcutaneous port or pump, without imaging guidance; age 5 years or older\n- Arterial puncture, withdrawal of blood for diagnosis\n- Radiologic examination, chest; single view, frontal\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Insertion of catheter into artery\n- Continuous invasive mechanical ventilation for 96 consecutive hours or more\n\n### Condition\n- Asthma\n- Cachexia\n- Disorder of nasal cavity\n- Disorder of pituitary gland\n- Obesity\n- Blind or low vision - both eyes\n- Diabetes insipidus\n- Heteronymous bilateral visual field defects\n- Swelling / lump finding\n- Atelectasis\n- Episodic mood disorder\n- Pleural effusion\n- Visual disturbance\n- Acute respiratory failure\n- Finding of head and neck region\n- Panhypopituitarism\n- Abnormal findings on diagnostic imaging of skull and head\n- Bipolar affective disorder, currently manic, severe, with psychosis\n- Disturbance of consciousness\n- Hyperosmolality and or hypernatremia\n- Lung field abnormal\n- Malnutrition (calorie)\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Pulmonary congestion and hypostasis\n- Acquired hypothyroidism\n- Fever\n- Homonymous hemianopia\n- Anxiety state\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n- Disorder of posterior pituitary\n- Blindness AND/OR vision impairment level\n- Pneumonitis due to inhaled substance\n- Tobacco dependence syndrome\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-07-14, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 3 Tabs by mouth every morning.\n- hydrocortisone 100 MG Injection, started on 2011-06-23, presumably until 2011-07-04\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2011-06-24, presumably until 2011-07-07\n- 50 ML sodium bicarbonate 84 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-07-12, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n- desmopressin acetate 0.2 MG Oral Tablet, through Oral route, started on 2011-07-08, presumably until 2011-07-09\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-11-16, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 250 MG Oral Capsule, through Oral route, started on 2011-07-08, presumably until 2011-11-15, with intended 0 refill(s). Instructions: take 2 Caps by mouth every bedtime.\n- levothyroxine sodium 0.2 MG Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-05\n- olanzapine 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- gabapentin 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-06-27\n- glycopyrrolate 0.2 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- acetaminophen 650 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed.\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2012-07-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- simvastatin 10 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 10 mg by mouth every bedtime.\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2011-06-29, presumably until 2011-07-05\n- haloperidol 5 MG/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-05\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-24, presumably until 2011-06-30\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2011-07-18, presumably until 2011-09-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- 500 ML glucose 50 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- fluticasone propionate 0.05 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, started on 2011-06-24, presumably until 2011-07-26. Instructions: 1 Puff by Nasal route Every Day.\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-26, presumably until 2012-01-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime as needed for Insomnia.\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2011-07-01, presumably until 2011-07-06\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-07-16\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-07-07, presumably until 2011-07-21\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2011-07-03, presumably until 2011-07-03\n- olanzapine 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2011-06-29, presumably until 2011-07-22\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2011-06-28, presumably until 2011-06-30\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2011-06-23, presumably until 2011-06-23\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2012-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily before dinner.\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-06-25\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2011-06-25, presumably until 2011-07-23\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2012-07-25, with intended 0 refill(s). Instructions: take 1 Cap by mouth 2 times a day.\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth every bedtime.\n- olanzapine 10 MG Injection, through Intramuscular route, started on 2011-06-24, presumably until 2011-06-30\n- hydrocortisone 20 MG Oral Tablet, through Oral route, started on 2011-07-05, presumably until 2011-07-13\n- 10 ML furosemide 10 MG/ML Injection, started on 2011-06-30, presumably until 2011-07-03\n- midodrine hydrochloride 5 MG Oral Tablet, through Oral route, started on 2011-07-01, presumably until 2011-07-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- NDA021457 200 ACTUAT albuterol 0.09 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2011-07-15, presumably until 2011-07-15, with intended 0 refill(s). Instructions: 2 Puffs by Inhalation route every 4 hours as needed.\n- 50 ML clindamycin 12 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-26\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-25\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2011-06-23, presumably until 2011-07-03\n- 1 ML vitamin K1 10 MG/ML Injection, through Intravenous route, started on 2011-06-28, presumably until 2011-07-02\n- valproic acid 50 MG/ML Oral Solution, through Oral route, started on 2011-06-27, presumably until 2011-07-08\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- piperacillin 3000 MG / tazobactam 375 MG Injection, through Intravenous route, started on 2011-06-25, presumably until 2011-06-27\n- cefepime 2000 MG Injection, through Intravenous route, started on 2011-06-27, presumably until 2011-07-07\n- atomoxetine 40 MG Oral Capsule, through Oral route, started on 2011-06-24, presumably until 2011-06-27. Instructions: take 40 mg by mouth 2 times a day.\n- 1000 ML potassium chloride 0.02 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2011-06-23, presumably until 2011-06-28\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-06-29\n- lorazepam 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- oxybutynin chloride 5 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2011-06-26, presumably until 2011-06-28\n- desmopressin acetate 0.004 MG/ML Injectable Solution, through Intravenous route, started on 2011-06-23, presumably until 2011-07-06\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2011-06-29, presumably until 2011-07-04\n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n- clonazepam 1 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-06-24. Instructions: take 1 mg by mouth 3 times a day.\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2011-07-05, presumably until 2011-07-06\n- midazolam 1 MG/ML Injectable Solution, started on 2011-06-30, presumably until 2011-06-30\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2011-06-24, presumably until 2011-07-11. Instructions: take 2 mg by mouth Every Day.\n- sodium chloride 6.5 MG/ML Nasal Spray, through Nasal route, started on 2011-07-02, presumably until 2012-07-14, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every 2 hours.\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2011-07-04, presumably until 2011-07-15\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2011-06-29, presumably until 2011-06-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-08-13 13:26:26, ended at 2011-08-13 14:48:05\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-08-13 17:32:00, ended at 2011-08-14 01:00:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.6 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.3 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.2 (percent)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.08 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.04 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 106 (unit per liter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.29 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 256 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.71 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Bipolar disorder\n- Neoplasm of uncertain behavior of pituitary gland\n- Visual disturbance\n- Postprocedural state finding\n- Essential hypertension\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-08-13, presumably until 2011-08-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:31, ended at 2011-09-13 12:56:18\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take  by mouth. 0.1 mg qhs, 0.05 mg in morning \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-09-13 10:31:48, ended at 2011-09-13 12:58:33\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-09-13 13:22:00, ended at 2011-09-13 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.4 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 34 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.1 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 25 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.9 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2011-11-15 10:10:00, ended at 2011-11-15 14:42:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n\n### Condition\n- Disorder of pituitary gland\n- Finding of head and neck region\n- Swelling / lump finding\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:56:54, ended at 2011-11-15 15:37:29\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route. Instructions: take  by mouth.\n- fluoxetine 20 MG Oral Capsule, through Oral route. Instructions: take  by mouth.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2011-11-15 12:57:10, ended at 2011-11-15 16:07:51\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2011-11-15 14:43:00, ended at 2011-11-16 15:45:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.2 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.44 (million per microliter)\n- Potassium [Moles/volume] in Blood: 3.9 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.23 (milli-international unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Carbon dioxide [Partial pressure] in Blood: 57.3 (millimeter mercury column)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.70 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 91.1 (femtoliter)\n- Sodium [Moles/volume] in Blood: 143 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 74 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 14.0 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.8 (gram per deciliter)\n- Prothrombin time (PT): 12.8 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 39 (percent)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 46.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Base excess in Blood by calculation: 5.0 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 31.0 (milliequivalent per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 13.3 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.1 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.24 (thousand per microliter)\n- Oxygen [Partial pressure] in Blood: 28 (millimeter mercury column)\n- Body height: 5' 3\" (inch (US))\n- Glucose [Mass/volume] in Serum or Plasma: 119 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.0 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.7 (nanogram per deciliter)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.5 (percent)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 57 (nanogram per deciliter)\n\n### Procedure\n- Radiologic examination, chest; single view, frontal\n- Insertion of temporary indwelling bladder catheter; simple (eg, Foley)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Diagnostic interview and evaluation, not otherwise specified\n\n### Condition\n- Edema\n- Seizure\n- Anxiety state\n- Neoplasm of uncertain behavior of pituitary gland\n- Organic anxiety disorder\n- Psychotic disorder\n- Acquired hypothyroidism\n- Blind or low vision - both eyes\n- Dysthymia\n- Low blood pressure\n- Panhypopituitarism\n- Insomnia\n- Diabetes insipidus\n- Hyperlipidemia\n- Visual disturbance\n- Cough\n- Disorder of pituitary gland\n- Failure to thrive\n- Heteronymous bilateral visual field defects\n- Adrenal cortical hypofunction\n- Bipolar I disorder, single manic episode\n\n### Drug\n- hydrocortisone 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 3 Tabs by mouth every morning.\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2012-01-03, with intended 3 refill(s). Instructions: take 2 Tabs by mouth daily.\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take  by mouth.\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 250 MG Extended Release Oral Tablet, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Tab by mouth 2 times a day.\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2011-11-16, presumably until 2011-11-16. Instructions: take 1 Cap by mouth 2 times a day.\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 20 mg by mouth daily.\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth every bedtime.\n- 0.5 ML Streptococcus pneumoniae type 1 capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 10A capsular polysaccharide antigen 0.05 MG/ML / Streptococcus pneumoniae type 11A capsular polysaccharide antigen 0.05 MG/ML / Streptococ..., started on 2011-11-16, presumably until 2011-11-16\n- 24 HR divalproex sodium 500 MG Extended Release Oral Tablet, through Oral route. Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-01-03 10:16:11, ended at 2012-01-03 11:43:09\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Panhypopituitarism\n\n### Drug\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, presumably until 2012-04-17. Instructions: take 100 mcg by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2012-01-03 11:51:00, ended at 2012-01-03 23:59:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.0 (nanogram per deciliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Panhypopituitarism\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-04-17 14:02:05, ended at 2012-04-17 17:12:17\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 3\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Panhypopituitarism\n- Adrenal cortical hypofunction\n- Disorder of pituitary gland\n- Diabetes insipidus\n\n### Drug\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route. Instructions: take 0.1 mg by mouth as directed. 0.05 mg po qAM, 0.1 mg po qhs \n- hydrocortisone 10 MG Oral Tablet, through Oral route. Instructions: take 10 mg by mouth 2 times a day.  \n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, presumably until 2015-02-17. Instructions: take  by mouth.  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2012-04-17 15:50:00, ended at 2012-04-18 12:30:00\nThe patient in this visit was 53 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.18 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Triiodothyronine (T3) [Mass/volume] in Serum or Plasma: 70 (nanogram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.78 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.41 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 15.0 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.54 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 5.3 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.9 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 43.6 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 21 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.35 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 111 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 42.6 (percent)\n- MCH [Entitic mass] by Automated count: 31.3 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 89 (unit per liter)\n- Globulin [Mass/volume] in Serum: 4.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 43.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Prolactin [Mass/volume] in Serum or Plasma: <1 (nanogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: <0.01 (milli-international unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.2 (nanogram per deciliter)\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, orbit, face, and/or neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Hospital discharge day management; 30 minutes or less\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n\n### Condition\n- Blindness AND/OR vision impairment level\n- Diabetes insipidus\n- Disorder of nasal cavity\n- Disorder of visual pathways\n- Panhypopituitarism\n- Severe visual impairment\n- Essential hypertension\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- desmopressin acetate 0.1 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- simvastatin 20 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- hydrocortisone 10 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- ramelteon 8 MG Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- divalproex sodium 500 MG Delayed Release Oral Tablet, through Oral route, started on 2012-04-18, presumably until 2012-04-18\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2012-04-17, presumably until 2012-04-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2012-10-19 00:00:00, ended at 2012-10-19 00:00:00\nThe patient in this visit was 54 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of pituitary gland\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Depressive disorder within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of depressive_disorder means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "e162d0a191d016a0fc6e7d0027afeb800783fe539f5b769d774b71f4ea97370c", "prompt_hash": "7a0e493312443bcaa1032d33d144d388016e2962ec48b9a993de8e4c56f83fcf", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 1, "doc": {"person_id": 115967631, "visit_occurrence_id": 150348663, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2020-02-09 08:42:20", "visit_end_datetime": "2020-02-09 09:51:28", "visit_length_in_hours": 1.1522222222222223, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2016-06-20 10:15:08", "patient_last_visit_date": "2022-04-17 13:33:28", "end_obs_date": "2021-02-08", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 15, "cumulated_visit_num": 15, "cumulated_approximate_token_count": 3258, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2016-06-20 10:15:08, ended at 2016-06-20 11:17:07\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-23 14:42:04, ended at 2017-02-23 14:51:19\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buspirone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every day\n- topiramate 100 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 04:42:00, ended at 2017-06-09 06:53:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transvaginal\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Hypokalemia\n- Disorder of female genital organs\n- Primary diagnosis: Loss of consciousness\n- Pain in pelvis\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2018-06-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-12-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-26 18:26:35, ended at 2017-07-26 19:35:57\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysmenorrhea\n\n### Drug\n- 24 HR naproxen 750 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2017-07-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth as directed Take one tab Q 4-8 hrs with meals\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2018-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-06 08:50:06, ended at 2017-08-06 09:46:35\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Insertion of intrauterine device (IUD)\n\n### Condition\n- Dysmenorrhea\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, started on 2017-08-06, presumably until 2017-08-06, with intended 0 refill(s). Instructions: 1 Intra Uterine Device by Intrauterine route One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-25 17:22:19, ended at 2017-09-25 17:58:47\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Dysmenorrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 15:04:35, ended at 2018-02-01 15:37:40\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized abdominal pain\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, with intended 0 refill(s). Instructions: 1 Device by Intrauterine route One Time\n- hyoscyamine sulfate 0.125 MG Sublingual Tablet, through Oral route, started on 2018-02-01, presumably until 2022-04-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-04 12:44:38, ended at 2018-04-04 13:41:52\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammation of cervix\n- Primary diagnosis: Pain in pelvis\n\n### Drug\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2019-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 08:06:00, ended at 2018-04-25 23:59:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transvaginal\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n\n### Condition\n- Pain in pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-28 16:36:46, ended at 2018-05-28 17:51:40\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysmenorrhea\n- Premenstrual tension syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-08 09:11:00, ended at 2019-07-08 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Allergic rhinitis due to pollen\n- Cough\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-11 08:30:00, ended at 2019-08-11 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-30 08:07:36, ended at 2019-12-30 08:57:56\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- clarithromycin 500 MG Oral Tablet, started on 2019-12-02, presumably until 2022-04-17, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Depressive disorder within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-06-20 10:15:08, ended at 2016-06-20 11:17:07\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-02-23 14:42:04, ended at 2017-02-23 14:51:19\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- buspirone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 5 mg by mouth every day\n- topiramate 100 MG Oral Tablet, through Oral route, presumably until 2022-04-17, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 00:00:00, ended at 2017-06-09 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2017-06-09 04:42:00, ended at 2017-06-09 06:53:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82.1 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 127 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.2 (picogram)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.86 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.46 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.7 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.92 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.4 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 4.42 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.60 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 40.6 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 58 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 45.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 219 (thousand per microliter)\n\n### Procedure\n- Ultrasound, transvaginal\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Hypokalemia\n- Disorder of female genital organs\n- Primary diagnosis: Loss of consciousness\n- Pain in pelvis\n\n### Drug\n- ibuprofen 800 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2018-06-09, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 8 hours as needed\n- acetaminophen 325 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2017-06-09, presumably until 2017-12-06, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed for Pain\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-07-26 18:26:35, ended at 2017-07-26 19:35:57\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Dysmenorrhea\n\n### Drug\n- 24 HR naproxen 750 MG Extended Release Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2017-07-26, with intended 1 refill(s). Instructions: take 1 Tab by mouth as directed Take one tab Q 4-8 hrs with meals\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2017-07-26, presumably until 2018-07-26, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-06 08:50:06, ended at 2017-08-06 09:46:35\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- Insertion of intrauterine device (IUD)\n\n### Condition\n- Dysmenorrhea\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, started on 2017-08-06, presumably until 2017-08-06, with intended 0 refill(s). Instructions: 1 Intra Uterine Device by Intrauterine route One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-25 17:22:19, ended at 2017-09-25 17:58:47\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Dysmenorrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-02-01 15:04:35, ended at 2018-02-01 15:37:40\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized abdominal pain\n\n### Drug\n- levonorgestrel 0.000833 MG/HR Intrauterine System, through Intrauterine route, with intended 0 refill(s). Instructions: 1 Device by Intrauterine route One Time\n- hyoscyamine sulfate 0.125 MG Sublingual Tablet, through Oral route, started on 2018-02-01, presumably until 2022-04-17, with intended 3 refill(s). Instructions: take 1 Tab by mouth 3 times a day as needed (pain)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-04 12:44:38, ended at 2018-04-04 13:41:52\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Inflammation of cervix\n- Primary diagnosis: Pain in pelvis\n\n### Drug\n- naproxen 500 MG Oral Tablet, through Oral route, started on 2018-04-04, presumably until 2019-04-04, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2018-04-25 08:06:00, ended at 2018-04-25 23:59:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, transvaginal\n- Ultrasound, pelvic (nonobstetric), real time with image documentation; complete\n\n### Condition\n- Pain in pelvis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-05-28 16:36:46, ended at 2018-05-28 17:51:40\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Dysmenorrhea\n- Premenstrual tension syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-07-08 09:11:00, ended at 2019-07-08 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest; 2 views\n\n### Condition\n- Allergic rhinitis due to pollen\n- Cough\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2019-08-11 08:30:00, ended at 2019-08-11 23:59:00\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, thorax, diagnostic; without contrast material\n\n### Condition\n- Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-12-30 08:07:36, ended at 2019-12-30 08:57:56\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Laryngoscopy, flexible or rigid telescopic, with stroboscopy\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- clarithromycin 500 MG Oral Tablet, started on 2019-12-02, presumably until 2022-04-17, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-02-09 08:42:20, ended at 2020-02-09 09:51:28\nThe patient in this visit was 22 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Behavioral and qualitative analysis of voice and resonance\n\n### Condition\n- Dysphonia\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Depressive disorder within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of depressive_disorder means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "5cefe9f6ed6138e55c0ad34b9fc0be2eded1bcdcfd679bf96c62573b41e4726e", "prompt_hash": "afe67f93dd79ec5ae38eaed057d772a7796ba47a43c4733ba0487c3075d55571", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 2, "doc": {"person_id": 115968035, "visit_occurrence_id": 174248134, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2021-02-07 00:00:00", "visit_end_datetime": "2021-02-07 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 82, "patient_first_visit_date": "2012-02-25 00:00:00", "patient_last_visit_date": "2023-01-06 00:00:00", "end_obs_date": "2022-02-07", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 1, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 69, "cumulated_visit_num": 69, "cumulated_approximate_token_count": 11418, "visit_cumulated": "## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-25 00:00:00, ended at 2012-02-25 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2012-02-25, presumably until 2019-05-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-26 00:00:00, ended at 2012-02-26 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, started on 2012-02-26, presumably until 2013-02-07, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-16 00:00:00, ended at 2013-01-16 00:00:00\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 113 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.779 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Primary cardiomyopathy\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-07 14:01:58, ended at 2013-02-07 14:47:43\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Attention deficit hyperactivity disorder, predominantly inattentive type\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Sleep apnea\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- lurasidone hydrochloride 40 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-21 16:51:40, ended at 2014-06-21 17:20:47\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic nonalcoholic liver disease\n- Primary diagnosis: Non-toxic multinodular goiter\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2014-06-21, presumably until 2015-08-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-04 00:00:00, ended at 2014-10-04 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2014-10-04, presumably until 2015-10-25, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-17 14:39:32, ended at 2015-04-17 15:09:27\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.679 (micro-international unit per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Primary cardiomyopathy\n- Primary diagnosis: Dysfunction of eustachian tube\n\n### Drug\n- ethacrynic acid 25 MG Oral Tablet, through Oral route, presumably until 2015-10-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-19 00:00:00, ended at 2015-04-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-01 00:00:00, ended at 2015-05-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2015-05-01, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-01 13:57:32, ended at 2015-05-01 14:38:58\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Non-toxic multinodular goiter\n- Bipolar disorder\n- Sleep apnea\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-05 00:00:00, ended at 2015-08-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-08-05, presumably until 2015-09-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-30 00:00:00, ended at 2015-08-30 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-09-02, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-25 00:00:00, ended at 2015-10-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2015-10-25, presumably until 2017-04-09, with intended 6 refill(s). Instructions: Use as directed\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-10-25, presumably until 2017-04-09, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-25 10:07:18, ended at 2015-10-25 11:09:46\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Attention deficit hyperactivity disorder\n- Posttraumatic stress disorder\n\n### Drug\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: 55 mcg by Nasal route daily\n- bumetanide 0.5 MG Oral Tablet, started on 2015-10-25, presumably until 2017-07-20, with intended 3 refill(s). Instructions: Take 1 po daily prn swelling\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 13:41:10, ended at 2016-02-27 14:07:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-18 00:00:00, ended at 2016-03-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-24 09:59:32, ended at 2016-03-24 11:15:21\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-14 09:42:59, ended at 2016-04-14 10:14:56\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-01 00:00:00, ended at 2016-05-01 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-12-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-05-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-07 00:00:00, ended at 2016-05-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Biceps tendinitis\n- Shoulder joint pain\n- Nontraumatic rotator cuff tear\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-13 09:29:30, ended at 2016-05-13 10:06:48\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n- Primary diagnosis: Acute bronchitis\n- Non-toxic multinodular goiter\n- Sleep apnea\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2016-05-13, presumably until 2017-05-13, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-07-10 00:00:00, ended at 2016-07-10 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anesthesia of skin\n- Primary diagnosis: Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 10:27:49, ended at 2016-11-13 11:24:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Primary diagnosis: Cardiomyopathy\n- Attention deficit hyperactivity disorder\n- Mixed bipolar I disorder in full remission\n- Mild intermittent asthma\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2016-11-13, presumably until 2017-11-13, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-12-16, presumably until 2018-04-21, with intended 11 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-09, presumably until 2018-07-26, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-04-09, presumably until 2017-12-07, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-30 10:51:26, ended at 2017-04-30 11:28:27\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Attention deficit hyperactivity disorder\n- Non-toxic multinodular goiter\n- Sleep apnea\n- Impaired glucose tolerance\n- Mixed bipolar I disorder in full remission\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-02 00:00:00, ended at 2017-07-02 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic uninodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-20 00:00:00, ended at 2017-07-20 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2017-07-21, presumably until 2019-04-07, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-27 00:00:00, ended at 2017-07-27 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-28, presumably until 2017-08-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-22 00:00:00, ended at 2017-09-22 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-09-23, presumably until 2017-09-24, with intended 0 refill(s). Instructions: inject 1 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-24 00:00:00, ended at 2017-09-24 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-08 13:54:03, ended at 2017-10-08 13:54:21\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Injection 0.5 mL into the muscle One Time\n- 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-10-26, presumably until 2017-10-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle as directed\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Take 1 tab po starting 1-2 days before trip,continue till one week after returning from trip\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-04 00:00:00, ended at 2017-11-04 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-11-04, presumably until 2018-04-21, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-12-08, presumably until 2019-06-06, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-13 00:00:00, ended at 2017-12-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-21 14:13:18, ended at 2018-04-21 14:51:16\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n- Primary diagnosis: Acute maxillary sinusitis\n- Bipolar disorder in remission\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2019-06-06, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-04-21, presumably until 2020-01-25, with intended 3 refill(s). Instructions: take 1 Cap by mouth every 7 days\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2018-05-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2018-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-26 00:00:00, ended at 2018-07-26 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-07-27, presumably until 2019-10-12, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-22 00:00:00, ended at 2018-08-22 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-08-22, presumably until 2019-03-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 30 days For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-18 00:00:00, ended at 2018-10-18 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-10-18, presumably until 2019-07-25, with intended 3 refill(s). Instructions: USE IN EACH NOSTRIL AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-14 00:00:00, ended at 2019-03-14 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney stone\n- Sleep apnea\n- Steatosis of liver\n- Uncomplicated asthma\n- Primary diagnosis: Urticaria due to cold and heat\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-25 00:00:00, ended at 2019-03-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ophthalmic herpes simplex\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2019-03-28, presumably until 2019-04-27, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-07 00:00:00, ended at 2019-04-07 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2019-04-07, presumably until 2020-06-14, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-10 10:43:15, ended at 2019-05-10 14:22:35\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n\n### Drug\n- soybean preparation, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- vitamin E, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- soy protein isolate, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- cannabidiol 100 MG/ML Oral Solution, through Topical route, with intended 0 refill(s). Instructions: by Topical route Compounded cream for inflammation\n- soybean allergenic extract, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- folic acid, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2022-02-12, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every day\n- wheat germ oil, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- alpha tocopherol, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2020-01-03, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day as needed\n- vitamin B complex, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-06 00:00:00, ended at 2019-06-06 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized anxiety disorder\n- Mild intermittent asthma\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2019-06-07, presumably until 2020-07-31, with intended 1 refill(s). Instructions: TAKE 1 TO 2 TABLETS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n- NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2019-06-07, presumably until 2021-06-21, with intended 6 refill(s). Instructions: USE AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-25 00:00:00, ended at 2019-07-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2019-07-26, presumably until 2020-01-08, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-12 00:00:00, ended at 2019-10-12 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2019-10-12, presumably until 2020-07-31, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2020-01-03, presumably until 2020-07-31, with intended 1 refill(s). Instructions: 1T 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-08, presumably until 2020-01-25, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-17 00:00:00, ended at 2020-01-17 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asteatosis cutis\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-23, presumably until 2020-01-23, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-25 15:31:41, ended at 2020-01-25 16:25:04\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute pansinusitis\n- Benign neoplasm of adrenal gland\n- Allergic rhinitis\n\n### Drug\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2020-01-25, presumably until 2020-02-01, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-25, presumably until 2021-07-29, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-29 10:04:04, ended at 2020-02-29 10:27:09\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- dexamethasone 1 MG Oral Tablet, started on 2020-02-29, presumably until 2020-10-01, with intended 1 refill(s). Instructions: 1 tab at 11 pm\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2020-02-09, presumably until 2020-02-09, with intended 0 refill(s). Instructions: Take 1 tablet (25 mg total) by mouth Takes 1 1/2 tab daily\n- 120 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-02-22, presumably until 2021-02-19, with intended 0 refill(s)\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, started on 2020-02-21, presumably until 2020-10-01, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-01 00:00:00, ended at 2020-03-01 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2020-03-07, presumably until 2021-02-19, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-06-03, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-04-30, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-03 00:00:00, ended at 2020-06-03 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-06-03, presumably until 2021-02-05, with intended 6 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-14 00:00:00, ended at 2020-06-14 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2020-06-14, presumably until 2022-01-04, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED for swelling (please allow 48 hours for refills)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-01, presumably until 2021-01-09, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-08-01, presumably until 2021-06-21, with intended 1 refill(s). Instructions: take 1-2 Tabs (0.5-1 mg total) by mouth every 4 hours as needed\n- valacyclovir 500 MG Oral Tablet, started on 2020-08-01, presumably until 2021-01-09, with intended 1 refill(s). Instructions: 1To 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-17 09:25:05, ended at 2020-09-17 09:54:27\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 45.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cortisol Free [Mass/time] in 24 hour Urine: 15 (microgram per 24 hours)\n- Cortisol Free [Mass/volume] in Urine: 5 (microgram per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Metanephrine Free [Mass/volume] in Serum or Plasma: 15.4 (picogram per milliliter)\n- Body height: 5' 1\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Normetanephrine [Mass/volume] in Serum or Plasma: 101.4 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-27 00:00:00, ended at 2020-09-27 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-01 10:21:33, ended at 2020-10-01 10:47:25\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n- Steatosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chalazion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2021-01-09, presumably until 2021-06-21, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR ONE MONTH DURING BREAKOUT\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2021-01-09, presumably until 2021-06-21, with intended 10 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Depressive disorder within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-25 00:00:00, ended at 2012-02-25 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2012-02-25, presumably until 2019-05-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-02-26 00:00:00, ended at 2012-02-26 00:00:00\nThe patient in this visit was 36 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, started on 2012-02-26, presumably until 2013-02-07, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2013-01-16 00:00:00, ended at 2013-01-16 00:00:00\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 113 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62 (percent)\n- Triglyceride [Moles/volume] in Serum or Plasma: 137 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (international unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (international unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.5 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 274 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.73 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.5 (thousand per microliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.2 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 82 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.779 (micro-international unit per milliliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Cholesterol in VLDL [Mass/volume] in Serum or Plasma by calculation: 27 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.3 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.5 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 87 (international unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.7 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 57 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.5 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 31 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.0 (gram per deciliter)\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Primary cardiomyopathy\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-07 14:01:58, ended at 2013-02-07 14:47:43\nThe patient in this visit was 37 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n- General examination of patient\n\n### Condition\n- Attention deficit hyperactivity disorder, predominantly inattentive type\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Sleep apnea\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- lurasidone hydrochloride 40 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, presumably until 2014-06-21. Instructions: take  by mouth. Split in 1/4 daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-06-21 16:51:40, ended at 2014-06-21 17:20:47\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Chronic nonalcoholic liver disease\n- Primary diagnosis: Non-toxic multinodular goiter\n- Bipolar disorder\n- Primary cardiomyopathy\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2014-06-21, presumably until 2015-08-05, with intended 0 refill(s). Instructions: take 1 Tab by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-10-04 00:00:00, ended at 2014-10-04 00:00:00\nThe patient in this visit was 38 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2014-10-04, presumably until 2015-10-25, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-04-17 14:39:32, ended at 2015-04-17 15:09:27\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Globulin [Mass/volume] in Serum: 2.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 287 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 96 (international unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.2 (percent)\n- Immature granulocytes/100 leukocytes in Blood: 0 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 83 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 6.9 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (international unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (international unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.1 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.6 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.0 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 10.3 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.5 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 67 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma by Detection limit <= 0.05 mIU/L: 0.679 (micro-international unit per milliliter)\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.8 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.4 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 77 (milligram per deciliter)\n- Immature granulocytes [#/volume] in Blood: 0.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 27.9 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Body height: 5' 1\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 1 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Chronic nonalcoholic liver disease\n- Primary cardiomyopathy\n- Primary diagnosis: Dysfunction of eustachian tube\n\n### Drug\n- ethacrynic acid 25 MG Oral Tablet, through Oral route, presumably until 2015-10-25, with intended 0 refill(s). Instructions: take 2 Tabs by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2015-04-19 00:00:00, ended at 2015-04-19 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-05-01 00:00:00, ended at 2015-05-01 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2015-05-01, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-01 13:57:32, ended at 2015-05-01 14:38:58\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- General examination of patient\n\n### Condition\n- Non-toxic multinodular goiter\n- Bipolar disorder\n- Sleep apnea\n- Primary cardiomyopathy\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-05 00:00:00, ended at 2015-08-05 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-08-05, presumably until 2015-09-02, with intended 3 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-08-30 00:00:00, ended at 2015-08-30 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic multinodular goiter\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2015-09-02, presumably until 2016-05-01, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2015-10-25 00:00:00, ended at 2015-10-25 00:00:00\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2015-10-25, presumably until 2017-04-09, with intended 6 refill(s). Instructions: Use as directed\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2015-10-25, presumably until 2017-04-09, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-10-25 10:07:18, ended at 2015-10-25 11:09:46\nThe patient in this visit was 39 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Attention deficit hyperactivity disorder\n- Posttraumatic stress disorder\n\n### Drug\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: 55 mcg by Nasal route daily\n- bumetanide 0.5 MG Oral Tablet, started on 2015-10-25, presumably until 2017-07-20, with intended 3 refill(s). Instructions: Take 1 po daily prn swelling\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: Take 1 tablet (81 mg total) by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-02-27 13:41:10, ended at 2016-02-27 14:07:45\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-03-18 00:00:00, ended at 2016-03-18 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-03-24 09:59:32, ended at 2016-03-24 11:15:21\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-04-14 09:42:59, ended at 2016-04-14 10:14:56\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Shoulder joint pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-05-01 00:00:00, ended at 2016-05-01 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-12-16, with intended 6 refill(s). Instructions: take 1 Tab by mouth Every Day\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2016-05-01, presumably until 2016-05-08, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2016-05-07 00:00:00, ended at 2016-05-07 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Biceps tendinitis\n- Shoulder joint pain\n- Nontraumatic rotator cuff tear\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-05-13 09:29:30, ended at 2016-05-13 10:06:48\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n- Primary diagnosis: Acute bronchitis\n- Non-toxic multinodular goiter\n- Sleep apnea\n\n### Drug\n- 14 ACTUAT fluticasone propionate 0.1 MG/ACTUAT / salmeterol 0.05 MG/ACTUAT Dry Powder Inhaler, through Inhalation, started on 2016-05-13, presumably until 2017-05-13, with intended 3 refill(s). Instructions: 1 Puff by Inhalation route 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2016-07-10 00:00:00, ended at 2016-07-10 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Anesthesia of skin\n- Primary diagnosis: Low back pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2016-11-13 10:27:49, ended at 2016-11-13 11:24:59\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Non-toxic multinodular goiter\n- Primary diagnosis: Cardiomyopathy\n- Attention deficit hyperactivity disorder\n- Mixed bipolar I disorder in full remission\n- Mild intermittent asthma\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, started on 2016-11-13, presumably until 2017-11-13, with intended 3 refill(s). Instructions: apply 1 Patch to skin daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2016-12-16 00:00:00, ended at 2016-12-16 00:00:00\nThe patient in this visit was 40 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thyroid (USP) 60 MG Oral Tablet, through Oral route, started on 2016-12-16, presumably until 2018-04-21, with intended 11 refill(s). Instructions: take 1 Tab by mouth every day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2017-04-09, presumably until 2018-07-26, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-04-09 00:00:00, ended at 2017-04-09 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-04-09, presumably until 2017-12-07, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-04-30 10:51:26, ended at 2017-04-30 11:28:27\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Attention deficit hyperactivity disorder\n- Non-toxic multinodular goiter\n- Sleep apnea\n- Impaired glucose tolerance\n- Mixed bipolar I disorder in full remission\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-07-02 00:00:00, ended at 2017-07-02 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-toxic uninodular goiter\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-20 00:00:00, ended at 2017-07-20 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2017-07-21, presumably until 2019-04-07, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-07-27 00:00:00, ended at 2017-07-27 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2017-07-28, presumably until 2017-08-04, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 7 days\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-22 00:00:00, ended at 2017-09-22 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- 1 ML hepatitis A vaccine (inactivated) strain HM175 720 UNT/ML / hepatitis B surface antigen vaccine 0.02 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-09-23, presumably until 2017-09-24, with intended 0 refill(s). Instructions: inject 1 mL into a muscle One Time\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-09-24 00:00:00, ended at 2017-09-24 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-10-08 13:54:03, ended at 2017-10-08 13:54:21\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.5 ML typhoid Vi polysaccharide vaccine, S typhi Ty2 strain 0.05 MG/ML Prefilled Syringe, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Injection 0.5 mL into the muscle One Time\n- 0.5 ML Japanese encephalitis virus vaccine Nakayama-NIH strain, inactivated 0.012 MG/ML Prefilled Syringe, through Intramuscular route, started on 2017-10-26, presumably until 2017-10-27, with intended 0 refill(s). Instructions: inject 0.5 mL into a muscle as directed\n- atovaquone 250 MG / proguanil hydrochloride 100 MG Oral Tablet, started on 2017-10-26, presumably until 2018-04-21, with intended 0 refill(s). Instructions: Take 1 tab po starting 1-2 days before trip,continue till one week after returning from trip\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-04 00:00:00, ended at 2017-11-04 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2017-11-04, presumably until 2018-04-21, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2017-12-07 00:00:00, ended at 2017-12-07 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- NDA019430 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2017-12-08, presumably until 2019-06-06, with intended 6 refill(s). Instructions: Use as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-12-13 00:00:00, ended at 2017-12-13 00:00:00\nThe patient in this visit was 41 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-04-21 14:13:18, ended at 2018-04-21 14:51:16\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n- Primary diagnosis: Acute maxillary sinusitis\n- Bipolar disorder in remission\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2019-06-06, with intended 1 refill(s). Instructions: take 1-2 Tabs by mouth every 4 to 6 hours as needed\n- ergocalciferol 1.25 MG Oral Capsule, through Oral route, started on 2018-04-21, presumably until 2020-01-25, with intended 3 refill(s). Instructions: take 1 Cap by mouth every 7 days\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2018-04-21, presumably until 2018-05-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 10 days\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2018-08-22, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-07-26 00:00:00, ended at 2018-07-26 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, through Inhalation, started on 2018-07-27, presumably until 2019-10-12, with intended 11 refill(s). Instructions: 2 Puffs by Inhalation route every 4 to 6 hours as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-08-22 00:00:00, ended at 2018-08-22 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, through Oral route, started on 2018-08-22, presumably until 2019-03-25, with intended 2 refill(s). Instructions: take 1 Tab by mouth 2 times a day for 30 days For 1 month during breakout\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-10-18 00:00:00, ended at 2018-10-18 00:00:00\nThe patient in this visit was 42 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2018-10-18, presumably until 2019-07-25, with intended 3 refill(s). Instructions: USE IN EACH NOSTRIL AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2019-03-14 00:00:00, ended at 2019-03-14 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Kidney stone\n- Sleep apnea\n- Steatosis of liver\n- Uncomplicated asthma\n- Primary diagnosis: Urticaria due to cold and heat\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-03-25 00:00:00, ended at 2019-03-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Ophthalmic herpes simplex\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2019-03-28, presumably until 2019-04-27, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-04-07 00:00:00, ended at 2019-04-07 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2019-04-07, presumably until 2020-06-14, with intended 3 refill(s). Instructions: Take one tablet by mouth daily as needed for swelling.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2019-05-10 10:43:15, ended at 2019-05-10 14:22:35\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diag\n\n### Condition\n- Sleep apnea\n- Cardiomyopathy\n\n### Drug\n- soybean preparation, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- vitamin E, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- soy protein isolate, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- cannabidiol 100 MG/ML Oral Solution, through Topical route, with intended 0 refill(s). Instructions: by Topical route Compounded cream for inflammation\n- soybean allergenic extract, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- folic acid, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- aspirin 81 MG / calcium carbonate 777 MG Oral Tablet, through Oral route, presumably until 2019-05-10, with intended 0 refill(s). Instructions: take 81 mg by mouth daily\n- triamcinolone acetonide 0.055 MG/ACTUAT Metered Dose Nasal Spray, through Nasal route, presumably until 2022-02-12, with intended 0 refill(s). Instructions: 2 Sprays by Nasal route every day\n- wheat germ oil, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- alpha tocopherol, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n- valacyclovir 500 MG Oral Tablet, through Oral route, presumably until 2020-01-03, with intended 0 refill(s). Instructions: take 500 mg by mouth 2 times a day as needed\n- vitamin B complex, through Oral route, with intended 0 refill(s). Instructions: take by mouth\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-06-06 00:00:00, ended at 2019-06-06 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Generalized anxiety disorder\n- Mild intermittent asthma\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, started on 2019-06-07, presumably until 2020-07-31, with intended 1 refill(s). Instructions: TAKE 1 TO 2 TABLETS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n- NDA201739 0.3 ML epinephrine 1 MG/ML Auto-Injector, started on 2019-06-07, presumably until 2021-06-21, with intended 6 refill(s). Instructions: USE AS DIRECTED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-07-25 00:00:00, ended at 2019-07-25 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2019-07-26, presumably until 2020-01-08, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2019-10-12 00:00:00, ended at 2019-10-12 00:00:00\nThe patient in this visit was 43 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2019-10-12, presumably until 2020-07-31, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-02 00:00:00, ended at 2020-01-02 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2020-01-03, presumably until 2020-07-31, with intended 1 refill(s). Instructions: 1T 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-07 00:00:00, ended at 2020-01-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-08, presumably until 2020-01-25, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-17 00:00:00, ended at 2020-01-17 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Asteatosis cutis\n- Primary diagnosis: Disorder of skin and/or subcutaneous tissue\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-01-22 00:00:00, ended at 2020-01-22 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Allergic rhinitis\n\n### Drug\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-23, presumably until 2020-01-23, with intended 2 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2020-01-25 15:31:41, ended at 2020-01-25 16:25:04\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Acute pansinusitis\n- Benign neoplasm of adrenal gland\n- Allergic rhinitis\n\n### Drug\n- doxycycline hyclate 100 MG Oral Capsule, through Oral route, started on 2020-01-25, presumably until 2020-02-01, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 2 times a day for 7 days\n- azelastine hydrochloride 0.206 MG/ACTUAT Metered Dose Nasal Spray, started on 2020-01-25, presumably until 2021-07-29, with intended 3 refill(s). Instructions: use in each nostril as directed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-02-29 10:04:04, ended at 2020-02-29 10:27:09\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 1\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- dexamethasone 1 MG Oral Tablet, started on 2020-02-29, presumably until 2020-10-01, with intended 1 refill(s). Instructions: 1 tab at 11 pm\n- carvedilol 25 MG Oral Tablet, through Oral route, started on 2020-02-09, presumably until 2020-02-09, with intended 0 refill(s). Instructions: Take 1 tablet (25 mg total) by mouth Takes 1 1/2 tab daily\n- 120 ACTUAT budesonide 0.08 MG/ACTUAT / formoterol fumarate 0.0045 MG/ACTUAT Metered Dose Inhaler, started on 2020-02-22, presumably until 2021-02-19, with intended 0 refill(s)\n- amoxicillin 875 MG / clavulanate 125 MG Oral Tablet, started on 2020-02-21, presumably until 2020-10-01, with intended 0 refill(s)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-03-01 00:00:00, ended at 2020-03-01 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- benzonatate 100 MG Oral Capsule, through Oral route, started on 2020-03-07, presumably until 2021-02-19, with intended 0 refill(s). Instructions: take 1 Cap (100 mg total) by mouth 3 times a day as needed\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-03-07 00:00:00, ended at 2020-03-07 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Cough\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-06-03, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-04-30 00:00:00, ended at 2020-04-30 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-04-30, presumably until 2020-04-30, with intended 1 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-03 00:00:00, ended at 2020-06-03 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- lidocaine 0.05 MG/MG Medicated Patch, started on 2020-06-03, presumably until 2021-02-05, with intended 6 refill(s). Instructions: Apply one patch daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-06-14 00:00:00, ended at 2020-06-14 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Cardiomyopathy\n\n### Drug\n- bumetanide 0.5 MG Oral Tablet, started on 2020-06-14, presumably until 2022-01-04, with intended 3 refill(s). Instructions: TAKE ONE TABLET BY MOUTH DAILY AS NEEDED for swelling (please allow 48 hours for refills)\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2020-08-01, presumably until 2021-01-09, with intended 11 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2020-07-31 00:00:00, ended at 2020-07-31 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Generalized anxiety disorder\n\n### Drug\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2020-08-01, presumably until 2021-06-21, with intended 1 refill(s). Instructions: take 1-2 Tabs (0.5-1 mg total) by mouth every 4 hours as needed\n- valacyclovir 500 MG Oral Tablet, started on 2020-08-01, presumably until 2021-01-09, with intended 1 refill(s). Instructions: 1To 2 TIMES A DAY FOR 1 MONTH DURING BREAKOUT\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-09-17 09:25:05, ended at 2020-09-17 09:54:27\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 102 (millimole per liter)\n- Creatinine [Mass/volume] in Urine: 45.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 22 (millimole per liter)\n- Cortisol Free [Mass/time] in 24 hour Urine: 15 (microgram per 24 hours)\n- Cortisol Free [Mass/volume] in Urine: 5 (microgram per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Metanephrine Free [Mass/volume] in Serum or Plasma: 15.4 (picogram per milliliter)\n- Body height: 5' 1\" (inch (US))\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Normetanephrine [Mass/volume] in Serum or Plasma: 101.4 (picogram per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-27 00:00:00, ended at 2020-09-27 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sleep apnea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-10-01 10:21:33, ended at 2020-10-01 10:47:25\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Disorder of adrenal gland\n- Steatosis of liver\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-12-16 00:00:00, ended at 2020-12-16 00:00:00\nThe patient in this visit was 44 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Chalazion\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2021-01-09 00:00:00, ended at 2021-01-09 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Mild intermittent asthma\n\n### Drug\n- valacyclovir 500 MG Oral Tablet, started on 2021-01-09, presumably until 2021-06-21, with intended 3 refill(s). Instructions: TAKE 1 TABLET BY MOUTH 2 TIMES A DAY FOR ONE MONTH DURING BREAKOUT\n- 200 ACTUAT ipratropium bromide 0.017 MG/ACTUAT Metered Dose Inhaler, started on 2021-01-09, presumably until 2021-06-21, with intended 10 refill(s). Instructions: INHALE 2 PUFFS BY MOUTH EVERY 4 TO 6 HOURS AS NEEDED\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-02-07 00:00:00, ended at 2021-02-07 00:00:00\nThe patient in this visit was 45 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Sciatica\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Depressive disorder within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of depressive_disorder means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "5a54a251c8fab7ff4520c8d2bb85622cc73b5c225566671138e0a6db41926e31", "prompt_hash": "33fde3cf2a05402413ba7afc599a914d5c3ca28fadfdb2a6104957361609afaf", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 3, "doc": {"person_id": 115968289, "visit_occurrence_id": 180707418, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2021-06-20 12:23:34", "visit_end_datetime": "2021-06-20 13:13:32", "visit_length_in_hours": 0.8327777777777777, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2021-06-20 12:23:34, ended at 2021-06-20 13:13:32\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n", "approximate_token_count": 89, "patient_first_visit_date": "2020-01-10 00:00:00", "patient_last_visit_date": "2022-10-21 13:54:00", "end_obs_date": "2022-06-20", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "recurrent", "prostate_cancer_one_year_diagnosis": 1, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 26, "cumulated_visit_num": 26, "cumulated_approximate_token_count": 6569, "visit_cumulated": "## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-10 00:00:00, ended at 2020-01-10 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-10 12:00:00, ended at 2020-01-10 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 10:51:00, ended at 2020-02-20 14:11:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2020-02-20, presumably until 2020-02-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Raised prostate specific antigen\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-21 09:54:00, ended at 2020-02-21 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n\n### Condition\n- Neoplasm of uncertain behavior of prostate\n- Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:56:20, ended at 2020-08-06 10:06:55\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-13 13:54:00, ended at 2020-08-13 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.0 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; radical prostatectomy (suprapubic, retropubic)\n- Venipuncture, age 3 years or older, necessitating the skill of a physician or other qualified health care professional (separate procedure), for diagnostic or therapeutic purposes (not to be used for routine venipuncture)\n\n### Condition\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Primary malignant neoplasm of prostate\n- Spermatocele\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- cefazolin 1000 MG Injection, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- ketamine 100 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- midazolam 1 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-14 10:44:00, ended at 2020-08-15 14:51:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Body height: 5' 11.5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n\n### Procedure\n- Excision of spermatocele, with or without epididymectomy\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing, includes robotic assistance, when performed\n- Laparoscopy, surgical; with bilateral total pelvic lymphadenectomy\n\n### Condition\n- Illness\n- Hydrocele of tunica vaginalis\n- Major depression, single episode\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Obstructive sleep apnea syndrome\n- Spermatocele\n- Primary malignant neoplasm of prostate\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2021-08-15, with intended 0 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth every 6 hours\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- cefazolin 1000 MG Injection, started on 2020-08-15, presumably until 2020-08-15\n- sodium chloride 9 MG/ML Injection, started on 2020-08-15, presumably until 2020-08-15\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2020-08-14, presumably until 2020-08-15\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-15\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2020-08-15, presumably until 2020-08-15\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-30 00:00:00, ended at 2020-09-30 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 0.67 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-11 00:00:00, ended at 2020-10-11 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-27 00:00:00, ended at 2020-11-27 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-24 00:00:00, ended at 2020-12-24 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.02 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-25 00:00:00, ended at 2020-12-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 08:18:34, ended at 2021-01-06 08:49:37\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-04-07, with intended 11 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n- tadalafil 5 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-07 09:15:17, ended at 2021-01-07 09:33:45\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-10 09:45:13, ended at 2021-01-10 11:37:05\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.496\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2022-09-15, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n- abiraterone acetate 250 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 4 Tabs (1,000 mg total) by mouth daily . Swallow tablets whole with water on an empty stomach.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-07 07:58:27, ended at 2021-04-07 08:24:07\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-04-07, presumably until 2022-04-07, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-07 00:00:00, ended at 2021-05-07 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.8 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Testosterone [Mass/volume] in Serum or Plasma: 472 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.36 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 41 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2534 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.6 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 21 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1046 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 459 (cells per microliter)\n- Nucleated erythrocytes [#/volume] in Blood: 0 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.6 (percent)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-05-13 15:14:07, ended at 2021-05-13 16:14:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 12:10:00, ended at 2021-06-10 14:26:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.52 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 261 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.3 (nanogram per milliliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 483 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 11.3 (microgram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 14:27:00, ended at 2021-06-10 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of prostate\n- Raised prostate specific antigen\n- Abnormal findings on diagnostic imaging of lung\n- Imaging of musculoskeletal system abnormal\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-17 12:05:23, ended at 2021-06-17 12:39:30\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-20 12:23:34, ended at 2021-06-20 13:13:32\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Depressive disorder within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-01-10 00:00:00, ended at 2020-01-10 00:00:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-01-10 12:00:00, ended at 2020-01-10 23:59:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Consultation and report on referred slides prepared elsewhere\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 10:51:00, ended at 2020-02-20 14:11:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, pelvis; without contrast material(s), followed by contrast material(s) and further sequences\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2020-02-20, presumably until 2020-02-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Abnormal findings on diagnostic imaging of lung\n- Raised prostate specific antigen\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-20 14:12:00, ended at 2020-02-20 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-02-21 09:54:00, ended at 2020-02-21 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- 3D rendering with interpretation and reporting of computed tomography, magnetic resonance imaging, ultrasound, or other tomographic modality with image postprocessing under concurrent supervision; requiring image postprocessing on an independent workstati\n\n### Condition\n- Neoplasm of uncertain behavior of prostate\n- Illness\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2020-08-06 08:56:20, ended at 2020-08-06 10:06:55\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-13 13:54:00, ended at 2020-08-13 23:59:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.6 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Globulin [Mass/volume] in Serum: 2.2 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.6 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 223 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.78 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.86 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 24 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 32.6 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.0 (percent)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Protein [Mass/volume] in Serum or Plasma: 6.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.7 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- bupivacaine hydrochloride 2.5 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2020-08-14 00:00:00, ended at 2020-08-14 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for extraperitoneal procedures in lower abdomen, including urinary tract; radical prostatectomy (suprapubic, retropubic)\n- Venipuncture, age 3 years or older, necessitating the skill of a physician or other qualified health care professional (separate procedure), for diagnostic or therapeutic purposes (not to be used for routine venipuncture)\n\n### Condition\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Primary malignant neoplasm of prostate\n- Spermatocele\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- calcium gluconate 100 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- cefazolin 1000 MG Injection, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML lidocaine hydrochloride 20 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- 2 ML ondansetron 2 MG/ML Injection, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- ketamine 100 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- midazolam 1 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2020-08-14 10:44:00, ended at 2020-08-15 14:51:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 16 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.9 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.11 (million per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 197 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.7 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 202 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Body height: 5' 11.5\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.82 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 32.4 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.1 (femtoliter)\n\n### Procedure\n- Excision of spermatocele, with or without epididymectomy\n- Collection of venous blood by venipuncture\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Level V - Surgical pathology, gross and microscopic examination Adrenal, resection Bone - biopsy/curettings Bone fragment(s), pathologic fracture Brain, biopsy Brain/meninges, tumor resection Breast, excision of lesion, requiring microscopic evaluation of\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Laparoscopy, surgical prostatectomy, retropubic radical, including nerve sparing, includes robotic assistance, when performed\n- Laparoscopy, surgical; with bilateral total pelvic lymphadenectomy\n\n### Condition\n- Illness\n- Hydrocele of tunica vaginalis\n- Major depression, single episode\n- Secondary malignant neoplasm of intrapelvic lymph nodes\n- Obstructive sleep apnea syndrome\n- Spermatocele\n- Primary malignant neoplasm of prostate\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2021-08-15, with intended 0 refill(s). Instructions: take 2 Tabs (1,000 mg total) by mouth every 6 hours\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2020-08-14, presumably until 2020-08-14\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- cefazolin 1000 MG Injection, started on 2020-08-15, presumably until 2020-08-15\n- sodium chloride 9 MG/ML Injection, started on 2020-08-15, presumably until 2020-08-15\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2020-08-14, presumably until 2020-08-15\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2020-08-14, presumably until 2020-08-15\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2020-08-14, presumably until 2020-08-14\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2020-08-14, presumably until 2020-08-15\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2020-08-15, presumably until 2020-08-15\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2020-08-14, presumably until 2020-08-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-09-30 00:00:00, ended at 2020-09-30 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 0.67 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-10-11 00:00:00, ended at 2020-10-11 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-11-27 00:00:00, ended at 2020-11-27 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n- Solitary nodule of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-24 00:00:00, ended at 2020-12-24 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.02 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2020-12-25 00:00:00, ended at 2020-12-25 00:00:00\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-06 08:18:34, ended at 2021-01-06 08:49:37\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-04-07, with intended 11 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n- tadalafil 5 MG Oral Tablet, through Oral route, started on 2021-01-06, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth every bedtime\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-07 09:15:17, ended at 2021-01-07 09:33:45\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal findings on diagnostic imaging of lung\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-01-10 09:45:13, ended at 2021-01-10 11:37:05\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.496\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2022-09-15, with intended 11 refill(s). Instructions: take 1 Tab (5 mg total) by mouth 2 times a day\n- abiraterone acetate 250 MG Oral Tablet, through Oral route, started on 2021-01-15, presumably until 2021-07-07, with intended 11 refill(s). Instructions: take 4 Tabs (1,000 mg total) by mouth daily . Swallow tablets whole with water on an empty stomach.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-04-07 07:58:27, ended at 2021-04-07 08:24:07\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- sildenafil 100 MG Oral Tablet, through Oral route, started on 2021-04-07, presumably until 2022-04-07, with intended 3 refill(s). Instructions: take 1 Tab (100 mg total) by mouth as needed Take 1/2 tab 1 hour prior to sexual intercourse. Increase to full tab as needed.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2021-05-07 00:00:00, ended at 2021-05-07 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin/Globulin [Mass Ratio] in Serum or Plasma: 1.8 (calculated)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 84 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.9 (percent)\n- Testosterone [Mass/volume] in Serum or Plasma: 472 (nanogram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma by Detection limit <= 0.01 ng/mL: 1.36 (nanogram per milliliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 41 (cells per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.51 (million per liter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.1 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2534 (cells per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.6 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.72 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 253 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- Platelet mean volume [Entitic volume] in Blood by Rees-Ecker: 10.6 (femtoliter)\n- Urea nitrogen/Creatinine [Mass Ratio] in Serum or Plasma: NOT APPLICABLE (calculated)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 2.5 (gram per deciliter calculated)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 21 (cells per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1046 (cells per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Monocytes [#/volume] in Blood by Automated count: 459 (cells per microliter)\n- Nucleated erythrocytes [#/volume] in Blood: 0 (cells per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 11.6 (percent)\n- MCV [Entitic volume] by Automated count: 95.1 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-05-13 15:14:07, ended at 2021-05-13 16:14:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 12:10:00, ended at 2021-06-10 14:26:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 3.52 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.80 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.1 (picogram)\n- MCV [Entitic volume] by Automated count: 98.2 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 261 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 82 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Prostate specific Ag [Mass/volume] in Serum or Plasma: 1.3 (nanogram per milliliter)\n- Testosterone [Mass/volume] in Serum or Plasma: 483 (nanogram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Cortisol [Mass/volume] in Serum or Plasma: 11.3 (microgram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 92 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.4 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.5 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 24 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.3 (percent)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2021-06-10 14:27:00, ended at 2021-06-10 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Primary malignant neoplasm of prostate\n- Raised prostate specific antigen\n- Abnormal findings on diagnostic imaging of lung\n- Imaging of musculoskeletal system abnormal\n\n### Drug\n\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2021-06-17 12:05:23, ended at 2021-06-17 12:39:30\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2021-06-20 12:23:34, ended at 2021-06-20 13:13:32\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Primary malignant neoplasm of prostate\n\n### Drug\n- No drugs.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Depressive disorder within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of depressive_disorder means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "c481ef563b30a2b17b7f1475d3c02917a852c9c6bfa8f4133c30241b30d96a54", "prompt_hash": "34a9b441060330479ebcb2b432c3c8510acfce635e5f7adcdc4aab08c12cb237", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 4, "doc": {"person_id": 115968945, "visit_occurrence_id": 41847305, "death_date": null, "visit_concept_name": "Emergency Room and Inpatient Visit", "visit_start_datetime": "2010-11-30 16:02:00", "visit_end_datetime": "2010-12-05 11:55:00", "visit_length_in_hours": 115.88333333333334, "integrated_visit_record": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n", "approximate_token_count": 2316, "patient_first_visit_date": "2008-07-01 02:25:00", "patient_last_visit_date": "2013-11-26 07:55:00", "end_obs_date": "2011-12-05", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 1, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "recurrent", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 1, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "recurrent", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "recurrent", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 50, "cumulated_visit_num": 50, "cumulated_approximate_token_count": 16603, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-01 02:25:00, ended at 2008-07-07 17:35:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.77 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- MCV [Entitic volume] by Automated count: 81.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Base deficit in Blood: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 58.3 (second)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' .11\" (inch (US))\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Osmolality of Urine: 462 (milliosmole per kilogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Essential hypertension\n- Iron deficiency anemia\n- Infective pneumonia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2008-07-01, presumably until 2008-07-02\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2008-07-01, presumably until 2008-07-07\n- haloperidol 5 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2008-07-04, presumably until 2008-07-04\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 15.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 8 hours as needed 1-2 tab prn nausea q6hr \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-01-03, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-06\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-07\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2008-07-05, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Packets by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-07-01, presumably until 2008-07-07\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2008-07-02, presumably until 2009-07-07, with intended 0 refill(s). Instructions: 3 mL by Inhalation route every 4 hours. \n- 10 ML furosemide 10 MG/ML Injection, started on 2008-07-04, presumably until 2008-07-04\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2008-07-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2008-07-06, presumably until 2008-07-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2008-07-01, presumably until 2008-07-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-07-05, presumably until 2008-07-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-01\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2008-07-02, presumably until 2009-01-03, with quantity of 120.0, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 hours as needed for Diarrhea. \n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2008-07-06, presumably until 2008-07-06\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-07-01, presumably until 2008-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-07-03, presumably until 2008-07-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-04, presumably until 2009-01-03, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2008-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 07:41:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-24 07:27:00, ended at 2009-10-24 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Iron deficiency anemia\n\n### Drug\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-10-24, presumably until 2009-10-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-02 08:06:18, ended at 2010-01-02 12:05:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2011-01-02, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 08:19:00, ended at 2010-01-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 496 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.74 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 367 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-08 00:00:00, ended at 2010-01-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 08:10:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-27 08:43:00, ended at 2010-01-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Hematochezia\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 08:02:34, ended at 2010-02-13 09:09:37\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Disorder of plasma protein metabolism\n- Left lower quadrant pain\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-28 06:26:00, ended at 2010-02-28 08:03:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report\n\n### Condition\n- Abdominal pain\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- vitamin E 90 MG Oral Tablet, through Oral route, presumably until 2013-05-28. Instructions: take by mouth. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2010-09-28. Instructions: take by mouth. \n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2010-12-07. Instructions: take 150 mg by mouth every bedtime. \n- morphine sulfate 10 MG Extended Release Oral Capsule, through Oral route, presumably until 2010-06-27. Instructions: take by mouth. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- zolpidem tartrate 12.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2010-02-28, presumably until 2010-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-06 08:51:00, ended at 2010-03-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Abdominal aortic aneurysm\n- Abdominal pain\n- Disorder of biliary tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-03-09 00:00:00, ended at 2010-03-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of intestine\n- Generalized abdominal pain\n- Iron deficiency anemia\n- Disorder of plasma protein metabolism\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-29 07:00:00, ended at 2010-03-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Generalized abdominal pain\n- Disorder of lung\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Abdominal aortic aneurysm\n- Disorder of biliary tract\n- Disorder of intestine\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-03 13:36:57, ended at 2010-04-03 14:59:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of biliary tract\n- Angiodysplasia of intestine\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 15:02:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 427 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Prothrombin time (PT): 14.3 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Angiodysplasia of intestine\n- Left lower quadrant pain\n- Diarrhea\n- Disorder of biliary tract\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Disorder of intestine\n- Generalized abdominal pain\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-04-09 17:45:00, ended at 2010-04-10 00:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 406 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.8 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Malaise\n- Dehydration\n- Cerebellar ataxia\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-17 11:35:32, ended at 2010-04-17 13:01:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 12:56:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.1 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: <2 (nanogram per milliliter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.28 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 15.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 11.74 (thousand per microliter)\n- Prothrombin time (PT): 14.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 15 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; molecular isolation or extraction, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-19 14:39:15, ended at 2010-06-19 16:42:24\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-27 11:46:00, ended at 2010-06-27 16:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Abdominal pain\n- Gastrojejunal ulcer without hemorrhage AND without perforation but with obstruction\n- Postprocedural state finding\n- Nausea and vomiting\n- Ulceration of intestine\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-06-27, presumably until 2010-06-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-06-27, presumably until 2010-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-07 08:36:00, ended at 2010-07-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-28 08:03:00, ended at 2010-07-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulceration of intestine\n- Postprocedural state finding\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-07-28 18:00:00, ended at 2010-07-28 19:19:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure reading\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 07:20:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Postgastric surgery syndrome\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-08 00:00:00, ended at 2010-08-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-11 08:11:00, ended at 2010-08-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Abdominal pain\n- Primary malignant neoplasm of colon\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-25 07:52:00, ended at 2010-08-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-30 10:19:00, ended at 2010-08-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-09-05 06:05:00, ended at 2010-09-12 12:15:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- Enteral infusion of concentrated nutritional substances\n- Collection of venous blood by venipuncture\n- Other enterostomy\n- Exploratory laparotomy\n\n### Condition\n- Depressive disorder\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Abdominal pain\n- Left lower quadrant pain\n- Malnutrition (calorie)\n- Adult failure to thrive syndrome\n- Chronic pain\n- Disorder of plasma protein metabolism\n- Disorder of function of stomach\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Benign essential hypertension\n- Vascular insufficiency of intestine\n- Abnormality of secretion of gastrin\n- Diarrhea\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-08\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-09-09, presumably until 2010-09-09\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2010-09-12, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2010-09-10, presumably until 2010-09-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-12-05, with quantity of 120.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-09\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11. Instructions: take 50 mg by mouth every bedtime.\n- heparin sodium, porcine 5000 UNT/ML Injectable Solution, through Intravenous route, started on 2010-09-05, presumably until 2010-09-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-09-06, presumably until 2010-09-11\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2010-09-10, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-11-17, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-18 09:43:58, ended at 2010-09-18 12:24:03\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 08:39:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-25 08:15:04, ended at 2010-09-25 08:49:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; more than 7 lesions\n- Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)\n\n### Condition\n- Periumbilical pain\n- Left lower quadrant pain\n- Abdominal pain\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2010-09-25, presumably until 2010-09-26, with quantity of 1.0, with intended 0 refill(s). Instructions: 20 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-09-28 18:19:00, ended at 2010-09-28 20:19:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication of internal prosthetic device\n- Late effect of complications of procedure\n\n### Drug\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. 4 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 15:00:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Postgastric surgery syndrome\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-10 08:16:54, ended at 2010-10-10 16:33:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- opium tincture 100 MG/ML Oral Solution, through Oral route, presumably until 2010-11-30. Instructions: take by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-13 15:55:35, ended at 2010-10-13 16:51:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n- Injection or infusion of other therapeutic or prophylactic substance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s); single or multiple trigger point(s), 3 or more muscles\n- Ultrasonography of digestive system\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Application of a modality to 1 or more areas; ultrasound, each 15 minutes\n\n### Condition\n- Stoma malfunction\n- Primary diagnosis: Abdominal pain\n- Chronic postoperative pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-10-17 12:11:00, ended at 2010-10-17 18:37:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Postgastric surgery syndrome\n- Intestinal volvulus\n- Abdominal pain\n- Disorder of biliary tract\n- Intestinal obstruction\n- Nausea and vomiting\n- Lumbosacral spondylosis without myelopathy\n- Abdominal aortic aneurysm\n- Imaging of gastrointestinal tract abnormal\n- Left lower quadrant pain\n- Vomiting\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, presumably until 2010-11-30. Instructions: take 1 Tab by mouth daily. \n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-10-17, presumably until 2010-10-17\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-10-17, presumably until 2010-10-17\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, presumably until 2011-03-06. Instructions: take 200 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 08:42:00, ended at 2010-10-20 09:47:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Disorder of plasma protein metabolism\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 09:48:00, ended at 2010-10-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postgastric surgery syndrome\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:22:00, ended at 2010-10-25 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of aorta\n- Disorder of biliary tract\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:27:00, ended at 2010-10-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of biliary tract\n- Atherosclerosis of aorta\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-06 14:36:24, ended at 2010-11-06 16:10:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-07 10:55:00, ended at 2010-11-07 14:38:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Stoma malfunction\n\n### Drug\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-07, presumably until 2010-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-10 15:48:00, ended at 2010-11-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-15 09:46:00, ended at 2010-11-15 15:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Mechanical complication of gastrostomy\n- Stoma malfunction\n- Nausea and vomiting\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-17 00:00:00, ended at 2010-11-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2010-11-17, presumably until 2010-11-30, with quantity of 1.0, with intended 0 refill(s). Instructions: 100 Units by Injection route One Time. For delivery from Los Altos Pharmacy for self-pay scar injection \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 08:15:01, ended at 2010-11-17 09:14:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take 5 mg by mouth. 1 tab  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-22 09:29:48, ended at 2010-11-22 16:34:58\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-22 16:40:00, ended at 2010-11-22 21:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Syncope and collapse\n- Diarrhea\n- Chronic pain\n- Chronic peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Generalized abdominal pain\n- Primary diagnosis: Seizure\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-22, presumably until 2010-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Depressive disorder within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2008-07-01 02:25:00, ended at 2008-07-07 17:35:00\nThe patient in this visit was 58 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Potassium [Moles/volume] in Blood: 4.1 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 1.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 109 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood by calculation: 10.5 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.77 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 45 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood: 31 (percent)\n- MCV [Entitic volume] by Automated count: 81.9 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.0 (percent)\n- Prothrombin time (PT): 20.0 (second)\n- Base deficit in Blood: 6.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 34 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.22 (millimole per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 37.9 (millimeter mercury column)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 82 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 58.3 (second)\n- Base excess in Blood by calculation: 4.0 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.83 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 495 (thousand per microliter)\n- Sodium [Moles/volume] in Blood: 138 (millimole per liter)\n- Body height: 5' .11\" (inch (US))\n- Monocytes [#/volume] in Blood by Automated count: 0.87 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.8 (ratio)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bicarbonate [Moles/volume] in Specimen: 26.9 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 26.5 (picogram)\n- Osmolality of Urine: 462 (milliosmole per kilogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Essential hypertension\n- Iron deficiency anemia\n- Infective pneumonia\n\n### Drug\n- 200 ACTUAT albuterol 0.09 MG/ACTUAT / ipratropium bromide 0.018 MG/ACTUAT Inhalation Spray, through Inhalation, started on 2008-07-01, presumably until 2008-07-02\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-02\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2008-07-01, presumably until 2008-07-07\n- haloperidol 5 MG/ML Injectable Solution, started on 2008-07-03, presumably until 2008-07-03\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2008-07-04, presumably until 2008-07-04\n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-07-07, with quantity of 15.0, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every 8 hours as needed 1-2 tab prn nausea q6hr \n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-05\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2009-01-03, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ceftriaxone 1000 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-06\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- pantoprazole 40 MG Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-07\n- potassium chloride 20 MEQ Powder for Oral Solution, through Oral route, started on 2008-07-05, presumably until 2009-07-07, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Packets by mouth daily. \n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2008-07-01, presumably until 2008-07-07\n- lidocaine hydrochloride 10 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-02\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2008-07-02, presumably until 2009-07-07, with intended 0 refill(s). Instructions: 3 mL by Inhalation route every 4 hours. \n- 10 ML furosemide 10 MG/ML Injection, started on 2008-07-04, presumably until 2008-07-04\n- levofloxacin 750 MG Oral Tablet, through Oral route, started on 2008-07-07, presumably until 2008-07-07, with quantity of 10.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- potassium chloride 1.33 MEQ/ML Oral Solution, through Oral route, started on 2008-07-06, presumably until 2008-07-07\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-07\n- acetaminophen 32 MG/ML Oral Solution, through Oral route, started on 2008-07-01, presumably until 2008-07-06\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2008-07-05, presumably until 2008-07-05\n- 10 ML etomidate 2 MG/ML Injection, through Intravenous route, started on 2008-07-01, presumably until 2008-07-01\n- opium tincture 100 MG/ML Oral Solution, through Oral route, started on 2008-07-02, presumably until 2009-01-03, with quantity of 120.0, with intended 0 refill(s). Instructions: take 5 mL by mouth every 4 hours as needed for Diarrhea. \n- succinylcholine chloride 20 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 150 ML levofloxacin 5 MG/ML Injection, through Intravenous route, started on 2008-07-06, presumably until 2008-07-06\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2008-07-01, presumably until 2008-07-01\n- midazolam 1 MG/ML Injectable Solution, started on 2008-07-01, presumably until 2008-07-01\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2008-07-03, presumably until 2008-07-06\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2008-07-04, presumably until 2009-01-03, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 6 hours as needed for Pain. \n- zolpidem tartrate 10 MG Oral Tablet, through Oral route, started on 2008-07-06, presumably until 2008-07-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-10 07:41:00, ended at 2009-10-10 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Essential hypertension\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-24 07:27:00, ended at 2009-10-24 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Iron deficiency anemia\n\n### Drug\n- lidocaine 40 MG/ML Topical Cream, through Topical route, started on 2009-10-24, presumably until 2009-10-24\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-01-02 08:06:18, ended at 2010-01-02 12:05:21\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2011-01-02, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-04 08:19:00, ended at 2010-01-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 496 (picogram per milliliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 1.74 (micro-international unit per milliliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 31 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 367 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 55 (unit per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-01-08 00:00:00, ended at 2010-01-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 08:10:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-27 08:43:00, ended at 2010-01-27 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Hematochezia\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Diarrhea\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-13 08:02:34, ended at 2010-02-13 09:09:37\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n- Disorder of plasma protein metabolism\n- Left lower quadrant pain\n- Iron deficiency anemia\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-28 06:26:00, ended at 2010-02-28 08:03:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 10\" (inch (US))\n\n### Procedure\n- Other nonoperative measurements and examinations\n- Gastrointestinal tract imaging, intraluminal (eg, capsule endoscopy), esophagus through ileum, with interpretation and report\n\n### Condition\n- Abdominal pain\n\n### Drug\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- promethazine hydrochloride 25 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- vitamin E 90 MG Oral Tablet, through Oral route, presumably until 2013-05-28. Instructions: take by mouth. \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- escitalopram 10 MG Oral Tablet, through Oral route, presumably until 2010-09-28. Instructions: take by mouth. \n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, presumably until 2010-12-07. Instructions: take 150 mg by mouth every bedtime. \n- morphine sulfate 10 MG Extended Release Oral Capsule, through Oral route, presumably until 2010-06-27. Instructions: take by mouth. \n- metoclopramide 5 MG Oral Tablet, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- zolpidem tartrate 12.5 MG Extended Release Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. \n- simethicone 66.7 MG/ML Oral Suspension, through Oral route, started on 2010-02-28, presumably until 2010-02-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-06 08:51:00, ended at 2010-03-06 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Abdominal aortic aneurysm\n- Abdominal pain\n- Disorder of biliary tract\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2010-03-09 00:00:00, ended at 2010-03-09 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of intestine\n- Generalized abdominal pain\n- Iron deficiency anemia\n- Disorder of plasma protein metabolism\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-29 07:00:00, ended at 2010-03-29 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Generalized abdominal pain\n- Disorder of lung\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Abdominal aortic aneurysm\n- Disorder of biliary tract\n- Disorder of intestine\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-03 13:36:57, ended at 2010-04-03 14:59:22\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of biliary tract\n- Angiodysplasia of intestine\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-03 15:02:00, ended at 2010-04-03 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 37 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.85 (million per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.42 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.8 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- MCH [Entitic mass] by Automated count: 24.4 (picogram)\n- Eosinophils [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- MCV [Entitic volume] by Automated count: 77.9 (femtoliter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- MCHC [Mass/volume] by Automated count: 31.4 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.34 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 427 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 70.7 (percent)\n- Prothrombin time (PT): 14.3 (second)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 17.0 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Angiodysplasia of intestine\n- Left lower quadrant pain\n- Diarrhea\n- Disorder of biliary tract\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Disorder of intestine\n- Generalized abdominal pain\n- Edema\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-04-09 17:45:00, ended at 2010-04-10 00:15:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 24.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 31.2 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 155 (unit per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.07 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.25 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 87 (unit per liter)\n- MCV [Entitic volume] by Automated count: 77.3 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 406 (thousand per microliter)\n- Prothrombin time (PT): 13.6 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.4 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.89 (million per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 5.7 (gram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 79 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 144 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.8 (second)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 68.0 (percent)\n\n### Procedure\n- Computed tomography, head or brain; without contrast material\n- Computed tomographic angiography, neck, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Computed tomographic angiography, head, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n\n### Condition\n- Malaise\n- Dehydration\n- Cerebellar ataxia\n\n### Drug\n- esomeprazole 40 MG Delayed Release Oral Capsule, through Oral route, presumably until 2010-09-12. Instructions: take by mouth. \n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 2 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-04-09, presumably until 2010-04-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-04-17 11:35:32, ended at 2010-04-17 13:01:03\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 5\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-04-17 12:56:00, ended at 2010-04-17 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Complement C3 [Mass/volume] in Serum or Plasma: 136 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 29 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Homocysteine [Moles/volume] in Serum or Plasma: 5.1 (micromole per liter)\n- MCHC [Mass/volume] by Automated count: 31.0 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.0 (percent)\n- Alpha-1-fetoprotein.tumor marker [Mass/volume] in Serum or Plasma: <2 (nanogram per milliliter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 41 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.8 (ratio)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 175 (unit per liter)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 343 (microgram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 76.0 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.28 (micro-international unit per milliliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lipoprotein a [Mass/volume] in Serum or Plasma: 15.1 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 23.5 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 11.74 (thousand per microliter)\n- Prothrombin time (PT): 14.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 84 (milligram per deciliter)\n- Erythrocyte sedimentation rate: 34 (millimeter per hour)\n- Ferritin [Mass/volume] in Serum or Plasma: 6 (nanogram per milliliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.66 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 152 (unit per liter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 171 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 286 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 62 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 15 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.1 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.2 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n- Molecular diagnostics; molecular isolation or extraction, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Molecular diagnostics; interpretation and report\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-06-19 14:39:15, ended at 2010-06-19 16:42:24\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-06-27 11:46:00, ended at 2010-06-27 16:42:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 9\" (inch (US))\n\n### Procedure\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n- Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple\n- Endoscopy and biopsy of upper gastrointestinal tract\n\n### Condition\n- Abdominal pain\n- Gastrojejunal ulcer without hemorrhage AND without perforation but with obstruction\n- Postprocedural state finding\n- Nausea and vomiting\n- Ulceration of intestine\n\n### Drug\n- benzocaine 140 MG/ML / butamben 20 MG/ML / tetracaine 20 MG/ML Mucosal Spray, through Topical route, started on 2010-06-27, presumably until 2010-06-27\n- midazolam 1 MG/ML Injectable Solution, started on 2010-06-27, presumably until 2010-06-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-07 08:36:00, ended at 2010-07-07 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postgastric surgery syndrome\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-07-28 08:03:00, ended at 2010-07-28 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Ulceration of intestine\n- Postprocedural state finding\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-07-28 18:00:00, ended at 2010-07-28 19:19:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Low blood pressure reading\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-04 07:20:00, ended at 2010-08-04 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, thorax, diagnostic; with contrast material(s)\n\n### Condition\n- Postgastric surgery syndrome\n- Primary malignant neoplasm of colon\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2010-08-08 00:00:00, ended at 2010-08-08 00:00:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-11 08:11:00, ended at 2010-08-11 23:59:00\nThe patient in this visit was 60 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, gastrointestinal tract, upper; with small intestine, includes multiple serial images\n\n### Condition\n- Abdominal pain\n- Primary malignant neoplasm of colon\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Postgastric surgery syndrome\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-25 07:52:00, ended at 2010-08-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postprocedural state finding\n- Ulceration of intestine\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-08-30 10:19:00, ended at 2010-08-30 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n\n### Condition\n- Lung field abnormal\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2010-09-05 06:05:00, ended at 2010-09-12 12:15:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.5 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.71 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 41.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 335 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 6 (milligram per deciliter)\n- Body height: 5' 10\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 8.6 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.0 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 23.5 (percent)\n- MCV [Entitic volume] by Automated count: 87.9 (femtoliter)\n\n### Procedure\n- Enteral infusion of concentrated nutritional substances\n- Collection of venous blood by venipuncture\n- Other enterostomy\n- Exploratory laparotomy\n\n### Condition\n- Depressive disorder\n- Iron deficiency anemia\n- Postgastric surgery syndrome\n- Abdominal pain\n- Left lower quadrant pain\n- Malnutrition (calorie)\n- Adult failure to thrive syndrome\n- Chronic pain\n- Disorder of plasma protein metabolism\n- Disorder of function of stomach\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Benign essential hypertension\n- Vascular insufficiency of intestine\n- Abnormality of secretion of gastrin\n- Diarrhea\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-08\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2010-09-09, presumably until 2010-09-09\n- calcium carbonate 1000 MG Chewable Tablet, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take 1 Tab by mouth daily.\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11\n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, started on 2010-09-12, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 12 hours. \n- 1 ML ketorolac tromethamine 30 MG/ML Injection, started on 2010-09-10, presumably until 2010-09-11\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-12-05, with quantity of 120.0, with intended 1 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12. Instructions: take by mouth.\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2010-09-05, presumably until 2010-09-09\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-11. Instructions: take 50 mg by mouth every bedtime.\n- heparin sodium, porcine 5000 UNT/ML Injectable Solution, through Intravenous route, started on 2010-09-05, presumably until 2010-09-05\n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2010-09-09, presumably until 2010-09-11\n- heparin sodium, porcine 10000 UNT/ML Injectable Solution, started on 2010-09-06, presumably until 2010-09-11\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-09-06, presumably until 2010-09-12\n- 12 HR oxycodone hydrochloride 10 MG Extended Release Oral Tablet, through Oral route, started on 2010-09-10, presumably until 2010-09-28, with quantity of 120.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 12 hours. \n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-09-05, presumably until 2010-09-11\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-09-09, presumably until 2010-11-17, with quantity of 100.0, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-18 09:43:58, ended at 2010-09-18 12:24:03\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 6\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-22 08:39:00, ended at 2010-09-22 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-09-25 08:15:04, ended at 2010-09-25 08:49:16\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection, intralesional; more than 7 lesions\n- Injection(s); single or multiple trigger point(s), 1 or 2 muscle(s)\n\n### Condition\n- Periumbilical pain\n- Left lower quadrant pain\n- Abdominal pain\n\n### Drug\n- bupivacaine hydrochloride 5 MG/ML Injectable Solution, started on 2010-09-25, presumably until 2010-09-26, with quantity of 1.0, with intended 0 refill(s). Instructions: 20 mL by Injection route One Time. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-09-28 18:19:00, ended at 2010-09-28 20:19:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Complication of internal prosthetic device\n- Late effect of complications of procedure\n\n### Drug\n- methadone hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take by mouth. 4 tabs daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-09-29 15:00:00, ended at 2010-09-29 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Postgastric surgery syndrome\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-10 08:16:54, ended at 2010-10-10 16:33:28\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- opium tincture 100 MG/ML Oral Solution, through Oral route, presumably until 2010-11-30. Instructions: take by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-10-13 15:55:35, ended at 2010-10-13 16:51:27\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n- Injection or infusion of other therapeutic or prophylactic substance\n- Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation\n- Injection(s); single or multiple trigger point(s), 3 or more muscles\n- Ultrasonography of digestive system\n- Injection of anesthetic agent into peripheral nerve for analgesia\n- Application of a modality to 1 or more areas; ultrasound, each 15 minutes\n\n### Condition\n- Stoma malfunction\n- Primary diagnosis: Abdominal pain\n- Chronic postoperative pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-10-17 12:11:00, ended at 2010-10-17 18:37:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 64 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Globulin [Mass/volume] in Serum: 4.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.09 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.6 (percent)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.50 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.84 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.3 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCV [Entitic volume] by Automated count: 88.8 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 82.2 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 214 (unit per liter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.49 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 113 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 358 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.61 (thousand per microliter)\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of a new substance/drug (List separately in addition to code for primary procedure)\n- Computed tomography, pelvis; with contrast material(s)\n- Computed tomography, abdomen; with contrast material(s)\n- Radiologic examination, abdomen; complete, including decubitus and/or erect views\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n\n### Condition\n- Postgastric surgery syndrome\n- Intestinal volvulus\n- Abdominal pain\n- Disorder of biliary tract\n- Intestinal obstruction\n- Nausea and vomiting\n- Lumbosacral spondylosis without myelopathy\n- Abdominal aortic aneurysm\n- Imaging of gastrointestinal tract abnormal\n- Left lower quadrant pain\n- Vomiting\n\n### Drug\n- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet, through Oral route, presumably until 2010-11-30. Instructions: take 1 Tab by mouth daily. \n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-10-17, presumably until 2010-10-17\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route. Instructions: take 1 Cap by mouth daily.\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2010-10-17, presumably until 2010-10-17\n- megestrol acetate 40 MG/ML Oral Suspension, through Oral route, presumably until 2011-03-06. Instructions: take 200 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 08:42:00, ended at 2010-10-20 09:47:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Abdominal pain\n- Disorder of plasma protein metabolism\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-20 09:48:00, ended at 2010-10-20 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.1 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 176 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 48 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 184 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Postgastric surgery syndrome\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:22:00, ended at 2010-10-25 10:26:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atherosclerosis of aorta\n- Disorder of biliary tract\n- Kidney stone\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-10-25 10:27:00, ended at 2010-10-25 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Duplex scan of arterial inflow and venous outflow of abdominal, pelvic, scrotal contents and/or retroperitoneal organs; limited study\n- Ultrasound, abdominal, real time with image documentation; complete\n- Magnetic resonance (eg, proton) imaging, abdomen; without contrast material(s), followed by with contrast material(s) and further sequences\n\n### Condition\n- Disorder of biliary tract\n- Atherosclerosis of aorta\n- Abdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-06 14:36:24, ended at 2010-11-06 16:10:47\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 4\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal pain\n- Peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-07 10:55:00, ended at 2010-11-07 14:38:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Stoma malfunction\n\n### Drug\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-07, presumably until 2010-11-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-11-10 15:48:00, ended at 2010-11-10 23:59:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Disorder of plasma protein metabolism\n- Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-15 09:46:00, ended at 2010-11-15 15:32:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Attention to gastrostomy\n- Change of gastrostomy tube, percutaneous, without imaging or endoscopic guidance\n- Radiologic examination, abdomen; single anteroposterior view\n\n### Condition\n- Gastrojejunal ulcer without hemorrhage, without perforation AND without obstruction\n- Mechanical complication of gastrostomy\n- Stoma malfunction\n- Nausea and vomiting\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2010-11-15, presumably until 2010-11-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-11-17 00:00:00, ended at 2010-11-17 00:00:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- onabotulinumtoxinA 100 UNT Injection, started on 2010-11-17, presumably until 2010-11-30, with quantity of 1.0, with intended 0 refill(s). Instructions: 100 Units by Injection route One Time. For delivery from Los Altos Pharmacy for self-pay scar injection \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-17 08:15:01, ended at 2010-11-17 09:14:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Mononeuritis\n\n### Drug\n- methadone hydrochloride 5 MG Oral Tablet, through Oral route, presumably until 2010-12-05. Instructions: take 5 mg by mouth. 1 tab  \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-11-22 09:29:48, ended at 2010-11-22 16:34:58\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Injection(s), anesthetic agent(s) and/or steroid; other peripheral nerve or branch\n\n### Condition\n- Primary diagnosis: Abdominal pain\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2010-11-22 16:40:00, ended at 2010-11-22 21:03:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 235 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.3 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- MCV [Entitic volume] by Automated count: 91.6 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.24 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.38 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.11 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 12 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 4.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 89.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.45 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Computed tomography, head or brain; without contrast material\n- Radiologic examination, chest; single view, frontal\n\n### Condition\n- Syncope and collapse\n- Diarrhea\n- Chronic pain\n- Chronic peptic ulcer without hemorrhage, without perforation AND without obstruction\n- Generalized abdominal pain\n- Primary diagnosis: Seizure\n\n### Drug\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-11-22, presumably until 2010-11-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2010-11-30 16:02:00, ended at 2010-12-05 11:55:00\nThe patient in this visit was 61 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 49 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma: 2.3 (picogram per milliliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.2 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Thyroperoxidase Ab [Units/volume] in Serum or Plasma: 11.5 (unit per milliliter)\n- 25-hydroxyvitamin D3 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Body height: 5' 9\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Ceruloplasmin [Mass/volume] in Serum or Plasma: 32 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.95 (thousand per microliter)\n- Calciferol (Vit D2) [Mass/volume] in Serum or Plasma: <4 (nanogram per milliliter)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 292 (picogram per milliliter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 44.1 (percent)\n- Iron binding capacity [Mass/volume] in Serum or Plasma: 276 (microgram per deciliter)\n- Iron saturation [Mass Fraction] in Serum or Plasma: 8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.8 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.9 (picogram)\n- aPTT in Platelet poor plasma by Coagulation assay: 35.7 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.73 (million per microliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.4 (ratio)\n- Iron [Mass/volume] in Serum or Plasma: 23 (microgram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.5 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 179 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Ferritin [Mass/volume] in Serum or Plasma: 14 (nanogram per milliliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.3 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.5 (percent)\n- Prothrombin time (PT): 16.2 (second)\n- Sodium [Moles/volume] in Serum or Plasma: 145 (millimole per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma: 127 (unit per liter)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 0.8 (nanogram per deciliter)\n- 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma: 21 (nanogram per milliliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.2 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 111 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 85.1 (percent)\n- Platelets [#/volume] in Blood by Automated count: 225 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.2 (femtoliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.20 (micro-international unit per milliliter)\n\n### Procedure\n- Spinal puncture, lumbar, diagnostic\n- Magnetic resonance angiography, head; without contrast material(s)\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); each additional sequential intravenous push of the same substance/drug provided in a facility (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, each nucleic acid sequence\n- Magnetic resonance angiography, neck; without contrast material(s), followed by contrast material(s) and further sequences\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Drug detoxification\n- Physical therapy evaluation\n- Collection of venous blood by venipuncture\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intravenous push, single or initial substance/drug\n- Magnetic resonance (eg, proton) imaging, brain (including brain stem); without contrast material, followed by contrast material(s) and further sequences\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomography, head or brain; without contrast material\n- Electroencephalogram (EEG) extended monitoring; 61-119 minutes\n\n### Condition\n- Benign prostatic hyperplasia without outflow obstruction\n- Chronic pain\n- Mood disorder caused by drug\n- Acquired hypothyroidism\n- Alcohol abuse\n- Blood chemistry abnormal\n- Coronary arteriosclerosis\n- Disorder of kidney and/or ureter\n- Opioid abuse\n- Type 2 diabetes mellitus without complication\n- Abdominal pain\n- Generalized hyperhidrosis\n- Intracerebral vascular finding\n- Postgastric surgery syndrome\n- Toxic encephalopathy\n- Adult failure to thrive syndrome\n- Benign essential hypertension\n- Bronchiectasis\n- Diarrhea\n- Mononeuritis\n- Aneurysm\n- Drug abuse in remission\n- Nausea and vomiting\n- Vitamin K deficiency\n- Accidental poisoning by barbiturates\n- Headache\n- Incoordination\n- Iron deficiency anemia\n- Altered mental status\n- Depressive disorder\n- Drug withdrawal\n- Obstructive sleep apnea syndrome\n- Opioid dependence\n- Seizure\n- Thiamine deficiency\n- Asthma\n- Organic mental disorder\n- Poisoning by barbiturate\n- Megaloblastic anemia due to folate deficiency\n\n### Drug\n- ferrous sulfate 325 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take 1 Tab by mouth daily. \n- duloxetine 30 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-02\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 30.0, with intended 3 refill(s). Instructions: take 2 Tabs by mouth 2 times a day. \n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- duloxetine 60 MG Delayed Release Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- phenobarbital 30 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- sodium hypochlorite 0.125 MG/ML Topical Solution, through Topical route, started on 2010-12-04, presumably until 2010-12-04\n- methadone hydrochloride 2 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-01\n- 2 ML ondansetron 2 MG/ML Injection, started on 2010-12-02, presumably until 2010-12-04\n- tamsulosin hydrochloride 0.4 MG Oral Capsule, through Oral route, started on 2010-12-01, presumably until 2010-12-05. Instructions: take by mouth daily.\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2010-12-01, presumably until 2010-12-05\n- methadone hydrochloride 1 MG/ML Oral Solution, through Oral route, started on 2010-12-01, presumably until 2010-12-07, with quantity of 20.0, with intended 0 refill(s). Instructions: take 40 mL by mouth every 12 hours. \n- acetaminophen 250 MG / aspirin 250 MG / caffeine 65 MG Oral Tablet, through Oral route, started on 2010-12-04, presumably until 2010-12-05\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML hydromorphone hydrochloride 2 MG/ML Injection, started on 2010-12-01, presumably until 2010-12-03\n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2010-12-03, presumably until 2010-12-04\n- 1 ML morphine sulfate 4 MG/ML Prefilled Syringe, started on 2010-11-30, presumably until 2010-11-30\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Depressive disorder within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of depressive_disorder means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "d8c873cd38fa139f2c72860e17bbaed4ce73aaeda7054f32e1a655755b2f4620", "prompt_hash": "38c71497359a17cd0955913f14148b38a333c294beaeaf426e79b9e9b5b59fd3", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 0.0, "f1_gu_yn": [0, 1], "recall_gu_yn": [0, 1]}
{"doc_id": 5, "doc": {"person_id": 115969163, "visit_occurrence_id": 123629933, "death_date": null, "visit_concept_name": "Office Visit", "visit_start_datetime": "2018-09-26 13:59:08", "visit_end_datetime": "2018-09-26 15:02:23", "visit_length_in_hours": 1.0541666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Office Visit, started at 2018-09-26 13:59:08, ended at 2018-09-26 15:02:23\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemorrhage of rectum and anus\n- Primary diagnosis: Nausea\n\n### Drug\n- colesevelam hydrochloride 625 MG Oral Tablet, through Oral route, started on 2018-09-26, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n", "approximate_token_count": 139, "patient_first_visit_date": "2015-01-29 07:01:00", "patient_last_visit_date": "2022-10-23 09:37:25", "end_obs_date": "2019-09-26", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 8, "cumulated_visit_num": 8, "cumulated_approximate_token_count": 7349, "visit_cumulated": "## Visit\nThis visit record, was from Inpatient Visit, started at 2015-01-29 07:01:00, ended at 2015-01-30 16:25:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.95 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 182 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 320 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 53.3 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Body height: 5' 7\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n\n### Procedure\n- Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; initial vein\n- Injection procedure for extremity venography (including introduction of needle or intracatheter)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up ca\n- Procedure on single vessel\n- Angioplasty of other non-coronary vessel(s)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Injection or infusion of thrombolytic agent\n- Introduction of catheter, superior or inferior vena cava\n- Insertion of one vascular stent\n- Venography, extremity, unilateral, radiological supervision and interpretation\n- Transcatheter therapy, venous infusion for thrombolysis, any method, including radiological supervision and interpretation, initial treatment day\n- Collection of venous blood by venipuncture\n- Insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s)\n\n### Condition\n- Cardiac arrhythmia\n- Electrocardiogram abnormal\n- Primary diagnosis: Acute deep vein thrombosis of lower limb\n- Swelling of limb\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2015-01-29\n- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth Patient takes every day\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2015-01-29\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 50 mcg by mouth every morning before breakfast. Take 100 mcg by mouth daily.\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-01-30, presumably until 2015-01-30\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 25 mg by mouth every 6 hours as needed.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-01-29, presumably until 2015-01-29\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2015-01-29, presumably until 2015-01-29\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-01-22, presumably until 2019-02-06, with intended 0 refill(s). Instructions: take 20 mg by mouth 2 times a day.\n- paroxetine hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2017-04-01, with intended 0 refill(s). Instructions: take  by mouth.\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-01-30, presumably until 2015-05-22, with intended 0 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours.\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2015-01-30, presumably until 2015-01-30\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2015-01-29, presumably until 2015-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-22 10:11:49, ended at 2015-05-22 10:58:25\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.157\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Swelling of limb\n\n### Drug\n- warfarin sodium 3 MG Oral Tablet, through Oral route, presumably until 2017-04-01, with intended 0 refill(s). Instructions: take 3 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-01 13:35:00, ended at 2017-04-01 13:53:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Abnormal urine\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-04-19 00:00:00, ended at 2017-04-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Dyspnea\n- Hypothyroidism\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-04-19, presumably until 2017-04-19\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- cefazolin 1000 MG Injection, started on 2017-04-19, presumably until 2017-04-19\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-04-19, presumably until 2017-04-19\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2017-04-19, presumably until 2017-04-19\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-04-19 06:24:00, ended at 2017-04-28 11:39:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.55 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.48 (thousand per microliter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 44.5 (millimeter mercury column)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.73 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: >500.0 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.0 (second)\n- Bicarbonate [Moles/volume] in Specimen: 26.5 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 48.2 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.66 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.1 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 83 (millimeter mercury column)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 99 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Left ventricular Ejection fraction: 38.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Base excess in Arterial blood by calculation: 1.7 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 155 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Prothrombin time (PT): 20.4 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Lactate [Moles/volume] in Blood: 5.1 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 61 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 19.1 (nanogram per milliliter)\n\n### Procedure\n- Repair Atrial Septum, Open Approach\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Radiologic examination, abdomen; single anteroposterior view\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Excision of Right Saphenous Vein, Open Approach\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Bypass Coronary Artery, One Artery from Aorta with Autologous Venous Tissue, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Supplement Mitral Valve with Synthetic Substitute, Open Approach\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Controlled ventilation procedure and therapy, initiation and management\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Performance of Cardiac Output, Continuous\n\n### Condition\n- Chronic kidney disease stage 1\n- Congestive heart failure\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Atrial premature complex\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Abdominal pain\n- Low back pain\n- Rheumatic disease of mitral valve\n- Right bundle branch block\n- Acute posthemorrhagic anemia\n- Ascorbic acid deficiency\n- Combined systolic and diastolic dysfunction\n- Compression of vein\n- Gastroesophageal reflux disease without esophagitis\n- Mitral valve prolapse\n- Pneumothorax\n- Conduction disorder of the heart\n- Hypothyroidism\n- Major depression, single episode\n- Anxiety disorder\n- Atrial fibrillation\n- Chronic pain\n- Electrocardiogram abnormal\n- Primary diagnosis: Persistent atrial fibrillation\n- Urinary tract infectious disease\n- Atherosclerosis of coronary artery without angina pectoris\n- Atrial septal defect\n- Bifascicular block\n- Chronic atrial fibrillation\n- Chronic combined systolic and diastolic heart failure\n- Headache\n- Nausea\n- Non-rheumatic mitral valve disease\n- Paroxysmal atrial fibrillation\n- Pleural effusion\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-23\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- rivaroxaban 15 MG Oral Tablet, through Oral route, started on 2017-04-28, presumably until 2017-04-28\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-21\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2017-04-27, presumably until 2017-05-03, with intended 0 refill(s). Instructions: take 1 Aminian by mouth every 12 hours for 5 days , first dose was on 3-28 at night, last dose will be 4-3\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-23\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-04-19, presumably until 2017-04-22\n- 250 ML dobutamine 2 MG/ML Injection, through Intravenous route, started on 2017-04-20, presumably until 2017-04-22\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2017-04-28, presumably until 2018-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-27\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2018-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-27\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-21\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-04-22\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- rivaroxaban, started on 2017-04-27, presumably until 2017-05-20, with intended 0 refill(s). Instructions: Take 1 round (15 mg) tab twice daily with food for 21 days then 1 triangle tab (20 mg) daily with food\n- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-27\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-04-20, presumably until 2017-04-21\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-28\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2017-04-22, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every morning before breakfast\n- ferrous sulfate 140 MG Extended Release Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-04-20, presumably until 2017-04-25\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2017-04-21, presumably until 2017-04-21\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth Daily at night\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-04-20, presumably until 2017-04-24\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-04-20, presumably until 2017-04-23\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth Daily at night\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2018-04-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-04-26, presumably until 2017-04-27\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2017-04-22, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-21\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-04-20, presumably until 2017-04-21\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-26\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-26\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-23\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain\n- 100 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2017-04-20, presumably until 2017-04-27\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-28\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2017-04-20, presumably until 2017-04-20\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-04-24, presumably until 2017-04-26\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-27 00:00:00, ended at 2017-04-27 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Compression of vein\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2017-04-27, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-20 11:02:41, ended at 2017-05-20 12:11:36\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.22\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- rivaroxaban 20 MG Oral Tablet, through Oral route, presumably until 2020-07-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 81 mg by mouth every Monday, Wednesday and Friday\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-26 13:59:08, ended at 2018-09-26 15:02:23\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemorrhage of rectum and anus\n- Primary diagnosis: Nausea\n\n### Drug\n- colesevelam hydrochloride 625 MG Oral Tablet, through Oral route, started on 2018-09-26, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Depressive disorder within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2015-01-29 07:01:00, ended at 2015-01-30 16:25:00\nThe patient in this visit was 69 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 131 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.7 (percent)\n- MCH [Entitic mass] by Automated count: 29.3 (picogram)\n- MCV [Entitic volume] by Automated count: 90.5 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.95 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.7 (percent)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 182 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 8 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 11 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 53 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.05 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.65 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 65.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 320 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.33 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 53.3 (second)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.7 (percent)\n- Body height: 5' 7\" (inch (US))\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.4 (gram per deciliter)\n\n### Procedure\n- Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; initial vein\n- Injection procedure for extremity venography (including introduction of needle or intracatheter)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Transcatheter therapy, arterial or venous infusion for thrombolysis other than coronary, any method, including radiological supervision and interpretation, continued treatment on subsequent day during course of thrombolytic therapy, including follow-up ca\n- Procedure on single vessel\n- Angioplasty of other non-coronary vessel(s)\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Injection or infusion of thrombolytic agent\n- Introduction of catheter, superior or inferior vena cava\n- Insertion of one vascular stent\n- Venography, extremity, unilateral, radiological supervision and interpretation\n- Transcatheter therapy, venous infusion for thrombolysis, any method, including radiological supervision and interpretation, initial treatment day\n- Collection of venous blood by venipuncture\n- Insertion of non-drug-eluting peripheral (non-coronary) vessel stent(s)\n\n### Condition\n- Cardiac arrhythmia\n- Electrocardiogram abnormal\n- Primary diagnosis: Acute deep vein thrombosis of lower limb\n- Swelling of limb\n\n### Drug\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2015-01-29\n- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth Patient takes every day\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2015-01-29, presumably until 2015-01-29\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 50 mcg by mouth every morning before breakfast. Take 100 mcg by mouth daily.\n- 0.8 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-01-30, presumably until 2015-01-30\n- promethazine hydrochloride 12.5 MG Oral Tablet, through Oral route, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 25 mg by mouth every 6 hours as needed.\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2015-01-29, presumably until 2015-01-29\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2015-01-29, presumably until 2015-01-29\n- omeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2015-01-22, presumably until 2019-02-06, with intended 0 refill(s). Instructions: take 20 mg by mouth 2 times a day.\n- paroxetine hydrochloride 10 MG Oral Tablet, through Oral route, presumably until 2017-04-01, with intended 0 refill(s). Instructions: take  by mouth.\n- 0.6 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2015-01-30, presumably until 2015-05-22, with intended 0 refill(s). Instructions: inject 0.6 mL subcutaneous (under the skin) every 12 hours.\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2015-01-30, presumably until 2015-01-30\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2015-01-29, presumably until 2015-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2015-05-22 10:11:49, ended at 2015-05-22 10:58:25\nThe patient in this visit was 70 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 5.157\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Swelling of limb\n\n### Drug\n- warfarin sodium 3 MG Oral Tablet, through Oral route, presumably until 2017-04-01, with intended 0 refill(s). Instructions: take 3 mg by mouth daily\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-04-01 13:35:00, ended at 2017-04-01 13:53:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Abnormal urine\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-04-19 00:00:00, ended at 2017-04-19 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transesophageal, real-time with image documentation (2D) (with or without M-mode recording); including probe placement, image acquisition, interpretation and report\n- Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography)\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Doppler echocardiography, pulsed wave and/or continuous wave with spectral display (List separately in addition to codes for echocardiographic imaging); follow-up or limited study (List separately in addition to codes for echocardiographic imaging)\n- Anesthesia for procedures on heart, pericardial sac, and great vessels of chest; with pump oxygenator, age 1 year or older, for all noncoronary bypass procedures (eg, valve procedures) or for re-operation for coronary bypass more than 1 month after origin\n- Insertion and placement of flow directed catheter (eg, Swan-Ganz) for monitoring purposes\n\n### Condition\n- Gastroesophageal reflux disease without esophagitis\n- Dyspnea\n- Hypothyroidism\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Atherosclerosis of coronary artery without angina pectoris\n\n### Drug\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML albumin human, USP 50 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- vancomycin 1000 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-04-19, presumably until 2017-04-19\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- cefazolin 1000 MG Injection, started on 2017-04-19, presumably until 2017-04-19\n- 250 ML nitroglycerin 0.2 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-04-19, presumably until 2017-04-19\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2017-04-19, presumably until 2017-04-19\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 50 ML sodium bicarbonate 84 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-04-19 06:24:00, ended at 2017-04-28 11:39:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.2 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 91 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.4 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 147 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.55 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.71 (milligram per deciliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: Full Field (per high power field)\n- Glucose [Mass/volume] in Blood: 99 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.7 (femtoliter)\n- Neutrophils [#/volume] in Blood by Automated count: 7.48 (thousand per microliter)\n- Base excess in Blood by calculation: 2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 44.5 (millimeter mercury column)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.47 (million per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.73 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: >500.0 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 5.6 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 96.0 (second)\n- Bicarbonate [Moles/volume] in Specimen: 26.5 (millimole per liter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 48.2 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 33 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 2.66 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.1 (percent)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 83 (millimeter mercury column)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 99 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 5.984\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 99 (millimole per liter)\n- Heparin unfractionated [Units/volume] in Platelet poor plasma: <0.10 (unit per milliliter)\n- Left ventricular Ejection fraction: 38.9 (percent)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.6 (percent)\n- Base excess in Arterial blood by calculation: 1.7 (millimole per liter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 155 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 3 - 5 (per high power field)\n- Leukocytes [#/volume] in Body fluid by Manual count: 1 (milli-international unit per milliliter)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 99 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.2 (milligram per deciliter)\n- Prothrombin time (PT): 20.4 (second)\n- Eosinophils [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Lactate [Moles/volume] in Blood: 5.1 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.10 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 61 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 19.1 (nanogram per milliliter)\n\n### Procedure\n- Repair Atrial Septum, Open Approach\n- Medical nutrition therapy; re-assessment and intervention, individual, face-to-face with the patient, each 15 minutes\n- Radiologic examination, chest; single view, frontal\n- Radiologic examination, abdomen; single anteroposterior view\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Pressurized or nonpressurized inhalation treatment for acute airway obstruction for therapeutic purposes and/or for diagnostic purposes such as sputum induction with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure b\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour\n- Excision of Right Saphenous Vein, Open Approach\n- Continuous inhalation treatment with aerosol medication for acute airway obstruction; each additional hour (List separately in addition to code for primary procedure)\n- Bypass Coronary Artery, One Artery from Aorta with Autologous Venous Tissue, Open Approach\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Supplement Mitral Valve with Synthetic Substitute, Open Approach\n- Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device\n- Controlled ventilation procedure and therapy, initiation and management\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Performance of Cardiac Output, Continuous\n\n### Condition\n- Chronic kidney disease stage 1\n- Congestive heart failure\n- Angina co-occurrent and due to coronary arteriosclerosis\n- Atrial premature complex\n- Non-rheumatic mitral valve stenosis with regurgitation\n- Abdominal pain\n- Low back pain\n- Rheumatic disease of mitral valve\n- Right bundle branch block\n- Acute posthemorrhagic anemia\n- Ascorbic acid deficiency\n- Combined systolic and diastolic dysfunction\n- Compression of vein\n- Gastroesophageal reflux disease without esophagitis\n- Mitral valve prolapse\n- Pneumothorax\n- Conduction disorder of the heart\n- Hypothyroidism\n- Major depression, single episode\n- Anxiety disorder\n- Atrial fibrillation\n- Chronic pain\n- Electrocardiogram abnormal\n- Primary diagnosis: Persistent atrial fibrillation\n- Urinary tract infectious disease\n- Atherosclerosis of coronary artery without angina pectoris\n- Atrial septal defect\n- Bifascicular block\n- Chronic atrial fibrillation\n- Chronic combined systolic and diastolic heart failure\n- Headache\n- Nausea\n- Non-rheumatic mitral valve disease\n- Paroxysmal atrial fibrillation\n- Pleural effusion\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-23\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- rivaroxaban 15 MG Oral Tablet, through Oral route, started on 2017-04-28, presumably until 2017-04-28\n- 100 ML milrinone lactate 0.2 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-21\n- nitrofurantoin, macrocrystals 25 MG / nitrofurantoin, monohydrate 75 MG Oral Capsule, through Oral route, started on 2017-04-27, presumably until 2017-05-03, with intended 0 refill(s). Instructions: take 1 Aminian by mouth every 12 hours for 5 days , first dose was on 3-28 at night, last dose will be 4-3\n- pantoprazole 20 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-23\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-04-19, presumably until 2017-04-22\n- 250 ML dobutamine 2 MG/ML Injection, through Intravenous route, started on 2017-04-20, presumably until 2017-04-22\n- furosemide 20 MG Oral Tablet, through Oral route, started on 2017-04-28, presumably until 2018-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-27\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2018-04-28, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every 6 hours as needed\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-27\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-21\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-04-22\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- rivaroxaban, started on 2017-04-27, presumably until 2017-05-20, with intended 0 refill(s). Instructions: Take 1 round (15 mg) tab twice daily with food for 21 days then 1 triangle tab (20 mg) daily with food\n- acetaminophen 325 MG / butalbital 50 MG / caffeine 40 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-04-28\n- lisinopril 2.5 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-27\n- insulin isophane, human 100 UNT/ML Injectable Suspension, through Subcutaneous route, started on 2017-04-20, presumably until 2017-04-21\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain\n- 10 ML furosemide 10 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-28\n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2017-04-22, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every morning before breakfast\n- ferrous sulfate 140 MG Extended Release Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-04-20, presumably until 2017-04-25\n- insulin lispro 100 UNT/ML Injectable Solution, through Subcutaneous route, started on 2017-04-21, presumably until 2017-04-21\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth Daily at night\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-04-20, presumably until 2017-04-24\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2017-04-20, presumably until 2017-04-23\n- lisinopril 5 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth Daily at night\n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2018-04-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 50 ML potassium chloride 0.4 MEQ/ML Injection, through Intravenous route, started on 2017-04-26, presumably until 2017-04-27\n- carvedilol 6.25 MG Oral Tablet, through Oral route, started on 2017-04-22, presumably until 2018-04-27, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- 1 ML ketorolac tromethamine 15 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-21\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-04-20, presumably until 2017-04-21\n- 200 ML vancomycin 5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-19\n- 100 ML amiodarone hydrochloride 1.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-26\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-26\n- gabapentin 600 MG Oral Tablet, through Oral route, started on 2017-04-21, presumably until 2017-04-23\n- 100 ML propofol 10 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-04-20, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1-2 Tabs by mouth every 4 hours as needed for Pain\n- 100 ML clevidipine 0.5 MG/ML Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n- 0.4 ML cyclosporine 0.5 MG/ML Ophthalmic Suspension, through Intraocular route, started on 2017-04-20, presumably until 2017-04-27\n- ascorbic acid 500 MG Oral Tablet, through Oral route, started on 2017-04-23, presumably until 2017-04-28\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-04-24, presumably until 2017-05-20, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- 100 ML dexmedetomidine 0.004 MG/ML Injection, through Intravenous route, started on 2017-04-20, presumably until 2017-04-20\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2017-04-20, presumably until 2017-04-22\n- magnesium sulfate 40 MG/ML Injection, through Intravenous route, started on 2017-04-24, presumably until 2017-04-26\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-04-19, presumably until 2017-04-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2017-04-27 00:00:00, ended at 2017-04-27 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Compression of vein\n- Primary diagnosis: Paroxysmal atrial fibrillation\n\n### Drug\n- apixaban 5 MG Oral Tablet, through Oral route, started on 2017-04-27, presumably until 2017-04-28, with intended 0 refill(s). Instructions: take 5 mg by mouth 2 times a day\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-05-20 11:02:41, ended at 2017-05-20 12:11:36\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 6.22\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Non-rheumatic mitral valve stenosis with regurgitation\n\n### Drug\n- rivaroxaban 20 MG Oral Tablet, through Oral route, presumably until 2020-07-08, with intended 0 refill(s). Instructions: take 1 Tab by mouth every day\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 81 mg by mouth every Monday, Wednesday and Friday\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2018-09-26 13:59:08, ended at 2018-09-26 15:02:23\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 7\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hemorrhage of rectum and anus\n- Primary diagnosis: Nausea\n\n### Drug\n- colesevelam hydrochloride 625 MG Oral Tablet, through Oral route, started on 2018-09-26, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Depressive disorder within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of depressive_disorder means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "8666d13960d637ca8d9e0a450d06902e03da589b9f9a6d5672eeac0b5b040c36", "prompt_hash": "4ea18321f54025b57e0c873dfe105bc7afed4e04b55c97f0fcefc2b8af09dcc1", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 6, "doc": {"person_id": 115969314, "visit_occurrence_id": 128640450, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2018-11-20 00:00:00", "visit_end_datetime": "2018-11-20 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-20 00:00:00, ended at 2018-11-20 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, started on 2018-11-20, presumably until 2018-11-20, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n", "approximate_token_count": 119, "patient_first_visit_date": "2017-08-01 13:17:23", "patient_last_visit_date": "2021-05-12 00:00:00", "end_obs_date": "2019-11-20", "hypertension_type": "recurrent", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "recurrent", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "recurrent", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 13, "cumulated_visit_num": 13, "cumulated_approximate_token_count": 9336, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2017-08-01 13:17:23, ended at 2017-08-01 14:50:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Thoracoabdominal aortic aneurysm\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 mg by mouth daily\n- prednisone 10 MG Oral Tablet, through Oral route, presumably until 2017-10-25, with intended 0 refill(s). Instructions: take 5 mg by mouth daily \n- amoxicillin 120 MG/ML / clavulanate 8.58 MG/ML Oral Suspension, through Oral route, presumably until 2017-10-25, with intended 0 refill(s). Instructions: take by mouth\n- alprazolam 0.25 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 0.25 mg by mouth every 4 hours as needed for Insomnia or Anxiety \n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, presumably until 2017-10-31, with intended 0 refill(s). Instructions: take 25 mg by mouth as needed Takes when systolic is greater than 120\n- omeprazole 20 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 20 mg by mouth daily \n- fluoxetine 40 MG Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 40 mg by mouth daily \n- methotrexate 2.5 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 2.5 mg by mouth every 7 days 2.5 mg tabs. Patient takes 8 tabs  Every Wednesday. Totally of 20 mg.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-03 13:38:00, ended at 2017-08-03 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 55.5 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Thoracoabdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-08-06 15:50:00, ended at 2017-08-10 15:02:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Glucose [Mass/volume] in Blood: 97 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.01 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 193 (millimeter mercury column)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 319 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 211 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 100 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide [Partial pressure] in Arterial blood: 40.1 (millimeter mercury column)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 234 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 43.2 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Lactate [Moles/volume] in Blood: 2.3 (millimole per liter)\n- Lactate [Moles/volume] in Serum or Plasma: 2.5 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Prothrombin time (PT): 15.3 (second)\n- Base excess in Blood by calculation: 0 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.53 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 215.0 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 25.1 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Base excess in Arterial blood by calculation: -1.9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Body height: 5' 0\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Restriction of Thoracic Aorta, Descending with Intraluminal Device, Percutaneous Approach\n- Transcatheter placement of an intravascular stent(s) (except lower extremity artery(s) for occlusive disease, cervical carotid, extracranial vertebral or intrathoracic carotid, intracranial, or coronary), open or percutaneous, including radiological super\n- Radiologic examination, chest; single view, frontal\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Open femoral artery exposure for delivery of endovascular prosthesis, by groin incision, unilateral (List separately in addition to code for primary procedure)\n- Open brachial artery exposure for delivery of endovascular prosthesis, unilateral (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; arterial, other than hemorrhage or tumor (eg, congenital or acquire\n- Radiologic examination, abdomen; single anteroposterior view\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Dilation of Superior Mesenteric Artery with Intraluminal Device, Percutaneous Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); each additional proximal extension (List separatel\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Selective catheter placement, arterial system; each first order abdominal, pelvic, or lower extremity artery branch, within a vascular family\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); initial extension\n- Endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); not involving coverage of left subclavian artery origin, initial endoprosthesis plus descending t\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperglycemia\n- Mild protein-calorie malnutrition (weight for age 75-89 percent of standard)\n- Acute posthemorrhagic anemia\n- Congestive heart failure\n- Chronic kidney disease stage 3\n- Major depression, single episode\n- Anxiety disorder\n- Temporal arteritis\n- Acute pancreatitis\n- Asthenia\n- Atelectasis\n- Chronic combined systolic and diastolic heart failure\n- Persistent pain following procedure\n- Thoracoabdominal aortic aneurysm\n- Atrial premature complex\n- Essential hypertension\n- Intraventricular conduction defect\n- Abdominal distension, gaseous\n- Anemia of chronic disease\n- Postoperative state\n- Thoracic aortic aneurysm without rupture\n- Complication associated with device\n- Electrocardiogram abnormal\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Late effects of poliomyelitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2017-08-07, presumably until 2017-08-10\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-09\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-08-10\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-08-10, presumably until 2017-08-10\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2017-08-09, presumably until 2017-08-10\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-08-09, presumably until 2017-08-10\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2017-08-06, presumably until 2017-10-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-08\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-08-07\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-08-10, presumably until 2018-08-10, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed for Constipation\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-08\n- alprazolam 0.25 MG Oral Tablet, through Oral route, started on 2017-08-08, presumably until 2017-08-09\n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-06, presumably until 2017-08-06\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-08\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-08-06, presumably until 2017-08-06\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-08-07\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-08-06, presumably until 2017-08-10\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-08-10\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2017-08-08, presumably until 2017-08-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-07, presumably until 2017-08-08\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-08-07, presumably until 2017-08-07\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-08-08, presumably until 2017-08-08\n- methotrexate 2.5 MG Oral Tablet, through Oral route, started on 2017-08-09, presumably until 2017-08-09\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-08-10, presumably until 2017-08-10\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-08-09, presumably until 2017-10-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2017-08-10, presumably until 2018-08-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-08-08, presumably until 2017-08-08\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2017-08-08, presumably until 2017-08-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-08-07 00:00:00, ended at 2017-08-07 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for therapeutic interventional radiological procedures involving the arterial system; intracranial, intracardiac, or aortic\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n\n### Condition\n- Temporal arteritis\n- Thoracoabdominal aortic aneurysm\n- Essential hypertension\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2017-08-07, presumably until 2017-08-07\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-08-07, presumably until 2017-08-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- cefazolin 1000 MG Injection, started on 2017-08-07, presumably until 2017-08-07\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-08-07, presumably until 2017-08-07\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-07, presumably until 2017-08-07\n- midazolam 1 MG/ML Injectable Solution, started on 2017-08-07, presumably until 2017-08-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-15 00:00:00, ended at 2017-08-15 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-15 11:15:17, ended at 2017-09-15 12:05:28\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal aortic aneurysm without rupture\n- Thoracoabdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-15 11:54:00, ended at 2017-09-15 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.53 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.1 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 339 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.40 (million per microliter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Abdominal aortic aneurysm without rupture\n- Thoracoabdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-10-25 15:26:00, ended at 2017-10-31 18:47:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Prothrombin time (PT): 13.9 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Lactate [Moles/volume] in Blood: 1.7 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Base excess in Arterial blood by calculation: 0.3 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.0 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 9.08 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 229.0 (millimeter mercury column)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Body height: 5' 0\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.45 (milligram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 2.2 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 84.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 24.1 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.9 (second)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 37.3 (millimeter mercury column)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 89 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Collection of capillary blood specimen (eg, finger, heel, ear stick)\n- Placement of proximal or distal extension prosthesis for endovascular repair of infrarenal abdominal aortic or iliac aneurysm, false aneurysm, or dissection; initial vessel\n- Radiologic examination, chest; single view, frontal\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Collection of venous blood by venipuncture\n- Fluoroscopy of Thoraco-Abdominal Aorta using Low Osmolar Contrast\n- Endovascular repair of visceral aorta and infrarenal abdominal aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption) with a fenestrated visceral aortic endograft and concomitant unibody or modula\n- Radiologic examination, abdomen; single anteroposterior view\n- Open femoral artery exposure for delivery of endovascular prosthesis, by groin incision, unilateral (List separately in addition to code for primary procedure)\n- Placement of proximal or distal extension prosthesis for endovascular repair of infrarenal aortic or iliac artery aneurysm, pseudoaneurysm, or dissection, radiological supervision and interpretation\n- Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Approach\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Restriction of Thoracic Aorta, Descending with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Approach\n\n### Condition\n- Intestinal obstruction co-occurrent and due to decreased peristalsis\n- Abnormal findings on diagnostic imaging of lung\n- Essential hypertension\n- Constipation\n- Electrocardiogram abnormal\n- Nausea and vomiting\n- Chronic congestive heart failure\n- Thoracoabdominal aortic aneurysm\n- Temporal arteritis\n- Chronic pain\n- Chronic systolic heart failure\n- Monoplegia of lower limb affecting non-dominant side\n- Nausea\n- Persistent pain following procedure\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Mild protein-calorie malnutrition (weight for age 75-89 percent of standard)\n- Acute posthemorrhagic anemia\n- Anemia of chronic disease\n- Chronic kidney disease stage 3\n- Late effects of poliomyelitis\n- Mechanical complication of aortic graft\n- Abdominal aortic aneurysm without rupture\n\n### Drug\n- glycerin, started on 2017-10-28, presumably until 2017-10-28\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-10-28, presumably until 2017-10-30\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2017-10-28, presumably until 2017-10-30\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-10-27, presumably until 2017-10-31\n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2017-10-28, presumably until 2017-10-28\n- acetaminophen 650 MG Rectal Suppository, through Rectal route, started on 2017-10-28, presumably until 2017-10-30\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-10-26, presumably until 2017-10-28\n- sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema, through Rectal route, started on 2017-10-28, presumably until 2017-10-28\n- amoxicillin 500 MG Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 500 mg by mouth every day\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2017-10-27, presumably until 2017-10-31\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-10-26, presumably until 2018-11-01, with intended 1 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2017-10-25, presumably until 2017-10-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2017-10-28, presumably until 2017-10-28\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-10-29, presumably until 2017-10-29\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-10-25, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- alprazolam 0.25 MG Oral Tablet, through Oral route, started on 2017-10-26, presumably until 2017-10-31\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-10-27, presumably until 2017-10-27\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2017-10-25, presumably until 2017-10-25\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2017-10-28, presumably until 2017-10-31\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2017-10-26, presumably until 2017-10-27\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-10-31, presumably until 2018-10-31, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2017-10-28, presumably until 2017-10-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-10-27, presumably until 2017-10-31\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-10-25, presumably until 2017-10-29\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-10-25, presumably until 2017-10-31, with intended 0 refill(s). Instructions: take 5 mg by mouth daily\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2017-10-27, presumably until 2017-10-28\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-10-28, presumably until 2017-10-29\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2017-10-27, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-10-26, presumably until 2017-10-31\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2017-10-26, presumably until 2017-10-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-10-25, presumably until 2017-10-27\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2017-10-28, presumably until 2017-10-28\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2017-10-26, presumably until 2017-10-30\n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2017-10-26, presumably until 2017-10-26\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2017-10-28, presumably until 2017-10-28\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-10-27, presumably until 2018-11-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2017-10-31, presumably until 2017-10-31\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-10-28, presumably until 2017-10-30\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2017-10-27, presumably until 2017-10-27\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-10-26, presumably until 2017-10-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for therapeutic interventional radiological procedures involving the arterial system; intracranial, intracardiac, or aortic\n\n### Condition\n- Abdominal aortic aneurysm without rupture\n- Essential hypertension\n- Anemia\n- Chronic kidney disease\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-10-26, presumably until 2017-10-26\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- cefazolin 1000 MG Injection, started on 2017-10-26, presumably until 2017-10-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-10-26, presumably until 2017-10-26\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-10-26, presumably until 2017-10-26\n- midazolam 1 MG/ML Injectable Solution, started on 2017-10-26, presumably until 2017-10-26\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-10-26, presumably until 2017-10-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2017-10-26, presumably until 2017-10-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-02 00:00:00, ended at 2017-11-02 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal aortic aneurysm without rupture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-29 00:00:00, ended at 2018-06-29 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, started on 2018-07-02, presumably until 2018-07-02, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-20 00:00:00, ended at 2018-11-20 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, started on 2018-11-20, presumably until 2018-11-20, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Depressive disorder within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-08-01 13:17:23, ended at 2017-08-01 14:50:55\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Body height: 5' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Thoracoabdominal aortic aneurysm\n\n### Drug\n- folic acid 1 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 1 mg by mouth daily\n- prednisone 10 MG Oral Tablet, through Oral route, presumably until 2017-10-25, with intended 0 refill(s). Instructions: take 5 mg by mouth daily \n- amoxicillin 120 MG/ML / clavulanate 8.58 MG/ML Oral Suspension, through Oral route, presumably until 2017-10-25, with intended 0 refill(s). Instructions: take by mouth\n- alprazolam 0.25 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 0.25 mg by mouth every 4 hours as needed for Insomnia or Anxiety \n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, presumably until 2017-10-31, with intended 0 refill(s). Instructions: take 25 mg by mouth as needed Takes when systolic is greater than 120\n- omeprazole 20 MG Delayed Release Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 20 mg by mouth daily \n- fluoxetine 40 MG Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 40 mg by mouth daily \n- methotrexate 2.5 MG Oral Tablet, through Oral route, with intended 0 refill(s). Instructions: take 2.5 mg by mouth every 7 days 2.5 mg tabs. Patient takes 8 tabs  Every Wednesday. Totally of 20 mg.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-08-03 13:38:00, ended at 2017-08-03 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Left ventricular Ejection fraction: 55.5 (percent)\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Thoracoabdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-08-06 15:50:00, ended at 2017-08-10 15:02:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.3 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 30.6 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 70 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.8 (percent)\n- Glucose [Mass/volume] in Blood: 97 (milligram per deciliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 6 - 10 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 94 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.57 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.01 (thousand per microliter)\n- Oxygen [Partial pressure] adjusted to patient's actual temperature in Blood: 193 (millimeter mercury column)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.96 (million per microliter)\n- Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay: 319 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 211 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.7 (percent)\n- Oxygen saturation Calculated from oxygen partial pressure in Blood: 100 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Carbon dioxide [Partial pressure] in Arterial blood: 40.1 (millimeter mercury column)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 234 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 79 (unit per liter)\n- Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Blood: 43.2 (millimeter mercury column)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Lactate [Moles/volume] in Blood: 2.3 (millimole per liter)\n- Lactate [Moles/volume] in Serum or Plasma: 2.5 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 5.5 (percent)\n- MCV [Entitic volume] by Automated count: 90.8 (femtoliter)\n- Prothrombin time (PT): 15.3 (second)\n- Base excess in Blood by calculation: 0 (millimole per liter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.53 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Oxygen [Partial pressure] in Arterial blood: 215.0 (millimeter mercury column)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 25.1 (millimole per liter)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 29.5 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 86.6 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.6 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 83 (unit per liter)\n- Base excess in Arterial blood by calculation: -1.9 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Body height: 5' 0\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n\n### Procedure\n- Computed tomographic angiography, abdomen and pelvis, with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Restriction of Thoracic Aorta, Descending with Intraluminal Device, Percutaneous Approach\n- Transcatheter placement of an intravascular stent(s) (except lower extremity artery(s) for occlusive disease, cervical carotid, extracranial vertebral or intrathoracic carotid, intracranial, or coronary), open or percutaneous, including radiological super\n- Radiologic examination, chest; single view, frontal\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Computed tomographic angiography, chest (noncoronary), with contrast material(s), including noncontrast images, if performed, and image postprocessing\n- Open femoral artery exposure for delivery of endovascular prosthesis, by groin incision, unilateral (List separately in addition to code for primary procedure)\n- Open brachial artery exposure for delivery of endovascular prosthesis, unilateral (List separately in addition to code for primary procedure)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; arterial, other than hemorrhage or tumor (eg, congenital or acquire\n- Radiologic examination, abdomen; single anteroposterior view\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Dilation of Superior Mesenteric Artery with Intraluminal Device, Percutaneous Approach\n- Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of \n- Placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); each additional proximal extension (List separatel\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Selective catheter placement, arterial system; each first order abdominal, pelvic, or lower extremity artery branch, within a vascular family\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Placement of proximal extension prosthesis for endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); initial extension\n- Endovascular repair of descending thoracic aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption); not involving coverage of left subclavian artery origin, initial endoprosthesis plus descending t\n- Collection of venous blood by venipuncture\n\n### Condition\n- Hyperglycemia\n- Mild protein-calorie malnutrition (weight for age 75-89 percent of standard)\n- Acute posthemorrhagic anemia\n- Congestive heart failure\n- Chronic kidney disease stage 3\n- Major depression, single episode\n- Anxiety disorder\n- Temporal arteritis\n- Acute pancreatitis\n- Asthenia\n- Atelectasis\n- Chronic combined systolic and diastolic heart failure\n- Persistent pain following procedure\n- Thoracoabdominal aortic aneurysm\n- Atrial premature complex\n- Essential hypertension\n- Intraventricular conduction defect\n- Abdominal distension, gaseous\n- Anemia of chronic disease\n- Postoperative state\n- Thoracic aortic aneurysm without rupture\n- Complication associated with device\n- Electrocardiogram abnormal\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Late effects of poliomyelitis\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2017-08-07, presumably until 2017-08-10\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-09\n- amoxicillin 500 MG / clavulanate 125 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-08-10\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-08-10, presumably until 2017-08-10\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2017-08-09, presumably until 2017-08-10\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-08-09, presumably until 2017-08-10\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2017-08-06, presumably until 2017-10-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours\n- pantoprazole 40 MG Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-08\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-08-07\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-08-10, presumably until 2018-08-10, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day as needed for Constipation\n- cefazolin 1000 MG Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-08\n- alprazolam 0.25 MG Oral Tablet, through Oral route, started on 2017-08-08, presumably until 2017-08-09\n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-08-06, presumably until 2017-08-06\n- 250 ML norepinephrine 0.016 MG/ML Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-08\n- melatonin 3 MG Oral Tablet, through Oral route, started on 2017-08-06, presumably until 2017-08-06\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-08-07\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-08-06, presumably until 2017-08-10\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-08-07, presumably until 2017-08-10\n- 100 ML acetaminophen 10 MG/ML Injection, through Intravenous route, started on 2017-08-08, presumably until 2017-08-09\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-07, presumably until 2017-08-08\n- 1 ML hydromorphone hydrochloride 1 MG/ML Prefilled Syringe, started on 2017-08-07, presumably until 2017-08-07\n- magnesium sulfate 20 MG/ML Injection, through Intravenous route, started on 2017-08-08, presumably until 2017-08-08\n- methotrexate 2.5 MG Oral Tablet, through Oral route, started on 2017-08-09, presumably until 2017-08-09\n- oxycodone hydrochloride 5 MG Oral Tablet, through Oral route, started on 2017-08-10, presumably until 2017-08-10\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-08-09, presumably until 2017-10-25, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2017-08-10, presumably until 2018-08-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-08-08, presumably until 2017-08-08\n- 1 ML promethazine hydrochloride 25 MG/ML Injection, started on 2017-08-08, presumably until 2017-08-08\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-08-07 00:00:00, ended at 2017-08-07 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Anesthesia for therapeutic interventional radiological procedures involving the arterial system; intracranial, intracardiac, or aortic\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Insertion of non-tunneled centrally inserted central venous catheter; age 5 years or older\n- Ultrasound guidance for vascular access requiring ultrasound evaluation of potential access sites, documentation of selected vessel patency, concurrent realtime ultrasound visualization of vascular needle entry, with permanent recording and reporting (Lis\n\n### Condition\n- Temporal arteritis\n- Thoracoabdominal aortic aneurysm\n- Essential hypertension\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2017-08-07, presumably until 2017-08-07\n- 10 ML calcium chloride 100 MG/ML Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- 10 ML epinephrine 0.1 MG/ML Prefilled Syringe, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-08-07, presumably until 2017-08-07\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- cefazolin 1000 MG Injection, started on 2017-08-07, presumably until 2017-08-07\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-08-07, presumably until 2017-08-07\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-08-07, presumably until 2017-08-07\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-08-07, presumably until 2017-08-07\n- midazolam 1 MG/ML Injectable Solution, started on 2017-08-07, presumably until 2017-08-07\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-08-15 00:00:00, ended at 2017-08-15 00:00:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Postoperative state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2017-09-15 11:15:17, ended at 2017-09-15 12:05:28\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abdominal aortic aneurysm without rupture\n- Thoracoabdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2017-09-15 11:54:00, ended at 2017-09-15 23:59:00\nThe patient in this visit was 71 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Creatinine [Mass/volume] in Serum or Plasma: 0.53 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.1 (percent)\n- MCHC [Mass/volume] by Automated count: 31.7 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 83 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 9.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 28.1 (picogram)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.9 (thousand per microliter)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Platelets [#/volume] in Blood by Automated count: 339 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 14 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.40 (million per microliter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Abdominal aortic aneurysm without rupture\n- Thoracoabdominal aortic aneurysm\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-10-25 15:26:00, ended at 2017-10-31 18:47:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 92 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Leukocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 2 (per high power field)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.3 (milligram per deciliter)\n- Prothrombin time (PT): 13.9 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.7 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.2 (gram per deciliter)\n- Lactate [Moles/volume] in Blood: 1.7 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.0 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 94.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 5.0 (millimole per liter)\n- Base excess in Arterial blood by calculation: 0.3 (millimole per liter)\n- Bilirubin.direct [Mass/volume] in Serum or Plasma: 0.1 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 97 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 27.0 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 9.08 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Oxygen [Partial pressure] in Arterial blood: 229.0 (millimeter mercury column)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 93 (unit per liter)\n- Body height: 5' 0\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 0.45 (milligram per deciliter)\n- Lactate [Moles/volume] in Serum or Plasma: 2.2 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 84.2 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Bicarbonate [Moles/volume] in Specimen: 24.1 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.3 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.92 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 26.9 (second)\n- Calcium.ionized [Mass/volume] in Serum or Plasma: 1.17 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 94 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.06 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.8 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Carbon dioxide [Partial pressure] in Arterial blood: 37.3 (millimeter mercury column)\n- Erythrocytes [#/area] in Urine sediment by Microscopy high power field: 0 - 3 (per high power field)\n- Lipase [Enzymatic activity/volume] in Serum or Plasma: 71 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 9.2 (percent)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 50 (unit per liter)\n- Amylase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Bilirubin.indirect [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Blood: 89 (milligram per deciliter)\n\n### Procedure\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Collection of capillary blood specimen (eg, finger, heel, ear stick)\n- Placement of proximal or distal extension prosthesis for endovascular repair of infrarenal abdominal aortic or iliac aneurysm, false aneurysm, or dissection; initial vessel\n- Radiologic examination, chest; single view, frontal\n- Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes\n- Collection of venous blood by venipuncture\n- Fluoroscopy of Thoraco-Abdominal Aorta using Low Osmolar Contrast\n- Endovascular repair of visceral aorta and infrarenal abdominal aorta (eg, aneurysm, pseudoaneurysm, dissection, penetrating ulcer, intramural hematoma, or traumatic disruption) with a fenestrated visceral aortic endograft and concomitant unibody or modula\n- Radiologic examination, abdomen; single anteroposterior view\n- Open femoral artery exposure for delivery of endovascular prosthesis, by groin incision, unilateral (List separately in addition to code for primary procedure)\n- Placement of proximal or distal extension prosthesis for endovascular repair of infrarenal aortic or iliac artery aneurysm, pseudoaneurysm, or dissection, radiological supervision and interpretation\n- Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Approach\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Introduction of Vasopressor into Peripheral Vein, Percutaneous Approach\n- Physical therapy evaluation: moderate complexity, requiring these components: A history of present problem with 1-2 personal factors and/or comorbidities that impact the plan of care; An examination of body systems using standardized tests and measures in\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Occupational therapy evaluation, moderate complexity, requiring these components: An occupational profile and medical and therapy history, which includes an expanded review of medical and/or therapy records and additional review of physical, cognitive, or\n- Restriction of Thoracic Aorta, Descending with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Approach\n\n### Condition\n- Intestinal obstruction co-occurrent and due to decreased peristalsis\n- Abnormal findings on diagnostic imaging of lung\n- Essential hypertension\n- Constipation\n- Electrocardiogram abnormal\n- Nausea and vomiting\n- Chronic congestive heart failure\n- Thoracoabdominal aortic aneurysm\n- Temporal arteritis\n- Chronic pain\n- Chronic systolic heart failure\n- Monoplegia of lower limb affecting non-dominant side\n- Nausea\n- Persistent pain following procedure\n- Hypertensive heart and renal disease with (congestive) heart failure\n- Mild protein-calorie malnutrition (weight for age 75-89 percent of standard)\n- Acute posthemorrhagic anemia\n- Anemia of chronic disease\n- Chronic kidney disease stage 3\n- Late effects of poliomyelitis\n- Mechanical complication of aortic graft\n- Abdominal aortic aneurysm without rupture\n\n### Drug\n- glycerin, started on 2017-10-28, presumably until 2017-10-28\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2017-10-28, presumably until 2017-10-30\n- bisacodyl 10 MG Rectal Suppository, through Rectal route, started on 2017-10-28, presumably until 2017-10-30\n- folic acid 1 MG Oral Tablet, through Oral route, started on 2017-10-27, presumably until 2017-10-31\n- 2 ML fentanyl 0.05 MG/ML Injection, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- 2 ML prochlorperazine 5 MG/ML Injection, started on 2017-10-28, presumably until 2017-10-28\n- acetaminophen 650 MG Rectal Suppository, through Rectal route, started on 2017-10-28, presumably until 2017-10-30\n- chlorhexidine gluconate 1.2 MG/ML Mouthwash, through Submucosal route, started on 2017-10-26, presumably until 2017-10-28\n- sodium phosphate, dibasic 59.3 MG/ML / sodium phosphate, monobasic 161 MG/ML Enema, through Rectal route, started on 2017-10-28, presumably until 2017-10-28\n- amoxicillin 500 MG Oral Capsule, through Oral route, with intended 0 refill(s). Instructions: take 500 mg by mouth every day\n- fluoxetine 20 MG Oral Capsule, through Oral route, started on 2017-10-27, presumably until 2017-10-31\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2017-10-26, presumably until 2018-11-01, with intended 1 refill(s). Instructions: take 1 Tab by mouth every morning before breakfast\n- acetaminophen 325 MG / hydrocodone bitartrate 10 MG Oral Tablet, through Oral route, started on 2017-10-25, presumably until 2017-10-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed\n- magnesium citrate 58.2 MG/ML Oral Solution, through Oral route, started on 2017-10-28, presumably until 2017-10-28\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2017-10-29, presumably until 2017-10-29\n- docusate sodium 100 MG Oral Capsule, through Oral route, started on 2017-10-25, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 2 Caps by mouth 2 times a day\n- alprazolam 0.25 MG Oral Tablet, through Oral route, started on 2017-10-26, presumably until 2017-10-31\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2017-10-27, presumably until 2017-10-27\n- 24 HR metoprolol succinate 25 MG Extended Release Oral Tablet, through Oral route, started on 2017-10-25, presumably until 2017-10-25\n- 5 ML metoprolol tartrate 1 MG/ML Injection, through Intravenous route, started on 2017-10-28, presumably until 2017-10-31\n- 250 ML dopamine hydrochloride 1.6 MG/ML Injection, through Intravenous route, started on 2017-10-26, presumably until 2017-10-27\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2017-10-31, presumably until 2018-10-31, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day\n- labetalol hydrochloride 5 MG/ML Injectable Solution, through Intravenous route, started on 2017-10-28, presumably until 2017-10-28\n- 0.5 ML heparin sodium, porcine 10000 UNT/ML Injection, started on 2017-10-27, presumably until 2017-10-31\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2017-10-25, presumably until 2017-10-29\n- prednisone 5 MG Oral Tablet, through Oral route, started on 2017-10-25, presumably until 2017-10-31, with intended 0 refill(s). Instructions: take 5 mg by mouth daily\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2017-10-27, presumably until 2017-10-28\n- polyethylene glycol 3350 17000 MG Powder for Oral Solution, through Oral route, started on 2017-10-28, presumably until 2017-10-29\n- ondansetron 4 MG Disintegrating Oral Tablet, through Oral route, started on 2017-10-27, presumably until 2018-10-31, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-10-26, presumably until 2017-10-31\n- 1 ML hydromorphone hydrochloride 2 MG/ML Prefilled Syringe, started on 2017-10-26, presumably until 2017-10-26\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2017-10-25, presumably until 2017-10-27\n- lidocaine hydrochloride 0.02 MG/MG Topical Gel, through Submucosal route, started on 2017-10-28, presumably until 2017-10-28\n- lidocaine 0.05 MG/MG Medicated Patch, through Topical route, started on 2017-10-26, presumably until 2017-10-30\n- aspirin 300 MG Rectal Suppository, through Rectal route, started on 2017-10-26, presumably until 2017-10-26\n- water 1000 MG/ML Irrigation Solution, through Topical route, started on 2017-10-28, presumably until 2017-10-28\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2017-10-27, presumably until 2018-11-01, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning with breakfast\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2017-10-31, presumably until 2017-10-31\n- 2 ML metoclopramide 5 MG/ML Injection, started on 2017-10-28, presumably until 2017-10-30\n- hydromorphone hydrochloride 2 MG/ML Injectable Solution, through Intravenous route, started on 2017-10-27, presumably until 2017-10-27\n- cefazolin 2000 MG Injection, through Intravenous route, started on 2017-10-26, presumably until 2017-10-27\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Arterial catheterization or cannulation for sampling, monitoring or transfusion (separate procedure); percutaneous\n- Anesthesia for therapeutic interventional radiological procedures involving the arterial system; intracranial, intracardiac, or aortic\n\n### Condition\n- Abdominal aortic aneurysm without rupture\n- Essential hypertension\n- Anemia\n- Chronic kidney disease\n\n### Drug\n- 2 ML sugammadex 100 MG/ML Injection, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- 5 ML protamine sulfate (USP) 10 MG/ML Injection, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- 1 ML ephedrine sulfate 50 MG/ML Injection, started on 2017-10-26, presumably until 2017-10-26\n- magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.0497 MEQ/ML / sodium acetate 0.0163 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- cefazolin 1000 MG Injection, started on 2017-10-26, presumably until 2017-10-26\n- phenylephrine hydrochloride 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2017-10-26, presumably until 2017-10-26\n- rocuronium bromide 10 MG/ML Injectable Solution, through Intravenous route, started on 2017-10-26, presumably until 2017-10-26\n- 2 ML ondansetron 2 MG/ML Injection, started on 2017-10-26, presumably until 2017-10-26\n- midazolam 1 MG/ML Injectable Solution, started on 2017-10-26, presumably until 2017-10-26\n- dexamethasone phosphate 4 MG/ML Injectable Solution, started on 2017-10-26, presumably until 2017-10-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2017-10-26 00:00:00, ended at 2017-10-26 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- thrombin, bovine 2000 UNT/ML Topical Solution, through Topical route, started on 2017-10-26, presumably until 2017-10-26\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2017-11-02 00:00:00, ended at 2017-11-02 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abdominal aortic aneurysm without rupture\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-06-29 00:00:00, ended at 2018-06-29 00:00:00\nThe patient in this visit was 72 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, started on 2018-07-02, presumably until 2018-07-02, with intended 2 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2018-11-20 00:00:00, ended at 2018-11-20 00:00:00\nThe patient in this visit was 73 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- metoprolol tartrate 25 MG Oral Tablet, started on 2018-11-20, presumably until 2018-11-20, with intended 0 refill(s). Instructions: TAKE 1 TABLET BY MOUTH TWICE DAILY\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Depressive disorder within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of depressive_disorder means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "49aefc9e33b6bb70b18a78dde8b76d6061c348249460fdc49cd670c64f6afe38", "prompt_hash": "9abe89f505100b1f18a35240455d5c0fc3cfa67e477d0bed3853f9fa4019f657", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 7, "doc": {"person_id": 115969402, "visit_occurrence_id": 68190298, "death_date": null, "visit_concept_name": "Telehealth", "visit_start_datetime": "2014-11-09 00:00:00", "visit_end_datetime": "2014-11-09 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Telehealth, started at 2014-11-09 00:00:00, ended at 2014-11-09 00:00:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression\n\n### Drug\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2014-11-09, presumably until 2015-01-19, with intended 2 refill(s). Instructions: take 20 mg by mouth Every Day.\n\n", "approximate_token_count": 126, "patient_first_visit_date": "2012-10-31 16:07:00", "patient_last_visit_date": "2017-05-09 09:34:50", "end_obs_date": "2015-11-09", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 1, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 40, "cumulated_visit_num": 40, "cumulated_approximate_token_count": 8523, "visit_cumulated": "## Visit\nThis visit record, was from Office Visit, started at 2012-10-31 16:07:00, ended at 2012-10-31 16:12:52\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychiatric diagnostic interview examination\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2012-10-31, presumably until 2012-11-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 100 MG Oral Tablet, through Oral route, started on 2012-10-31, presumably until 2012-11-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-07 00:00:00, ended at 2012-11-07 00:00:00\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2012-11-07, presumably until 2012-11-07, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY MORNING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-07 11:03:15, ended at 2012-11-07 11:25:46\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Individual psychotherapy\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2012-11-07, presumably until 2012-11-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 100 MG Oral Tablet, through Oral route, started on 2012-11-07, presumably until 2012-11-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-11-11 14:46:00, ended at 2012-11-12 15:55:00\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.5 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.75 (milli-international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Body height: 5' 9\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.19 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n\n### Condition\n- Low compliance bladder\n- Suicidal thoughts\n- Primary diagnosis: Recurrent major depression\n- Cannabis abuse\n- Episodic mood disorder\n\n### Drug\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2012-11-12, presumably until 2012-11-12\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2012-11-12, presumably until 2012-11-12\n- modafinil 100 MG Oral Tablet, through Oral route, started on 2012-11-12, presumably until 2012-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-13 09:03:29, ended at 2012-11-13 10:02:18\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Individual psychotherapy\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, through Oral route, started on 2012-11-13, presumably until 2012-11-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-09 00:00:00, ended at 2012-12-09 18:04:29\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-30 17:02:13, ended at 2012-12-30 17:05:18\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-28 09:03:39, ended at 2013-01-28 09:56:32\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-03 09:03:33, ended at 2013-02-03 09:52:28\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2013-02-03, presumably until 2013-02-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-10 13:30:49, ended at 2013-02-10 13:57:19\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2013-02-10, presumably until 2013-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-02-24 00:00:00, ended at 2013-02-24 00:00:00\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, started on 2013-02-24, presumably until 2013-03-24, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-24 09:14:58, ended at 2013-02-24 10:34:38\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-03-06 00:00:00, ended at 2013-03-06 00:00:00\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal involuntary movement\n\n### Drug\n- clonazepam 0.5 MG Oral Tablet, through Oral route, started on 2013-03-06, presumably until 2013-04-21, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-03-10 10:04:35, ended at 2013-03-10 10:31:02\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- escitalopram 5 MG Oral Tablet, through Oral route, started on 2013-03-10, presumably until 2013-04-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. After 7 days, decrease to 1/2 tablet daily.\n- vilazodone, through Oral route, started on 2013-03-10, presumably until 2013-03-26, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day. After 7 days, increase to 20 mg every day.  After another 7 days increase to 40 mg every day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-03-24 10:04:46, ended at 2013-03-24 10:47:56\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2013-03-24, presumably until 2013-04-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-03-26 00:00:00, ended at 2013-03-26 00:00:00\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- vilazodone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2013-03-26, presumably until 2013-04-21, with intended 0 refill(s). Instructions: take 20 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-07 10:02:25, ended at 2013-04-07 10:19:13\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-21 09:58:13, ended at 2013-04-21 11:05:06\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-09-01, with intended 1 refill(s). Instructions: take 1 Tab by mouth every morning.\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-09-01, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-29 00:00:00, ended at 2013-09-29 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression in full remission\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2013-09-29, presumably until 2014-01-09, with intended 2 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2013-09-29, presumably until 2014-01-16, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2013-09-29, presumably until 2014-01-16, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-09 00:00:00, ended at 2014-01-09 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2014-01-09, presumably until 2014-01-16, with intended 2 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY MORNING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-16 14:35:03, ended at 2014-01-16 14:56:03\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression in full remission\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-01-16, presumably until 2014-03-27, with intended 2 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2014-01-16, presumably until 2014-03-27, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2014-01-16, presumably until 2014-02-03, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-21 10:08:00, ended at 2014-01-21 23:59:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 94 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Recurrent major depression\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-01-26 00:00:00, ended at 2014-01-26 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Episodic mood disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-30 11:26:00, ended at 2014-01-30 23:59:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Episodic mood disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-17 10:56:18, ended at 2014-02-17 12:47:46\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2014-02-17, presumably until 2014-03-11, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-27 00:00:00, ended at 2014-02-27 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.28 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.85 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.11 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2014-02-27 19:38:00, ended at 2014-02-28 00:52:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 150 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Collection of venous blood by venipuncture\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n\n### Condition\n- Primary diagnosis: Abdominal pain\n- Right lower quadrant pain\n- Splenomegaly\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-03-11 00:00:00, ended at 2014-03-11 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-05-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-27 09:09:22, ended at 2014-03-27 12:53:08\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression in full remission\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-03-27, presumably until 2014-05-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2014-03-27, presumably until 2014-05-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-08 10:05:40, ended at 2014-05-08 10:14:26\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression in full remission\n- Recurrent major depression\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2014-05-08, presumably until 2014-08-05, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-05-08, presumably until 2014-09-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2014-05-08, presumably until 2014-09-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-05 00:00:00, ended at 2014-08-05 00:00:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, started on 2014-08-05, presumably until 2014-08-26, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-08-26 00:00:00, ended at 2014-08-26 00:00:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2014-08-26, presumably until 2014-10-01, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-27 15:15:15, ended at 2014-08-27 15:28:17\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-16 08:52:44, ended at 2014-09-16 09:41:59\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression in full remission\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-09-16, presumably until 2014-10-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2014-09-16, presumably until 2014-10-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-22 08:34:00, ended at 2014-09-22 23:59:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 208 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 132 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.1 (ratio)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Recurrent major depression in full remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-30 11:06:24, ended at 2014-09-30 13:08:46\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2014-09-30, presumably until 2014-10-20, with intended 0 refill(s). Instructions: take 20 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-10-16 00:00:00, ended at 2014-10-16 00:00:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression in full remission\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-10-16, presumably until 2014-11-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2014-10-16, presumably until 2014-11-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-20 12:28:21, ended at 2014-10-20 12:59:21\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression\n\n### Drug\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2014-10-20, presumably until 2014-11-09, with intended 2 refill(s). Instructions: take 20 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-11-03 23:26:00, ended at 2014-11-06 15:40:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.0 (ratio)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 929 (picogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 139 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.02 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.78 (milli-international unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Body height: 5' 9\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 216 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.09 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.6 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.9 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n\n### Procedure\n- Therapeutic procedure(s), group (2 or more individuals)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Occupational therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Hospital discharge day management; 30 minutes or less\n\n### Condition\n- Cannabis abuse\n- Low compliance bladder\n- Recurrent major depression\n- Sinus node dysfunction\n- Suicidal thoughts\n- Cocaine abuse\n- Alcohol abuse\n- Alcohol-induced organic mental disorder\n\n### Drug\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2014-11-04, presumably until 2014-11-05\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2014-11-04, presumably until 2014-11-05\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-11-04, presumably until 2014-11-04\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, through Oral route, started on 2014-11-05, presumably until 2014-11-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- isotretinoin 40 MG Oral Capsule, through Oral route, started on 2014-11-04, presumably until 2014-11-06\n- modafinil 100 MG Oral Tablet, through Oral route, started on 2014-11-04, presumably until 2014-11-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-09 00:00:00, ended at 2014-11-09 00:00:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression\n\n### Drug\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2014-11-09, presumably until 2015-01-19, with intended 2 refill(s). Instructions: take 20 mg by mouth Every Day.\n\n"}, "target": "Yes", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Depressive disorder within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-10-31 16:07:00, ended at 2012-10-31 16:12:52\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychiatric diagnostic interview examination\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2012-10-31, presumably until 2012-11-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 100 MG Oral Tablet, through Oral route, started on 2012-10-31, presumably until 2012-11-07, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2012-11-07 00:00:00, ended at 2012-11-07 00:00:00\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2012-11-07, presumably until 2012-11-07, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY MORNING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-07 11:03:15, ended at 2012-11-07 11:25:46\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Individual psychotherapy\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2012-11-07, presumably until 2012-11-13, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 100 MG Oral Tablet, through Oral route, started on 2012-11-07, presumably until 2012-11-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room and Inpatient Visit, started at 2012-11-11 14:46:00, ended at 2012-11-12 15:55:00\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCH [Entitic mass] by Automated count: 31.4 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 81.5 (percent)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.75 (milli-international unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 13 (milligram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 12.6 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.3 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.7 (percent)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 197 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.1 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 8.5 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.7 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 164 (unit per liter)\n- Body height: 5' 9\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.00 (thousand per microliter)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.19 (million per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n\n### Procedure\n- Occupational therapy evaluation\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n\n### Condition\n- Low compliance bladder\n- Suicidal thoughts\n- Primary diagnosis: Recurrent major depression\n- Cannabis abuse\n- Episodic mood disorder\n\n### Drug\n- trazodone hydrochloride 50 MG Oral Tablet, through Oral route, started on 2012-11-12, presumably until 2012-11-12\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2012-11-12, presumably until 2012-11-12\n- modafinil 100 MG Oral Tablet, through Oral route, started on 2012-11-12, presumably until 2012-11-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-11-13 09:03:29, ended at 2012-11-13 10:02:18\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Individual psychotherapy\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, through Oral route, started on 2012-11-13, presumably until 2012-11-19, with intended 0 refill(s). Instructions: take 1 Tab by mouth every morning.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-09 00:00:00, ended at 2012-12-09 18:04:29\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2012-12-30 17:02:13, ended at 2012-12-30 17:05:18\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-01-28 09:03:39, ended at 2013-01-28 09:56:32\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychotherapy, 30 minutes with patient when performed with an evaluation and management service (List separately in addition to the code for primary procedure)\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2013-01-28, presumably until 2013-02-24, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-03 09:03:33, ended at 2013-02-03 09:52:28\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- sertraline 50 MG Oral Tablet, through Oral route, started on 2013-02-03, presumably until 2013-02-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-10 13:30:49, ended at 2013-02-10 13:57:19\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- escitalopram 10 MG Oral Tablet, through Oral route, started on 2013-02-10, presumably until 2013-03-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2013-02-24 00:00:00, ended at 2013-02-24 00:00:00\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, started on 2013-02-24, presumably until 2013-03-24, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-02-24 09:14:58, ended at 2013-02-24 10:34:38\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-03-06 00:00:00, ended at 2013-03-06 00:00:00\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Abnormal involuntary movement\n\n### Drug\n- clonazepam 0.5 MG Oral Tablet, through Oral route, started on 2013-03-06, presumably until 2013-04-21, with intended 0 refill(s). Instructions: take 0.5 Tabs by mouth every bedtime.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-03-10 10:04:35, ended at 2013-03-10 10:31:02\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- escitalopram 5 MG Oral Tablet, through Oral route, started on 2013-03-10, presumably until 2013-04-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. After 7 days, decrease to 1/2 tablet daily.\n- vilazodone, through Oral route, started on 2013-03-10, presumably until 2013-03-26, with intended 0 refill(s). Instructions: take 10 mg by mouth Every Day. After 7 days, increase to 20 mg every day.  After another 7 days increase to 40 mg every day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-03-24 10:04:46, ended at 2013-03-24 10:47:56\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2013-03-24, presumably until 2013-04-21, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2013-03-26 00:00:00, ended at 2013-03-26 00:00:00\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- vilazodone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2013-03-26, presumably until 2013-04-21, with intended 0 refill(s). Instructions: take 20 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-07 10:02:25, ended at 2013-04-07 10:19:13\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-04-21 09:58:13, ended at 2013-04-21 11:05:06\nThe patient in this visit was 19 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-09-01, with intended 1 refill(s). Instructions: take 1 Tab by mouth every morning.\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2013-04-21, presumably until 2013-09-01, with intended 1 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2013-09-29 00:00:00, ended at 2013-09-29 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression in full remission\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2013-09-29, presumably until 2014-01-09, with intended 2 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2013-09-29, presumably until 2014-01-16, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2013-09-29, presumably until 2014-01-16, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-01-09 00:00:00, ended at 2014-01-09 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Major depression, single episode\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, started on 2014-01-09, presumably until 2014-01-16, with intended 2 refill(s). Instructions: TAKE 1 TAB BY MOUTH EVERY MORNING.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-01-16 14:35:03, ended at 2014-01-16 14:56:03\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression in full remission\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-01-16, presumably until 2014-03-27, with intended 2 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2014-01-16, presumably until 2014-03-27, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n- aripiprazole 2 MG Oral Tablet, through Oral route, started on 2014-01-16, presumably until 2014-02-03, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-21 10:08:00, ended at 2014-01-21 23:59:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 94 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 166 (milligram per deciliter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 61 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 2.7 (ratio)\n- Triglyceride [Moles/volume] in Serum or Plasma: 86 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Recurrent major depression\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-01-26 00:00:00, ended at 2014-01-26 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Episodic mood disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-01-30 11:26:00, ended at 2014-01-30 23:59:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hemoglobin A1c/Hemoglobin.total in Blood: 5.3 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Episodic mood disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-02-17 10:56:18, ended at 2014-02-17 12:47:46\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2014-02-17, presumably until 2014-03-11, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2014-02-27 00:00:00, ended at 2014-02-27 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 28.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 16.4 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- MCHC [Mass/volume] by Automated count: 35.6 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 62.3 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- MCV [Entitic volume] by Automated count: 87.5 (femtoliter)\n- Platelets [#/volume] in Blood by Automated count: 170 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.28 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 8.9 (percent)\n- C reactive protein [Mass/volume] in Serum or Plasma: <0.2 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 46.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.6 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.85 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.11 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocyte sedimentation rate: 2 (millimeter per hour)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2014-02-27 19:38:00, ended at 2014-02-28 00:52:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 54 (unit per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 150 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.3 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 96 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.3 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.9 (gram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.9 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n- Collection of venous blood by venipuncture\n- Computed tomography, abdomen and pelvis; with contrast material(s)\n- Ultrasound, abdominal, real time with image documentation; limited (eg, single organ, quadrant, follow-up)\n\n### Condition\n- Primary diagnosis: Abdominal pain\n- Right lower quadrant pain\n- Splenomegaly\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-03-11 00:00:00, ended at 2014-03-11 00:00:00\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2014-03-11, presumably until 2014-05-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-03-27 09:09:22, ended at 2014-03-27 12:53:08\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression in full remission\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-03-27, presumably until 2014-05-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2014-03-27, presumably until 2014-05-08, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-05-08 10:05:40, ended at 2014-05-08 10:14:26\nThe patient in this visit was 20 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression in full remission\n- Recurrent major depression\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2014-05-08, presumably until 2014-08-05, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-05-08, presumably until 2014-09-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2014-05-08, presumably until 2014-09-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2014-08-05 00:00:00, ended at 2014-08-05 00:00:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, started on 2014-08-05, presumably until 2014-08-26, with intended 0 refill(s). Instructions: TAKE 1 TAB BY MOUTH DAILY.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-08-26 00:00:00, ended at 2014-08-26 00:00:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- aripiprazole 5 MG Oral Tablet, through Oral route, started on 2014-08-26, presumably until 2014-10-01, with intended 2 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-08-27 15:15:15, ended at 2014-08-27 15:28:17\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-16 08:52:44, ended at 2014-09-16 09:41:59\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression in full remission\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-09-16, presumably until 2014-10-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2014-09-16, presumably until 2014-10-16, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2014-09-22 08:34:00, ended at 2014-09-22 23:59:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Cholesterol [Mass/volume] in Serum or Plasma: 208 (milligram per deciliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 76 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay: 132 (milligram per deciliter)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 3.1 (ratio)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 68 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Recurrent major depression in full remission\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-09-30 11:06:24, ended at 2014-09-30 13:08:46\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Recurrent major depression\n\n### Drug\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2014-09-30, presumably until 2014-10-20, with intended 0 refill(s). Instructions: take 20 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-10-16 00:00:00, ended at 2014-10-16 00:00:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression in full remission\n\n### Drug\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-10-16, presumably until 2014-11-06, with intended 3 refill(s). Instructions: take 1 Tab by mouth every morning.\n- modafinil 200 MG Oral Tablet, through Oral route, started on 2014-10-16, presumably until 2014-11-10, with intended 3 refill(s). Instructions: take 1 Tab by mouth daily.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2014-10-20 12:28:21, ended at 2014-10-20 12:59:21\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression\n\n### Drug\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2014-10-20, presumably until 2014-11-09, with intended 2 refill(s). Instructions: take 20 mg by mouth Every Day.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2014-11-03 23:26:00, ended at 2014-11-06 15:40:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Lymphocytes/100 leukocytes in Blood by Automated count: 33.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 186 (thousand per microliter)\n- Triglyceride [Moles/volume] in Serum or Plasma: 116 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Cholesterol.total/Cholesterol in HDL [Mass Ratio] in Serum or Plasma: 4.0 (ratio)\n- Cobalamin (Vitamin B12) [Mass/volume] in Serum or Plasma: 929 (picogram per milliliter)\n- Glucose [Mass/volume] in Serum or Plasma: 86 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 15.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.2 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 57 (unit per liter)\n- Cholesterol in HDL [Mass/volume] in Serum or Plasma: 54 (milligram per deciliter)\n- Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation: 139 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 45.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.32 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.02 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 8.0 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 2.78 (milli-international unit per liter)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Body height: 5' 9\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 9.4 (milligram per deciliter)\n- Cholesterol [Mass/volume] in Serum or Plasma: 216 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.2 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 101 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 5.09 (million per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.2 (milligram per deciliter)\n- Cholesterol non HDL/Cholesterol.total [Mass Ratio] in Serum or Plasma: 2.6 (ratio)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD): N/A (milliliter per minute per square meter)\n- MCV [Entitic volume] by Automated count: 89.5 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 135 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 26 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 0.52 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.9 (percent)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n\n### Procedure\n- Therapeutic procedure(s), group (2 or more individuals)\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Occupational therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only\n- Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moder\n- Hospital discharge day management; 30 minutes or less\n\n### Condition\n- Cannabis abuse\n- Low compliance bladder\n- Recurrent major depression\n- Sinus node dysfunction\n- Suicidal thoughts\n- Cocaine abuse\n- Alcohol abuse\n- Alcohol-induced organic mental disorder\n\n### Drug\n- hydroxyzine hydrochloride 25 MG Oral Tablet, through Oral route, started on 2014-11-04, presumably until 2014-11-05\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2014-11-04, presumably until 2014-11-05\n- 24 HR bupropion hydrochloride 150 MG Extended Release Oral Tablet, through Oral route, started on 2014-11-04, presumably until 2014-11-04\n- 24 HR bupropion hydrochloride 300 MG Extended Release Oral Tablet, through Oral route, started on 2014-11-05, presumably until 2014-11-10, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily.\n- isotretinoin 40 MG Oral Capsule, through Oral route, started on 2014-11-04, presumably until 2014-11-06\n- modafinil 100 MG Oral Tablet, through Oral route, started on 2014-11-04, presumably until 2014-11-06\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2014-11-09 00:00:00, ended at 2014-11-09 00:00:00\nThe patient in this visit was 21 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Recurrent major depression\n\n### Drug\n- lurasidone hydrochloride 20 MG Oral Tablet, through Oral route, started on 2014-11-09, presumably until 2015-01-19, with intended 2 refill(s). Instructions: take 20 mg by mouth Every Day.\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Depressive disorder within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of depressive_disorder means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["Yes"]], "filtered_resps": ["Yes"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "df31a424bb6d061500377a814e9da125acbedc6215a2ed08c8b0c095aa7fde2d", "prompt_hash": "df238b5652b9966b8aa93d3b25cfc9f41d957e2762bb68d1444e0c57a675b2c5", "target_hash": "85a39ab345d672ff8ca9b9c6876f3adcacf45ee7c1e2dbd2408fd338bd55e07e", "exact_match": 1.0, "f1_gu_yn": [1, 1], "recall_gu_yn": [1, 1]}
{"doc_id": 8, "doc": {"person_id": 115969886, "visit_occurrence_id": 39082554, "death_date": null, "visit_concept_name": "Pharmacy visit", "visit_start_datetime": "2010-03-19 00:00:00", "visit_end_datetime": "2010-03-19 00:00:00", "visit_length_in_hours": 0.0, "integrated_visit_record": "## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-19 00:00:00, ended at 2010-03-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-10-13, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n", "approximate_token_count": 135, "patient_first_visit_date": "2009-01-29 09:00:00", "patient_last_visit_date": "2013-12-28 00:00:00", "end_obs_date": "2011-03-19", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "recurrent", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "recurrent", "coronary_arteriosclerosis_one_year_diagnosis": 1, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "recurrent", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 1, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 71, "cumulated_visit_num": 71, "cumulated_approximate_token_count": 29932, "visit_cumulated": "## Visit\nThis visit record, was from Hospital, started at 2009-01-29 09:00:00, ended at 2009-01-29 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-01-29, presumably until 2009-01-29\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-01-29, presumably until 2009-01-29\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-01-29, presumably until 2009-01-29\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-01-29, presumably until 2009-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-01-30 09:40:00, ended at 2009-01-30 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-01-30, presumably until 2009-01-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-02-18 10:00:00, ended at 2009-02-18 10:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.5 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 157 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 450 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-02-18, presumably until 2009-02-18\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-02-18, presumably until 2009-02-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-02-18, presumably until 2009-02-18\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-02-18, presumably until 2009-02-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-02-19 08:40:00, ended at 2009-02-19 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-02-19, presumably until 2009-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-03-11 10:18:00, ended at 2009-03-11 11:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.37 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 178 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.26 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 354 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-03-11, presumably until 2009-03-11\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-03-11, presumably until 2009-03-11\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-03-11, presumably until 2009-03-11\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-03-11, presumably until 2009-03-11\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-03-11, presumably until 2009-03-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-03-12 09:20:00, ended at 2009-03-12 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-03-12, presumably until 2009-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-04-01 10:38:00, ended at 2009-04-01 11:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 365 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.34 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-04-01, presumably until 2009-04-01\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-04-01, presumably until 2009-04-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-04-01, presumably until 2009-04-01\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-04-01, presumably until 2009-04-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-04-02 09:39:00, ended at 2009-04-02 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-04-02, presumably until 2009-04-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-13 12:50:00, ended at 2009-08-13 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-26 10:17:00, ended at 2009-08-26 11:06:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.71 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.58 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.3 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-26 11:07:00, ended at 2009-08-26 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n- Reticulosarcoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-02 00:00:00, ended at 2009-09-02 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-02 09:00:00, ended at 2009-09-02 12:36:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Diagnostic bone marrow; biopsy(ies)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Reticulosarcoma\n- Anemia\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-02 12:37:00, ended at 2009-09-02 14:42:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 161 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Body height: 5' 10.866\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.72 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.87 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n\n### Procedure\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; separation and identification by high resolution technique (eg, capillary electrophoresis), each nucleic acid preparation\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-09-02 14:43:00, ended at 2009-09-04 17:05:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 10.866\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.82 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 293 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n- Injection or infusion of biological response modifier [BRM] as an antineoplastic agent\n\n### Condition\n- Acquired absence of organ\n- Depressive disorder\n- Malignant lymphoma of lymph nodes of multiple sites\n- Hyperlipidemia\n- Acquired hypothyroidism\n- Atrial fibrillation\n- Malignant lymphoma\n- Gastroesophageal reflux disease\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04. Instructions: take 1 Tab by mouth 2 times a day. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed Take twice a day for 4 days after chemo and then as needed for nausea \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-02\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-04. Instructions: take 1 Tab by mouth daily. \n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04. Instructions: take 125 mcg by mouth daily. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-09-04, presumably until 2009-10-03, with quantity of 40.0, with intended 1 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2010-01-14, with quantity of 0.0, with intended 0 refill(s). Instructions: take by mouth daily.\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-09-02, presumably until 2009-09-24, with intended 3 refill(s). Instructions: 0.6 mL by SUBCUTANEOUS route One Time. \n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-09-04, presumably until 2009-09-04\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-09-02, presumably until 2009-09-02\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-17, with quantity of 120.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-03\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2010-01-23, with quantity of 30.0, with intended 1 refill(s). Instructions: take 8 mg by mouth 2 times a day. Take 2 times per day for 4 days after chemo and then as needed for nausea and vomiting \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-10 00:00:00, ended at 2009-09-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-10 00:00:00, ended at 2009-09-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-17 09:47:00, ended at 2009-09-17 11:28:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-17 11:29:00, ended at 2009-09-17 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 183 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.59 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 157 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-09-19 00:00:00, ended at 2009-09-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 07:58:00, ended at 2009-09-23 08:40:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.63 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Prothrombin time (PT): 13.6 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 142 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.7 (second)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 08:41:00, ended at 2009-09-23 11:07:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Reticulosarcoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 11:08:00, ended at 2009-09-23 16:25:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Carbon monoxide diffusing capacity (eg, single breath, steady state)\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-09-23 16:26:00, ended at 2009-09-25 17:30:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 11.654\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.37 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n\n### Condition\n- Depressive disorder\n- Malignant lymphoma of lymph nodes of multiple sites\n- Gastroesophageal reflux disease\n- Acquired hypothyroidism\n- Malignant lymphoma\n- Chronic pain\n- Hyperlipidemia\n- Right upper quadrant pain\n- Atrial fibrillation\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25. Instructions: take 1 Tab by mouth 2 times a day. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-24\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-23\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 1 Tab by mouth daily. \n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25. Instructions: take 1 Tab by mouth 2 times a day. \n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 125 mcg by mouth daily. \n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 125 mcg by mouth daily. \n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-09-23, presumably until 2009-09-23\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-10-01, with quantity of 0.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day before meals and bedtime. For 4 days after chemo and then as needed \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-03 10:00:00, ended at 2009-10-03 13:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Antineoplastic poisoning\n- Malignant lymphoma\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-03 12:17:32, ended at 2009-10-03 12:34:14\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Atrial fibrillation\n- Malignant lymphoma\n- Aneurysm of thoracic aorta\n- Congenital insufficiency of aortic valve\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-10-03, presumably until 2010-01-14, with quantity of 90.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 3 times a day. \n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-10-03, presumably until 2010-01-23, with quantity of 30.0, with intended 6 refill(s). Instructions: take 10 mEq by mouth Every Day. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-10-03, presumably until 2010-03-13. Instructions: take 1 Cap by mouth 2 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-03 14:00:00, ended at 2009-10-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-22 10:48:00, ended at 2009-10-22 10:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Malignant lymphoma\n- Hodgkin's disease (clinical)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-22 11:00:00, ended at 2009-10-22 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.24 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 398 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.97 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- rifampin 300 MG Oral Capsule, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 14.0, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. Start on 12/2 and Stop on first day of apheresis. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours. Start after chemo and continue for 4-5 days post chemo \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 28.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Start on 12/2 and Stop on first day of apheresis. \n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2010-01-23, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting. \n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-10-22, presumably until 2009-10-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-27 08:39:00, ended at 2009-10-27 14:55:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- Removal of foreign body from skin and/or subcutaneous tissue by incision\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Ultrasonography of head and neck\n- Removal of tunneled central venous access device, with subcutaneous port or pump, central or peripheral insertion\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Venous catheterization, not elsewhere classified\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-28 08:00:00, ended at 2009-10-28 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-10-28, presumably until 2009-10-28\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-10-28, presumably until 2009-10-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-10-28, presumably until 2009-10-28\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-10-28, presumably until 2009-10-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-03 13:24:00, ended at 2009-11-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 315 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 18.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-11-03, presumably until 2009-11-03\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-03, presumably until 2009-11-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-11-03, presumably until 2009-11-03\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-11-03, presumably until 2009-11-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-11-04 10:49:00, ended at 2009-11-05 14:15:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 289 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 206 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Body height: 6' .441\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n- Injection or infusion of biological response modifier [BRM] as an antineoplastic agent\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Congenital insufficiency of aortic valve\n- Depressive disorder\n- Gastroesophageal reflux disease\n- Malignant lymphoma of lymph nodes of inguinal region AND/OR lower limb\n- Hyperlipidemia\n- Malignant lymphoma\n- Acquired hypothyroidism\n- Atrial fibrillation\n- Acquired absence of organ\n- Diffuse large B-cell lymphoma (nodal/systemic with skin involvement)\n\n### Drug\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-11-05, presumably until 2009-11-05\n- acetazolamide 250 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-11-04, presumably until 2009-11-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-04\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-11-04, presumably until 2009-11-04\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-11-04, presumably until 2009-11-04\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-04, presumably until 2009-11-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-11-05, presumably until 2009-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-14 07:25:00, ended at 2009-11-14 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.20 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 58 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.82 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.8 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-14, presumably until 2009-11-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-16 07:14:00, ended at 2009-11-16 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 101.0 (femtoliter)\n- Body height: 5' 11.654\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 18 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 27.5 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 29.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-16, presumably until 2009-11-16\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-16, presumably until 2009-11-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 07:30:00, ended at 2009-11-17 17:15:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- MCV [Entitic volume] by Automated count: 104.0 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 45 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 34.7 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-17, presumably until 2009-11-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 17:16:00, ended at 2009-11-17 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-17, presumably until 2009-11-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-18 07:30:00, ended at 2009-11-18 17:13:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 45 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 49.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.20 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-18, presumably until 2009-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-18 17:14:00, ended at 2009-11-18 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-18, presumably until 2009-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-19 07:30:00, ended at 2009-11-19 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 33 (thousand per microliter)\n- Body height: 5' 11.969\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 52.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.03 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-19, presumably until 2009-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-19 17:30:00, ended at 2009-11-19 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-19, presumably until 2009-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-20 07:30:00, ended at 2009-11-20 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 53.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 103.0 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 28 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-20, presumably until 2009-11-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-20 17:30:00, ended at 2009-11-20 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-20, presumably until 2009-11-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 07:30:00, ended at 2009-11-21 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.86 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.9 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 54.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 20 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.8 (percent)\n- Body height: 5' 11.969\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2010-01-14. Instructions: take 500 mg by mouth as needed \n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-21, presumably until 2009-11-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 09:08:00, ended at 2009-12-03 12:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Bone marrow transplant present\n- Disorder of gallbladder\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 13:00:00, ended at 2009-12-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.9 (femtoliter)\n- CD3+CD4+ (T4 helper) cells [#/volume] in Blood: 165 (per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- CD19 cells [#/volume] in Blood: 0 (per microliter)\n- CD3 cells/100 cells in Blood: 87 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- CD19 cells/100 cells in Blood: 0 (percent)\n- CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood: 585 (per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.12 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- CD3 cells [#/volume] in Blood: 717 (per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-09 17:17:00, ended at 2009-12-09 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-12-09, presumably until 2009-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-10 07:21:00, ended at 2009-12-10 16:41:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 67.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 106.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 31 (percent)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 7.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 11 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 5 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 54.9 (thousand per microliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, presumably until 2009-12-24. Instructions: 22.5 mg by SUBCUTANEOUS route as directed. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-10 16:42:00, ended at 2009-12-10 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-12-10, presumably until 2009-12-10\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-12-10, presumably until 2009-12-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-11 07:14:00, ended at 2009-12-11 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 94 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 265 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 461 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 78.0 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.19 (million per microliter)\n- MCV [Entitic volume] by Automated count: 106.0 (femtoliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-11, presumably until 2009-12-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-12 07:30:00, ended at 2009-12-12 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 73.9 (thousand per microliter)\n- Body height: 5' 11.969\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 51 (thousand per microliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-12-12, presumably until 2009-12-12\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-12, presumably until 2009-12-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 13:53:00, ended at 2009-12-24 14:17:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 14:18:00, ended at 2009-12-24 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.00 (million per microliter)\n- MCH [Entitic mass] by Automated count: 35.4 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- MCV [Entitic volume] by Automated count: 105.4 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.55 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-25 09:33:00, ended at 2010-01-14 14:30:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 125 (unit per liter)\n- MCH [Entitic mass] by Automated count: 36.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Body height: 6' .598\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.1 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.74 (micro-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.15 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 41 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n\n### Procedure\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Injection procedure during cardiac catheterization; for selective left ventricular or left atrial angiography\n- Autologous bone marrow transplant without purging\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n- Intravascular pressure measurement of coronary arteries\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Platelet transfusion\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Packed blood cell transfusion\n- Therapeutic procedure(s), group (2 or more individuals)\n- Angiocardiography of left heart\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; ventricular and/or atrial angiography\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Infusion chemotherapy for malignant neoplasm\n- Catheterization of left heart\n- Coronary arteriography using two catheters\n- Left heart catheterization, retrograde, from the brachial artery, axillary artery or femoral artery; percutaneous\n- Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary pro\n\n### Condition\n- Lung field abnormal\n- Acute subendocardial infarction\n- Atrial fibrillation\n- Depressive disorder\n- Tachycardia\n- Acquired hypothyroidism\n- Malignant lymphoma\n- Coronary arteriosclerosis\n- Iatrogenic hypotension\n- Osteoarthritis\n- Disorder of teeth AND/OR supporting structures\n- Malignant lymphoma of lymph nodes of inguinal region AND/OR lower limb\n- Arthropathy\n- Gastroesophageal reflux disease\n- Hodgkin's disease, nodular sclerosis (clinical)\n- Anxiety state\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2009-12-28, presumably until 2010-01-01\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2010-03-19, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-31, presumably until 2010-01-14\n- acetazolamide 250 MG Oral Tablet, through Oral route, started on 2009-12-29, presumably until 2009-12-31\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-01-03, presumably until 2010-01-03\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-25\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-30\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2009-12-30, presumably until 2010-01-13\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-12-25, presumably until 2010-01-12\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2010-01-01, presumably until 2011-01-14, with quantity of 90.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day. \n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-29\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-28\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2009-12-25, presumably until 2010-01-13\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2009-12-29, presumably until 2010-01-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-01-13\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2010-01-14, presumably until 2011-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 40 mg by mouth every morning before breakfast. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-25, presumably until 2009-12-25\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2009-12-31, presumably until 2010-01-01\n- neomycin sulfate 500 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-01-12\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2010-01-07, presumably until 2010-01-09\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2009-12-26, presumably until 2009-12-26\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2010-01-02\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2010-01-14, presumably until 2010-04-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 500 mg by mouth every 6 hours as needed \n- aspirin 325 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-28\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2010-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-28\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2009-12-31, presumably until 2011-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-12-27, presumably until 2010-01-05\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-02-11, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2010-01-02, presumably until 2010-01-14\n- 50 ML ondansetron 0.64 MG/ML Injection, through Intravenous route, started on 2009-12-26, presumably until 2009-12-31\n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-01-04, presumably until 2010-01-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-12-31, presumably until 2009-12-31\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-26\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-30\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2009-12-25, presumably until 2010-01-11\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-27\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2010-01-06, presumably until 2010-01-12\n- soybean oil 200 MG/ML Injectable Suspension, through Intravenous route, started on 2010-01-02, presumably until 2010-01-11\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2010-01-03, presumably until 2010-01-11\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2010-01-01\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-25, presumably until 2010-01-02\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-25\n- clindamycin 0.01 MG/MG Topical Gel, through Topical route, started on 2010-01-07, presumably until 2010-01-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-12-27, presumably until 2009-12-28\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2010-01-07, presumably until 2010-01-09\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-01-10, presumably until 2010-01-10\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2009-12-25, presumably until 2010-01-01\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2009-12-27, presumably until 2010-01-13\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-01-01\n- vancomycin 250 MG Oral Capsule, through Oral route, started on 2010-01-04, presumably until 2010-01-12\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2009-12-27, presumably until 2010-01-09\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2010-01-01, presumably until 2010-01-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-26 09:21:21, ended at 2009-12-26 18:07:01\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Aortic valve disorder\n- Antineoplastic poisoning\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-15 11:22:00, ended at 2010-01-15 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 163 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 28 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.64 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-01-15, presumably until 2010-01-15\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2010-01-15, presumably until 2010-01-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-01-15, presumably until 2010-01-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 09:19:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.96 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 81 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Multiple myeloma\n- Malignant lymphoma\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-01-19, presumably until 2010-01-19\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2010-01-19, presumably until 2010-01-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-23 12:21:00, ended at 2010-01-23 12:22:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- MCV [Entitic volume] by Automated count: 100.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-23 12:23:00, ended at 2010-01-23 13:29:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2010-03-13. Instructions: take 80 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-04 14:04:00, ended at 2010-02-04 14:21:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.53 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.16 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-04 14:22:00, ended at 2010-02-04 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-03-13. Instructions: take 81 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-11 09:55:55, ended at 2010-02-11 11:46:16\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Coronary atherosclerosis\n\n### Drug\n- citalopram 20 MG Oral Tablet, through Oral route. Instructions: take 20 mg by mouth 2 times a day. \n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2011-02-04, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2010-02-11. Instructions: take by mouth daily. \n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2010-03-13, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals. \n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2010-03-25. Instructions: by Sublingual route as needed \n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2010-05-06, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-11 11:57:00, ended at 2010-02-11 13:06:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-11 13:07:00, ended at 2010-02-11 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.02 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.32 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-02-13 00:00:00, ended at 2010-02-13 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-02-13, presumably until 2011-02-13, with quantity of 30.0. Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:00:00, ended at 2010-02-20 11:27:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:28:00, ended at 2010-02-20 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.32 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.13 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- MCV [Entitic volume] by Automated count: 100.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-02 10:44:00, ended at 2010-03-03 11:48:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Body height: 6' .047\" (inch (US))\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.08 (million per microliter)\n- Potassium [Moles/volume] in Blood: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood: 35 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n\n### Procedure\n- Percutaneous transluminal coronary angioplasty\n- Transcatheter placement of an intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel\n- Procedure on single vessel\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Placement of stent in coronary artery\n- Insertion of one vascular stent\n\n### Condition\n- Coronary arteriosclerosis\n- Malignant lymphoma\n- Bone marrow transplant present\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-02\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-13 13:07:00, ended at 2010-03-13 13:37:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.52 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.88 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.42 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-13 13:38:00, ended at 2010-03-13 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-19 00:00:00, ended at 2010-03-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-10-13, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Depressive disorder within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Hospital, started at 2009-01-29 09:00:00, ended at 2009-01-29 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-01-29, presumably until 2009-01-29\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-01-29, presumably until 2009-01-29\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-01-29, presumably until 2009-01-29\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-01-29, presumably until 2009-01-29\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-01-30 09:40:00, ended at 2009-01-30 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-01-30, presumably until 2009-01-30\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-02-18 10:00:00, ended at 2009-02-18 10:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 15.6 (percent)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.5 (femtoliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 105 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 157 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.89 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.4 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 4.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 6.44 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 20 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 74.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 450 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.3 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-02-18, presumably until 2009-02-18\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-02-18, presumably until 2009-02-18\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-02-18, presumably until 2009-02-18\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-02-18, presumably until 2009-02-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-02-19 08:40:00, ended at 2009-02-19 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-02-19, presumably until 2009-02-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-03-11 10:18:00, ended at 2009-03-11 11:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 113 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.37 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.7 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 178 (unit per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.9 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.7 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.2 (percent)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.5 (percent)\n- Anion gap in Serum or Plasma: 8 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.3 (percent)\n- MCHC [Mass/volume] by Automated count: 34.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 96.7 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.41 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.26 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 354 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-03-11, presumably until 2009-03-11\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-03-11, presumably until 2009-03-11\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-03-11, presumably until 2009-03-11\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-03-11, presumably until 2009-03-11\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-03-11, presumably until 2009-03-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-03-12 09:20:00, ended at 2009-03-12 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-03-12, presumably until 2009-03-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-04-01 10:38:00, ended at 2009-04-01 11:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 19.7 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- MCHC [Mass/volume] by Automated count: 34.3 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 130 (unit per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 2.7 (gram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.38 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 365 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 97.4 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.7 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.3 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 19 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 95 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.34 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.0 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-04-01, presumably until 2009-04-01\n- 5 ML palonosetron 0.05 MG/ML Injection, through Intravenous route, started on 2009-04-01, presumably until 2009-04-01\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-04-01, presumably until 2009-04-01\n- 5 ML doxorubicin hydrochloride 2 MG/ML Injection, through Intravenous route, started on 2009-04-01, presumably until 2009-04-01\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-04-02 09:39:00, ended at 2009-04-02 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-04-02, presumably until 2009-04-02\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-13 12:50:00, ended at 2009-08-13 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-26 10:17:00, ended at 2009-08-26 11:06:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.9 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.28 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.71 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.5 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.3 (percent)\n- Platelets [#/volume] in Blood by Automated count: 281 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.20 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.58 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.8 (percent)\n- MCH [Entitic mass] by Automated count: 31.1 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.3 (percent)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 18 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 6.6 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.16 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-08-26 11:07:00, ended at 2009-08-26 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n- Reticulosarcoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-02 00:00:00, ended at 2009-09-02 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-02 09:00:00, ended at 2009-09-02 12:36:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Decalcification procedure (List separately in addition to code for surgical pathology examination)\n- Diagnostic bone marrow; biopsy(ies)\n- Level IV - Surgical pathology, gross and microscopic examination Abortion - spontaneous/missed Artery, biopsy Bone marrow, biopsy Bone exostosis Brain/meninges, other than for tumor resection Breast, biopsy, not requiring microscopic evaluation of surgica\n\n### Condition\n- Reticulosarcoma\n- Anemia\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-02 12:37:00, ended at 2009-09-02 14:42:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.1 (percent)\n- Globulin [Mass/volume] in Serum: 3.1 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 38.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.2 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.6 (picogram)\n- MCV [Entitic volume] by Automated count: 92.8 (femtoliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Urate [Mass/volume] in Serum or Plasma: 5.1 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 161 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.17 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Anion gap in Serum or Plasma: 4 (millimole per liter)\n- Body height: 5' 10.866\" (inch (US))\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.7 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.72 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.01 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.87 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 56.1 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 4.0 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 2.0 (percent)\n\n### Procedure\n- Molecular diagnostics; separation by gel electrophoresis (eg, agarose, polyacrylamide), each nucleic acid preparation\n- Molecular diagnostics; isolation or extraction of highly purified nucleic acid, each nucleic acid type (ie, DNA or RNA)\n- Molecular diagnostics; amplification, target, multiplex, each additional nucleic acid sequence beyond 2 (List separately in addition to code for primary procedure)\n- Molecular diagnostics; amplification, target, multiplex, first 2 nucleic acid sequences\n- Molecular diagnostics; interpretation and report\n- Molecular diagnostics; separation and identification by high resolution technique (eg, capillary electrophoresis), each nucleic acid preparation\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-09-02 14:43:00, ended at 2009-09-04 17:05:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Anion gap in Serum or Plasma: 7 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.5 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 107 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.8 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.0 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 10.866\" (inch (US))\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.23 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.80 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 1.3 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 8.82 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 15 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 138 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 29 (millimole per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 293 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.7 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.13 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 90.4 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.1 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.2 (percent)\n- MCV [Entitic volume] by Automated count: 94.1 (femtoliter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n- Injection or infusion of biological response modifier [BRM] as an antineoplastic agent\n\n### Condition\n- Acquired absence of organ\n- Depressive disorder\n- Malignant lymphoma of lymph nodes of multiple sites\n- Hyperlipidemia\n- Acquired hypothyroidism\n- Atrial fibrillation\n- Malignant lymphoma\n- Gastroesophageal reflux disease\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04. Instructions: take 1 Tab by mouth 2 times a day. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04, with quantity of 30.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth every 12 hours as needed Take twice a day for 4 days after chemo and then as needed for nausea \n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-02\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-04. Instructions: take 1 Tab by mouth daily. \n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-04. Instructions: take 125 mcg by mouth daily. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-09-04, presumably until 2009-10-03, with quantity of 40.0, with intended 1 refill(s). Instructions: take 1 Cap by mouth 2 times a day. \n- dexamethasone 2 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2009-09-03\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-09-02, presumably until 2010-01-14, with quantity of 0.0, with intended 0 refill(s). Instructions: take by mouth daily.\n- 0.6 ML pegfilgrastim 10 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-09-02, presumably until 2009-09-24, with intended 3 refill(s). Instructions: 0.6 mL by SUBCUTANEOUS route One Time. \n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-09-04, presumably until 2009-09-04\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-09-02, presumably until 2009-09-02\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-17, with quantity of 120.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth 4 times a day as needed \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2009-09-03\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2009-09-03, presumably until 2010-01-23, with quantity of 30.0, with intended 1 refill(s). Instructions: take 8 mg by mouth 2 times a day. Take 2 times per day for 4 days after chemo and then as needed for nausea and vomiting \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-10 00:00:00, ended at 2009-09-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Case Management Visit, started at 2009-09-10 00:00:00, ended at 2009-09-10 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-17 09:47:00, ended at 2009-09-17 11:28:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-17 11:29:00, ended at 2009-09-17 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.9 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.3 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.92 (million per microliter)\n- Globulin [Mass/volume] in Serum: 3.4 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 103 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 12.1 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 94.7 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 103 (millimole per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.2 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.1 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.7 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 183 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 12.59 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.4 (milligram per deciliter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 157 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.5 (percent)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 16 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Anion gap in Serum or Plasma: 12 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.28 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 15.0 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.4 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 125 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Telehealth, started at 2009-09-19 00:00:00, ended at 2009-09-19 00:00:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 07:58:00, ended at 2009-09-23 08:40:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 10.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 10.63 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.5 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.5 (percent)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 93.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.34 (thousand per microliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 263 (thousand per microliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Prothrombin time (PT): 13.6 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 13.4 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 31.9 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 142 (unit per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.68 (million per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 34.7 (second)\n- Globulin [Mass/volume] in Serum: 3.3 (gram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Neutrophils/100 leukocytes in Blood by Automated count: 79.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 25 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.10 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 93 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 08:41:00, ended at 2009-09-23 11:07:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Reticulosarcoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-09-23 11:08:00, ended at 2009-09-23 16:25:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Spirometry, including graphic record, total and timed vital capacity, expiratory flow rate measurement(s), with or without maximal voluntary ventilation\n- Carbon monoxide diffusing capacity (eg, single breath, steady state)\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-09-23 16:26:00, ended at 2009-09-25 17:30:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium [Mass/volume] in Serum or Plasma: 8.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 16.6 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.52 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.59 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Body height: 5' 11.654\" (inch (US))\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 31.8 (picogram)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- MCV [Entitic volume] by Automated count: 93.3 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.9 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.2 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 13.37 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 95.5 (percent)\n- Platelets [#/volume] in Blood by Automated count: 282 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 14.0 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.2 (percent)\n- MCHC [Mass/volume] by Automated count: 34.1 (gram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.8 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 143 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n\n### Condition\n- Depressive disorder\n- Malignant lymphoma of lymph nodes of multiple sites\n- Gastroesophageal reflux disease\n- Acquired hypothyroidism\n- Malignant lymphoma\n- Chronic pain\n- Hyperlipidemia\n- Right upper quadrant pain\n- Atrial fibrillation\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25. Instructions: take 1 Tab by mouth 2 times a day. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-24\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-23\n- dexamethasone 4 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 1 Tab by mouth daily. \n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-09-25. Instructions: take 1 Tab by mouth 2 times a day. \n- levothyroxine sodium 0.1 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 125 mcg by mouth daily. \n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25. Instructions: take 125 mcg by mouth daily. \n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-09-23, presumably until 2009-09-23\n- metoclopramide 10 MG Oral Tablet, through Oral route, started on 2009-09-23, presumably until 2009-10-01, with quantity of 0.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 4 times a day before meals and bedtime. For 4 days after chemo and then as needed \n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2009-09-24, presumably until 2009-09-25\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-03 10:00:00, ended at 2009-10-03 13:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Antineoplastic poisoning\n- Malignant lymphoma\n- Aortic valve disorder\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-03 12:17:32, ended at 2009-10-03 12:34:14\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Hyperlipidemia\n- Atrial fibrillation\n- Malignant lymphoma\n- Aneurysm of thoracic aorta\n- Congenital insufficiency of aortic valve\n\n### Drug\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-10-03, presumably until 2010-01-14, with quantity of 90.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth 3 times a day. \n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-10-03, presumably until 2010-01-23, with quantity of 30.0, with intended 6 refill(s). Instructions: take 10 mEq by mouth Every Day. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-10-03, presumably until 2010-03-13. Instructions: take 1 Cap by mouth 2 times a day as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-03 14:00:00, ended at 2009-10-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Positron emission tomography (PET) with concurrently acquired computed tomography (CT) for attenuation correction and anatomical localization imaging; skull base to mid-thigh\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-22 10:48:00, ended at 2009-10-22 10:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Malignant lymphoma\n- Hodgkin's disease (clinical)\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-22 11:00:00, ended at 2009-10-22 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.24 (million per microliter)\n- MCH [Entitic mass] by Automated count: 32.8 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 28 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 18.6 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 16.0 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 15 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.9 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- aPTT in Platelet poor plasma by Coagulation assay: 27.3 (second)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.1 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.9 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.21 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 398 (thousand per microliter)\n- Prothrombin time (PT): 13.0 (second)\n- Basophils/100 leukocytes in Blood by Automated count: 1.8 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.97 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 121 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 81 (milligram per deciliter)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- MCV [Entitic volume] by Automated count: 98.4 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- rifampin 300 MG Oral Capsule, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 14.0, with intended 2 refill(s). Instructions: take 1 Cap by mouth daily. Start on 12/2 and Stop on first day of apheresis. \n- ondansetron 8 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 8 hours. Start after chemo and continue for 4-5 days post chemo \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2009-11-14, with quantity of 28.0, with intended 3 refill(s). Instructions: take 1 Tab by mouth 2 times a day. Start on 12/2 and Stop on first day of apheresis. \n- prochlorperazine 10 MG Oral Tablet, through Oral route, started on 2009-10-22, presumably until 2010-01-23, with quantity of 30.0, with intended 1 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Nausea/Vomiting. \n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-10-22, presumably until 2009-10-22\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-27 08:39:00, ended at 2009-10-27 14:55:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- Removal of foreign body from skin and/or subcutaneous tissue by incision\n- Fluoroscopic guidance for central venous access device placement, replacement (catheter only or complete), or removal (includes fluoroscopic guidance for vascular access and catheter manipulation, any necessary contrast injections through access site or c\n- Ultrasonography of head and neck\n- Removal of tunneled central venous access device, with subcutaneous port or pump, central or peripheral insertion\n- Insertion of tunneled centrally inserted central venous catheter, without subcutaneous port or pump; age 5 years or older\n- Venous catheterization, not elsewhere classified\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-10-28 08:00:00, ended at 2009-10-28 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-10-28, presumably until 2009-10-28\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-10-28, presumably until 2009-10-28\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-10-28, presumably until 2009-10-28\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-10-28, presumably until 2009-10-28\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-03 13:24:00, ended at 2009-11-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.4 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- MCV [Entitic volume] by Automated count: 100.3 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 6.5 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.6 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.22 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.6 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.97 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 315 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 134 (unit per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 31 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.45 (million per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 18.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.37 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 52.7 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-11-03, presumably until 2009-11-03\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-03, presumably until 2009-11-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-11-03, presumably until 2009-11-03\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2009-11-03, presumably until 2009-11-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-11-04 10:49:00, ended at 2009-11-05 14:15:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- MCH [Entitic mass] by Automated count: 33.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.3 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 289 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 206 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 139 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.7 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Body height: 6' .441\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.8 (percent)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.21 (million per microliter)\n\n### Procedure\n- Infusion chemotherapy for malignant neoplasm\n- Injection or infusion of biological response modifier [BRM] as an antineoplastic agent\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- Congenital insufficiency of aortic valve\n- Depressive disorder\n- Gastroesophageal reflux disease\n- Malignant lymphoma of lymph nodes of inguinal region AND/OR lower limb\n- Hyperlipidemia\n- Malignant lymphoma\n- Acquired hypothyroidism\n- Atrial fibrillation\n- Acquired absence of organ\n- Diffuse large B-cell lymphoma (nodal/systemic with skin involvement)\n\n### Drug\n- 0.5 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-11-05, presumably until 2009-11-05\n- acetazolamide 250 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-11-04, presumably until 2009-11-05\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-04\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- Microencapsulated potassium chloride 10 MEQ Extended Release Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-11-04, presumably until 2009-11-04\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-11-04, presumably until 2009-11-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-11-04, presumably until 2009-11-04\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-11-05, presumably until 2009-11-05\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-04, presumably until 2009-11-05\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-11-05, presumably until 2009-11-05\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-14 07:25:00, ended at 2009-11-14 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 5.8 (percent)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 5.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.6 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.20 (million per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Platelets [#/volume] in Blood by Automated count: 58 (thousand per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.58 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.0 (picogram)\n- Monocytes [#/volume] in Blood by Automated count: 0.64 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- MCHC [Mass/volume] by Automated count: 32.9 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 9.82 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 83.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 11.8 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-14, presumably until 2009-11-14\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-16 07:14:00, ended at 2009-11-16 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- MCV [Entitic volume] by Automated count: 101.0 (femtoliter)\n- Body height: 5' 11.654\" (inch (US))\n- Lymphocytes [#/volume] in Blood by Manual count: 0.9 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.16 (million per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 3 (percent)\n- Neutrophils/100 leukocytes in Blood by Manual count: 18 (percent)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.18 (millimole per liter)\n- Monocytes [#/volume] in Blood by Manual count: 0.6 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Manual count: 27.5 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 29.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 77 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-16, presumably until 2009-11-16\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-16, presumably until 2009-11-16\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 07:30:00, ended at 2009-11-17 17:15:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 5' 11.654\" (inch (US))\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- MCV [Entitic volume] by Automated count: 104.0 (femtoliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 45 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.05 (million per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 34.7 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-17, presumably until 2009-11-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-17 17:16:00, ended at 2009-11-17 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-17, presumably until 2009-11-17\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-18 07:30:00, ended at 2009-11-18 17:13:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.04 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.1 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.3 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.0 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 45 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.2 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 49.0 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.8 (picogram)\n- MCV [Entitic volume] by Automated count: 102.4 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.6 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.20 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- alteplase 1 MG/ML Injectable Solution, through Intraluminal route, started on 2009-11-18, presumably until 2009-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-18 17:14:00, ended at 2009-11-18 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-18, presumably until 2009-11-18\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-19 07:30:00, ended at 2009-11-19 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 33 (thousand per microliter)\n- Body height: 5' 11.969\" (inch (US))\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 52.5 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.03 (million per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.5 (percent)\n- MCV [Entitic volume] by Automated count: 103.2 (femtoliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-19, presumably until 2009-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-19 17:30:00, ended at 2009-11-19 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-19, presumably until 2009-11-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-20 07:30:00, ended at 2009-11-20 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 2.85 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.8 (gram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.4 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 53.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 103.0 (femtoliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 28 (thousand per microliter)\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.16 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 9.9 (gram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-20, presumably until 2009-11-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-20 17:30:00, ended at 2009-11-20 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-11-20, presumably until 2009-11-20\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-11-21 07:30:00, ended at 2009-11-21 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 2.86 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 9.7 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 103.9 (femtoliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 54.7 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 32.7 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 20 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 29.8 (percent)\n- Body height: 5' 11.969\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- acetaminophen 500 MG Oral Tablet, through Oral route, presumably until 2010-01-14. Instructions: take 500 mg by mouth as needed \n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-11-21, presumably until 2009-11-21\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 09:08:00, ended at 2009-12-03 12:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Ultrasound, abdominal, real time with image documentation; complete\n\n### Condition\n- Bone marrow transplant present\n- Disorder of gallbladder\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-03 13:00:00, ended at 2009-12-03 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.3 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 60.9 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 269 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 104.9 (femtoliter)\n- CD3+CD4+ (T4 helper) cells [#/volume] in Blood: 165 (per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 32.7 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.6 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 18 (unit per liter)\n- CD19 cells [#/volume] in Blood: 0 (per microliter)\n- CD3 cells/100 cells in Blood: 87 (percent)\n- MCH [Entitic mass] by Automated count: 34.8 (picogram)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 141 (unit per liter)\n- CD19 cells/100 cells in Blood: 0 (percent)\n- CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood: 585 (per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.12 (million per microliter)\n- Hemoglobin [Mass/volume] in Blood: 10.8 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.9 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.17 (thousand per microliter)\n- CD3 cells [#/volume] in Blood: 717 (per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 21.1 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.6 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 104 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-09 17:17:00, ended at 2009-12-09 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-12-09, presumably until 2009-12-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-10 07:21:00, ended at 2009-12-10 16:41:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Calcium.ionized [Moles/volume] in Serum or Plasma: 1.25 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 34.9 (picogram)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 67.8 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 32.8 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.23 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.3 (percent)\n- Lymphocytes [#/volume] in Blood by Manual count: 3.4 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 106.3 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 31 (percent)\n- Platelets [#/volume] in Blood by Automated count: 199 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Manual count: 2.0 (thousand per microliter)\n- Eosinophils/100 leukocytes in Blood by Manual count: 3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Manual count: 7.5 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Monocytes/100 leukocytes in Blood by Manual count: 11 (percent)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 5 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 54.9 (thousand per microliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, presumably until 2009-12-24. Instructions: 22.5 mg by SUBCUTANEOUS route as directed. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-10 16:42:00, ended at 2009-12-10 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-12-10, presumably until 2009-12-10\n- 1.2 ML plerixafor 20 MG/ML Injection, through Subcutaneous route, started on 2009-12-10, presumably until 2009-12-10\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-11 07:14:00, ended at 2009-12-11 17:29:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 42 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 142 (millimole per liter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.9 (percent)\n- Phosphate [Mass/volume] in Serum or Plasma: 3.0 (milligram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Globulin [Mass/volume] in Serum: 2.8 (gram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 101 (milligram per deciliter)\n- Protein [Mass/volume] in Serum or Plasma: 6.3 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.2 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 94 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 265 (unit per liter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 27 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 461 (unit per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.5 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.6 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 78.0 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.19 (million per microliter)\n- MCV [Entitic volume] by Automated count: 106.0 (femtoliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-11, presumably until 2009-12-11\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-12 07:30:00, ended at 2009-12-12 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Leukocytes [#/volume] in Specimen by Automated count: 73.9 (thousand per microliter)\n- Body height: 5' 11.969\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.17 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 33.2 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 105.6 (femtoliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.7 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 35.0 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 51 (thousand per microliter)\n\n### Procedure\n- Blood-derived hematopoietic progenitor cell harvesting for transplantation, per collection; autologous\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2009-12-12, presumably until 2009-12-12\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-12, presumably until 2009-12-12\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 13:53:00, ended at 2009-12-24 14:17:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Radiologic examination, chest, 2 views, frontal and lateral\n\n### Condition\n- No conditions.\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-24 14:18:00, ended at 2009-12-24 23:59:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Platelets [#/volume] in Blood by Automated count: 224 (thousand per microliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.2 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.00 (million per microliter)\n- MCH [Entitic mass] by Automated count: 35.4 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.14 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 31.6 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.68 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 15.2 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.2 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- MCV [Entitic volume] by Automated count: 105.4 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.4 (gram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 17.7 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.5 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.55 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-25 09:33:00, ended at 2010-01-14 14:30:00\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 112 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.4 (percent)\n- Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction: 125 (unit per liter)\n- MCH [Entitic mass] by Automated count: 36.0 (picogram)\n- MCHC [Mass/volume] by Automated count: 34.9 (gram per deciliter)\n- Prothrombin time (PT): 13.5 (second)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: <0.1 (nanogram per milliliter)\n- Body height: 6' .598\" (inch (US))\n- Erythrocytes [#/volume] in Blood by Automated count: 3.74 (million per microliter)\n- MCV [Entitic volume] by Automated count: 99.9 (femtoliter)\n- Monocytes/100 leukocytes in Blood by Manual count: 25 (percent)\n- Neutrophils [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 7.4 (milligram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 88 (thousand per microliter)\n- aPTT in Platelet poor plasma by Coagulation assay: 98.9 (second)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Anion gap in Serum or Plasma: <2 (millimole per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Thyroxine (T4) free [Mass/volume] in Serum or Plasma: 1.1 (nanogram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 9 (milligram per deciliter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 88 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.3 (percent)\n- Hemoglobin [Mass/volume] in Blood: 9.6 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.67 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Manual count: 0.3 (thousand per microliter)\n- Thyrotropin [Units/volume] in Serum or Plasma: 0.74 (micro-international unit per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.3 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.5 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.1 (ratio)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.6 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 8.15 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 143 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Leukocytes [#/volume] in Specimen by Automated count: 9.7 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Manual count: 0.4 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Manual count: 4 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: <10 (unit per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 8.8 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 255 (milligram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.61 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Manual count: 41 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 9.0 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: Not avail (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.7 (millimole per liter)\n\n### Procedure\n- Physical therapy evaluation\n- Therapeutic procedure, 1 or more areas, each 15 minutes; therapeutic exercises to develop strength and endurance, range of motion and flexibility\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Injection procedure during cardiac catheterization; for selective left ventricular or left atrial angiography\n- Autologous bone marrow transplant without purging\n- Injection procedure during cardiac catheterization; for selective coronary angiography (injection of radiopaque material may be by hand)\n- Radiologic examination, chest, 2 views, frontal and lateral\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; pulmonary angiography, aortography, and/or selective coronary angiography including venous bypass grafts and arterial conduits (whether native or use\n- Intravascular pressure measurement of coronary arteries\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Platelet transfusion\n- Therapeutic procedure, 1 or more areas, each 15 minutes; gait training (includes stair climbing)\n- Packed blood cell transfusion\n- Therapeutic procedure(s), group (2 or more individuals)\n- Angiocardiography of left heart\n- Imaging supervision, interpretation and report for injection procedure(s) during cardiac catheterization; ventricular and/or atrial angiography\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Infusion chemotherapy for malignant neoplasm\n- Catheterization of left heart\n- Coronary arteriography using two catheters\n- Left heart catheterization, retrograde, from the brachial artery, axillary artery or femoral artery; percutaneous\n- Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary pro\n\n### Condition\n- Lung field abnormal\n- Acute subendocardial infarction\n- Atrial fibrillation\n- Depressive disorder\n- Tachycardia\n- Acquired hypothyroidism\n- Malignant lymphoma\n- Coronary arteriosclerosis\n- Iatrogenic hypotension\n- Osteoarthritis\n- Disorder of teeth AND/OR supporting structures\n- Malignant lymphoma of lymph nodes of inguinal region AND/OR lower limb\n- Arthropathy\n- Gastroesophageal reflux disease\n- Hodgkin's disease, nodular sclerosis (clinical)\n- Anxiety state\n\n### Drug\n- hydrocortisone 100 MG Injection, started on 2009-12-28, presumably until 2010-01-01\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2010-03-19, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-31, presumably until 2010-01-14\n- acetazolamide 250 MG Oral Tablet, through Oral route, started on 2009-12-29, presumably until 2009-12-31\n- aprepitant 125 MG Oral Capsule, through Oral route, started on 2010-01-03, presumably until 2010-01-03\n- flecainide acetate 50 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-25\n- levothyroxine sodium 0.05 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-30\n- loperamide hydrochloride 2 MG Oral Capsule, through Oral route, started on 2009-12-30, presumably until 2010-01-13\n- diphenhydramine hydrochloride 50 MG/ML Injectable Solution, started on 2009-12-25, presumably until 2010-01-12\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2010-01-01, presumably until 2011-01-14, with quantity of 90.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day. \n- allopurinol 300 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-29\n- lorazepam 0.5 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-28\n- lorazepam 2 MG/ML Injectable Solution, through Intravenous route, started on 2009-12-25, presumably until 2010-01-13\n- 100 ML potassium chloride 0.1 MEQ/ML Injection, through Intravenous route, started on 2009-12-29, presumably until 2010-01-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-01-13\n- esomeprazole 20 MG Delayed Release Oral Capsule, through Oral route, started on 2010-01-14, presumably until 2011-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 40 mg by mouth every morning before breakfast. \n- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-25, presumably until 2009-12-25\n- zolpidem tartrate 5 MG Oral Tablet, through Oral route, started on 2009-12-31, presumably until 2010-01-01\n- neomycin sulfate 500 MG Oral Tablet, through Oral route, started on 2010-01-04, presumably until 2010-01-12\n- diphenhydramine hydrochloride 2.5 MG/ML Oral Solution, through Oral route, started on 2010-01-07, presumably until 2010-01-09\n- docusate sodium 10 MG/ML Oral Solution, through Oral route, started on 2009-12-26, presumably until 2009-12-26\n- acetaminophen 325 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2010-01-02\n- acetaminophen 500 MG Oral Tablet, through Oral route, started on 2010-01-14, presumably until 2010-04-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 500 mg by mouth every 6 hours as needed \n- aspirin 325 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-28\n- atorvastatin 10 MG Oral Tablet, through Oral route, started on 2010-01-02, presumably until 2010-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 2 Tabs by mouth every bedtime. \n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-28\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2009-12-31, presumably until 2011-01-14, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth daily. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-12-27, presumably until 2010-01-05\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-02-11, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- nystatin 100000 UNT/ML Oral Suspension, through Oral route, started on 2010-01-02, presumably until 2010-01-14\n- 50 ML ondansetron 0.64 MG/ML Injection, through Intravenous route, started on 2009-12-26, presumably until 2009-12-31\n- aprepitant 80 MG Oral Capsule, through Oral route, started on 2010-01-04, presumably until 2010-01-05\n- 10 ML furosemide 10 MG/ML Injection, started on 2009-12-31, presumably until 2009-12-31\n- metoprolol tartrate 25 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-26\n- levothyroxine sodium 0.025 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2009-12-30\n- heparin sodium, porcine 1000 UNT/ML Injectable Solution, started on 2009-12-25, presumably until 2010-01-11\n- sennosides, USP 8.6 MG Oral Tablet, through Oral route, started on 2009-12-27, presumably until 2009-12-27\n- 0.8 ML filgrastim 0.6 MG/ML Prefilled Syringe, started on 2010-01-06, presumably until 2010-01-12\n- soybean oil 200 MG/ML Injectable Suspension, through Intravenous route, started on 2010-01-02, presumably until 2010-01-11\n- insulin, regular, human 100 UNT/ML Injectable Solution, started on 2010-01-03, presumably until 2010-01-11\n- atorvastatin 20 MG Oral Tablet, through Oral route, started on 2009-12-26, presumably until 2010-01-01\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2009-12-25, presumably until 2010-01-02\n- aspirin 81 MG Chewable Tablet, through Oral route, started on 2009-12-25, presumably until 2009-12-25\n- clindamycin 0.01 MG/MG Topical Gel, through Topical route, started on 2010-01-07, presumably until 2010-01-13\n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-12-27, presumably until 2009-12-28\n- lidocaine hydrochloride 20 MG/ML Mucous Membrane Topical Solution, through Submucosal route, started on 2010-01-07, presumably until 2010-01-09\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-01-10, presumably until 2010-01-10\n- 250 ML heparin sodium, porcine 100 UNT/ML Injection, through Intravenous route, started on 2009-12-25, presumably until 2010-01-01\n- 100 ML potassium chloride 0.2 MEQ/ML Injection, through Intravenous route, started on 2009-12-27, presumably until 2010-01-13\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2009-12-25, presumably until 2010-01-01\n- vancomycin 250 MG Oral Capsule, through Oral route, started on 2010-01-04, presumably until 2010-01-12\n- aluminum hydroxide 40 MG/ML / magnesium hydroxide 40 MG/ML / simethicone 4 MG/ML Oral Suspension, through Oral route, started on 2009-12-27, presumably until 2010-01-09\n- ondansetron 8 MG Disintegrating Oral Tablet, through Oral route, started on 2010-01-01, presumably until 2010-01-09\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Inpatient Visit, started at 2009-12-26 09:21:21, ended at 2009-12-26 18:07:01\nThe patient in this visit was 62 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography\n\n### Condition\n- Aortic valve disorder\n- Antineoplastic poisoning\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-15 11:22:00, ended at 2010-01-15 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.5 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.91 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.75 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 106 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.8 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 163 (unit per liter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 6.3 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.6 (femtoliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 41 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.4 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 25.9 (percent)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.4 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 59.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 28 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.64 (thousand per microliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-01-15, presumably until 2010-01-15\n- heparin sodium, porcine 100 UNT/ML Prefilled Syringe, through Intravenous route, started on 2010-01-15, presumably until 2010-01-15\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-01-15, presumably until 2010-01-15\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-19 09:19:00, ended at 2010-01-19 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.5 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.1 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.96 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 81 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.49 (million per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 146 (unit per liter)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.87 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 99.8 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.8 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 120 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 1.20 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 14.9 (percent)\n- Basophils [#/volume] in Blood by Automated count: 0.04 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.0 (gram per deciliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.1 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.5 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.7 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 33 (unit per liter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.0 (gram per deciliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 13 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.0 (percent)\n- MCH [Entitic mass] by Automated count: 34.0 (picogram)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Multiple myeloma\n- Malignant lymphoma\n\n### Drug\n- Microencapsulated potassium chloride 20 MEQ Extended Release Oral Tablet, through Oral route, started on 2010-01-19, presumably until 2010-01-19\n- lidocaine hydrochloride 20 MG/ML Injectable Solution, started on 2010-01-19, presumably until 2010-01-19\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-23 12:21:00, ended at 2010-01-23 12:22:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocyte distribution width [Ratio] by Automated count: 18.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- MCV [Entitic volume] by Automated count: 100.6 (femtoliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.1 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.3 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 32 (millimole per liter)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 143 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.76 (million per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 94 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-01-23 12:23:00, ended at 2010-01-23 13:29:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- atorvastatin 20 MG Oral Tablet, through Oral route, presumably until 2010-03-13. Instructions: take 80 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-04 14:04:00, ended at 2010-02-04 14:21:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.53 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 11.9 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 33.3 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 247 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 17 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.01 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 22.5 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 128 (unit per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 102 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 35.4 (percent)\n- Neutrophils/100 leukocytes in Blood by Automated count: 57.9 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.7 (percent)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.58 (million per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 17.2 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.2 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 5.16 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 98.9 (femtoliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-04 14:22:00, ended at 2010-02-04 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, presumably until 2010-03-13. Instructions: take 81 mg by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2010-02-11 09:55:55, ended at 2010-02-11 11:46:16\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Body height: 6' 0\" (inch (US))\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Coronary atherosclerosis\n\n### Drug\n- citalopram 20 MG Oral Tablet, through Oral route. Instructions: take 20 mg by mouth 2 times a day. \n- atorvastatin 80 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2011-02-04, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n- aspirin 81 MG Chewable Tablet, through Oral route, presumably until 2010-02-11. Instructions: take by mouth daily. \n- carvedilol 3.125 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2010-03-13, with quantity of 60.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth 2 times a day with meals. \n- nitroglycerin 0.4 MG Sublingual Tablet, through Sublingual route, presumably until 2010-03-25. Instructions: by Sublingual route as needed \n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2010-02-11, presumably until 2010-05-06, with quantity of 30.0, with intended 11 refill(s). Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-11 11:57:00, ended at 2010-02-11 13:06:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-11 13:07:00, ended at 2010-02-11 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Erythrocytes [#/volume] in Blood by Automated count: 3.35 (million per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 53.4 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 19 (unit per liter)\n- Magnesium [Mass/volume] in Serum or Plasma: 1.9 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 7.5 (thousand per microliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.2 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 123 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.5 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.3 (gram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 36 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.5 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.0 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 4.02 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 229 (thousand per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.32 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 30.8 (percent)\n- MCH [Entitic mass] by Automated count: 33.6 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.6 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.98 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.19 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 18.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 88 (milligram per deciliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-02-13 00:00:00, ended at 2010-02-13 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-02-13, presumably until 2011-02-13, with quantity of 30.0. Instructions: take 1 Tab by mouth daily. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:00:00, ended at 2010-02-20 11:27:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-02-20 11:28:00, ended at 2010-02-20 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.32 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 2.13 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 24.4 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 5.11 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 58.7 (percent)\n- Sodium [Moles/volume] in Serum or Plasma: 138 (millimole per liter)\n- Platelets [#/volume] in Blood by Automated count: 206 (thousand per microliter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 23 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.16 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- MCHC [Mass/volume] by Automated count: 33.4 (gram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 33.2 (percent)\n- Hemoglobin [Mass/volume] in Blood: 11.1 (gram per deciliter)\n- MCH [Entitic mass] by Automated count: 33.4 (picogram)\n- Albumin [Mass/volume] in Serum or Plasma: 3.1 (gram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 3.1 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 100 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.27 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.7 (thousand per microliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 107 (unit per liter)\n- MCV [Entitic volume] by Automated count: 100.0 (femtoliter)\n- Monocytes [#/volume] in Blood by Automated count: 1.04 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 11.9 (percent)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-02 10:44:00, ended at 2010-03-03 11:48:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.1 (milligram per deciliter)\n- Body height: 6' .047\" (inch (US))\n- Platelets [#/volume] in Blood by Automated count: 172 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.9 (millimole per liter)\n- Sodium [Moles/volume] in Blood: 139 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 30.8 (percent)\n- Hemoglobin [Mass/volume] in Blood: 10.4 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.08 (million per microliter)\n- Potassium [Moles/volume] in Blood: 4.7 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 137 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 17 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 5 (millimole per liter)\n- Creatine kinase [Enzymatic activity/volume] in Serum or Plasma: 62 (unit per liter)\n- Hematocrit [Volume Fraction] of Blood: 35 (percent)\n- MCH [Entitic mass] by Automated count: 33.7 (picogram)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 28 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 19.8 (percent)\n- Hemoglobin [Mass/volume] in Blood by calculation: 11.9 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 100.2 (femtoliter)\n- Glucose [Mass/volume] in Serum or Plasma: 87 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 8.5 (thousand per microliter)\n\n### Procedure\n- Percutaneous transluminal coronary angioplasty\n- Transcatheter placement of an intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel\n- Procedure on single vessel\n- Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report\n- Collection of venous blood by venipuncture\n- Placement of stent in coronary artery\n- Insertion of one vascular stent\n\n### Condition\n- Coronary arteriosclerosis\n- Malignant lymphoma\n- Bone marrow transplant present\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- acyclovir 400 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-03\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- diazepam 5 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- aspirin 325 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- lorazepam 1 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- levothyroxine sodium 0.125 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- citalopram 20 MG Oral Tablet, through Oral route, started on 2010-03-02, presumably until 2010-03-03\n- 150 ML sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2010-03-02, presumably until 2010-03-02\n- diphenhydramine hydrochloride 25 MG Oral Capsule, through Oral route, started on 2010-03-02, presumably until 2010-03-02\n- atorvastatin 40 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- aspirin 81 MG Delayed Release Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n- clopidogrel 75 MG Oral Tablet, through Oral route, started on 2010-03-03, presumably until 2010-03-03\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-13 13:07:00, ended at 2010-03-13 13:37:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- Basophils/100 leukocytes in Blood by Automated count: 0.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.2 (milligram per deciliter)\n- MCV [Entitic volume] by Automated count: 101.9 (femtoliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.1 (milligram per deciliter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 105 (milligram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.52 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.6 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.12 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 34.1 (picogram)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 35.6 (percent)\n- Eosinophils/100 leukocytes in Blood by Automated count: 2.3 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 20.0 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 34.8 (percent)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.88 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.72 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 48.0 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 110 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Hemoglobin [Mass/volume] in Blood: 11.7 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.3 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 3.42 (million per microliter)\n- Platelets [#/volume] in Blood by Automated count: 166 (thousand per microliter)\n\n### Procedure\n- Collection of venous blood by venipuncture\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2010-03-13 13:38:00, ended at 2010-03-13 23:59:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malignant lymphoma\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Pharmacy visit, started at 2010-03-19 00:00:00, ended at 2010-03-19 00:00:00\nThe patient in this visit was 63 years old, White, Not Hispanic or Latino, MALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Atrial fibrillation\n\n### Drug\n- amiodarone hydrochloride 200 MG Oral Tablet, through Oral route, started on 2010-03-19, presumably until 2010-10-13, with quantity of 30.0, with intended 6 refill(s). Instructions: take 1 Tab by mouth daily. \n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Depressive disorder within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of depressive_disorder means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "ea3599556b984675c618058e6ebf057e306bd08e9dd7b6a9f63f55307a9498b5", "prompt_hash": "051bb1dcaea13fbad7281d96750cdbf63f0b05e97381d1aa246963682af32358", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
{"doc_id": 9, "doc": {"person_id": 115969897, "visit_occurrence_id": 37990307, "death_date": null, "visit_concept_name": "Outpatient Visit", "visit_start_datetime": "2009-12-21 17:42:00", "visit_end_datetime": "2009-12-22 17:04:00", "visit_length_in_hours": 23.366666666666667, "integrated_visit_record": "## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-21 17:42:00, ended at 2009-12-22 17:04:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44.3 (percent)\n- MCV [Entitic volume] by Automated count: 89.1 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 36.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 169 (thousand per microliter)\n- Body height: 5' 4.8\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Diagnostic interview and evaluation, not otherwise specified\n- Collection of venous blood by venipuncture\n\n### Condition\n- Gastroesophageal reflux disease\n- Spinal stenosis\n- Diverticulitis of colon\n- Anxiety state\n- Abdominal pain\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-22\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-21, presumably until 2009-12-22\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-12-21, presumably until 2009-12-21\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2009-12-22\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2009-12-21, presumably until 2009-12-22\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-22\n- oxazepam 15 MG Oral Capsule, through Oral route, started on 2009-12-21, presumably until 2009-12-22\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-22\n\n", "approximate_token_count": 1006, "patient_first_visit_date": "2008-05-30 09:34:00", "patient_last_visit_date": "2018-12-22 19:07:00", "end_obs_date": "2010-12-22", "hypertension_type": "new", "hypertension_one_year_diagnosis": 0, "obesity_type": "new", "obesity_one_year_diagnosis": 0, "asthma_type": "new", "asthma_one_year_diagnosis": 0, "hyperlipidemia_type": "new", "hyperlipidemia_one_year_diagnosis": 0, "depressive_disorder_type": "recurrent", "depressive_disorder_one_year_diagnosis": 0, "chronic_kidney_disease_type": "new", "chronic_kidney_disease_one_year_diagnosis": 0, "chronic_obstructive_pulmonary_disease_type": "new", "chronic_obstructive_pulmonary_disease_one_year_diagnosis": 0, "coronary_arteriosclerosis_type": "new", "coronary_arteriosclerosis_one_year_diagnosis": 0, "type_ii_diabetes_type": "new", "type_ii_diabetes_one_year_diagnosis": 0, "breast_cancer_type": "new", "breast_cancer_one_year_diagnosis": 0, "prostate_cancer_type": "new", "prostate_cancer_one_year_diagnosis": 0, "pancreatic_cancer_type": "new", "pancreatic_cancer_one_year_diagnosis": 0, "lupus_type": "new", "lupus_one_year_diagnosis": 0, "acute_myocardial_infarction_type": "new", "acute_myocardial_infarction_one_year_diagnosis": 0, "ischemic_stroke_type": "new", "ischemic_stroke_one_year_diagnosis": 0, "heart_failure_type": "new", "heart_failure_one_year_diagnosis": 0, "dementia_type": "new", "dementia_one_year_diagnosis": 0, "intestinal_cancer_type": "new", "intestinal_cancer_one_year_diagnosis": 0, "gastric_cancer_type": "new", "gastric_cancer_one_year_diagnosis": 0, "lung_cancer_type": "new", "lung_cancer_one_year_diagnosis": 0, "liver_cancer_type": "new", "liver_cancer_one_year_diagnosis": 0, "visit_sequence_number": 8, "cumulated_visit_num": 8, "cumulated_approximate_token_count": 5680, "visit_cumulated": "## Visit\nThis visit record, was from Emergency Room Visit, started at 2008-05-30 09:34:00, ended at 2008-05-30 14:50:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.85 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 177 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.28 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.3 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n\n### Drug\n- gabapentin 300 MG Oral Tablet, through Oral route, presumably until 2009-03-10. Instructions: take 300 mg by mouth daily. \n- oxazepam 15 MG Oral Capsule, through Oral route, presumably until 2018-12-20. Instructions: take by mouth as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-01-25 16:06:00, ended at 2009-01-25 21:13:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.60 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 435 (microgram of fibrinogen equivalent unit per milliliter)\n- MCV [Entitic volume] by Automated count: 87.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.5 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-03-12 21:13:00, ended at 2009-03-13 11:15:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 1.93 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 150 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malaise\n- Cough\n\n### Drug\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2009-03-12, presumably until 2009-03-12\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2009-03-13, presumably until 2009-03-13\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2009-03-12, presumably until 2009-03-13\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-03-12, presumably until 2009-03-12\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2009-03-13, presumably until 2009-03-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-16 14:17:31, ended at 2009-10-16 16:33:02\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2018-12-20. Instructions: take 300 mg by mouth 3 times a day. \n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, presumably until 2018-12-20. Instructions: 1 Patch by Transdermal route. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-21 10:18:42, ended at 2009-10-21 13:38:21\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychiatric diagnostic interview examination\n- Psychological testing (includes psychodiagnostic assessment of emotionality, intellectual abilities, personality and psychopathology, eg, MMPI, Rorschach, WAIS), per hour of the psychologist's or physician's time, both face-to-face time administering test\n\n### Condition\n- Recurrent major depressive episodes, mild\n- Pain disorder with psychological factor\n- Anxiety state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-12-18 21:46:00, ended at 2009-12-19 03:53:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.6 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 150 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.02 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n\n### Condition\n- Diverticulitis of colon\n- Nausea\n\n### Drug\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-12-19, presumably until 2010-12-19, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-12-19, presumably until 2009-12-19, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily. \n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2009-12-19, presumably until 2010-12-19, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-12-19, presumably until 2009-12-22, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-12-19 09:47:00, ended at 2009-12-19 13:20:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 147 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Prothrombin time (PT): 15.1 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Base excess in Blood by calculation: 0.0 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.66 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-12-19, presumably until 2009-12-19\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2009-12-19, presumably until 2010-12-19, with quantity of 25.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-12-19, presumably until 2009-12-19\n- oxazepam 15 MG Oral Capsule, through Oral route, presumably until 2014-11-29. Instructions: take 15 mg by mouth 3 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-21 17:42:00, ended at 2009-12-22 17:04:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44.3 (percent)\n- MCV [Entitic volume] by Automated count: 89.1 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 36.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 169 (thousand per microliter)\n- Body height: 5' 4.8\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Diagnostic interview and evaluation, not otherwise specified\n- Collection of venous blood by venipuncture\n\n### Condition\n- Gastroesophageal reflux disease\n- Spinal stenosis\n- Diverticulitis of colon\n- Anxiety state\n- Abdominal pain\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-22\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-21, presumably until 2009-12-22\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-12-21, presumably until 2009-12-21\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2009-12-22\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2009-12-21, presumably until 2009-12-22\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-22\n- oxazepam 15 MG Oral Capsule, through Oral route, started on 2009-12-21, presumably until 2009-12-22\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-22\n\n"}, "target": "No", "arguments": {"gen_args_0": {"arg_0": "<|im_start|>user\nThis is a task about predicting if the patient will receive a recurrent diagnosis of Depressive disorder within the next year based on their recent EHR visit data: \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2008-05-30 09:34:00, ended at 2008-05-30 14:50:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Albumin [Mass/volume] in Serum or Plasma: 4.0 (gram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.2 (percent)\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 43 (unit per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.5 (milligram per deciliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.1 (milligram per deciliter)\n- Magnesium [Mass/volume] in Serum or Plasma: 2.0 (milligram per deciliter)\n- Phosphate [Mass/volume] in Serum or Plasma: 2.3 (milligram per deciliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 25 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.8 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.1 (percent)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 126 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 21 (unit per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.6 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 23.6 (percent)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Anion gap in Serum or Plasma: 9 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.85 (million per microliter)\n- MCHC [Mass/volume] by Automated count: 34.2 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.49 (thousand per microliter)\n- Platelets [#/volume] in Blood by Automated count: 177 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.07 (thousand per microliter)\n- Glucose [Mass/volume] in Serum or Plasma: 117 (milligram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 29.8 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.2 (percent)\n- Neutrophils [#/volume] in Blood by Automated count: 2.28 (thousand per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.3 (percent)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.7 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 87.3 (femtoliter)\n- Chloride [Moles/volume] in Serum or Plasma: 106 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 7 (milligram per deciliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Diarrhea\n\n### Drug\n- gabapentin 300 MG Oral Tablet, through Oral route, presumably until 2009-03-10. Instructions: take 300 mg by mouth daily. \n- oxazepam 15 MG Oral Capsule, through Oral route, presumably until 2018-12-20. Instructions: take by mouth as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-01-25 16:06:00, ended at 2009-01-25 21:13:00\nThe patient in this visit was 77 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 35 (unit per liter)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Hemoglobin [Mass/volume] in Blood: 14.8 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 3.60 (thousand per microliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 1.4 (percent)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.0 (percent)\n- Calcium [Mass/volume] in Serum or Plasma: 9.8 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.2 (percent)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 42.8 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.0 (ratio)\n- Lymphocytes [#/volume] in Blood by Automated count: 1.55 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 34.6 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.6 (percent)\n- aPTT in Platelet poor plasma by Coagulation assay: 24.7 (second)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.89 (million per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.43 (thousand per microliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Protein [Mass/volume] in Serum or Plasma: 7.6 (gram per deciliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 97 (unit per liter)\n- Globulin [Mass/volume] in Serum: 3.5 (gram per deciliter)\n- Platelets [#/volume] in Blood by Automated count: 184 (thousand per microliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 31 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 112 (milligram per deciliter)\n- MCH [Entitic mass] by Automated count: 30.3 (picogram)\n- Potassium [Moles/volume] in Serum or Plasma: 4.3 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.08 (thousand per microliter)\n- Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma: 435 (microgram of fibrinogen equivalent unit per milliliter)\n- MCV [Entitic volume] by Automated count: 87.6 (femtoliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 63.5 (percent)\n- Prothrombin time (PT): 13.0 (second)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 14 (milligram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 4.1 (gram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.7 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 27.3 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.01 (nanogram per milliliter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Abnormal breathing\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Hospital, started at 2009-03-12 21:13:00, ended at 2009-03-13 11:15:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 32 (unit per liter)\n- MCV [Entitic volume] by Automated count: 88.5 (femtoliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.5 (gram per deciliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 61.8 (percent)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 22 (unit per liter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.8 (percent)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 13.9 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 34.7 (gram per deciliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.22 (thousand per microliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 40.0 (percent)\n- Troponin I.cardiac [Mass/volume] in Serum or Plasma: 0.00 (nanogram per milliliter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 91 (unit per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.03 (thousand per microliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.52 (million per microliter)\n- MCH [Entitic mass] by Automated count: 30.7 (picogram)\n- Neutrophils [#/volume] in Blood by Automated count: 1.93 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 4.0 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.3 (gram per deciliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 29.8 (percent)\n- Monocytes/100 leukocytes in Blood by Automated count: 7.0 (percent)\n- Platelets [#/volume] in Blood by Automated count: 150 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: <0.5 (milligram per deciliter)\n- Chloride [Moles/volume] in Serum or Plasma: 100 (millimole per liter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 0.6 (percent)\n- Erythrocyte distribution width [Ratio] by Automated count: 12.9 (percent)\n- Globulin [Mass/volume] in Serum: 3.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.93 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 3.1 (thousand per microliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Glucose [Mass/volume] in Serum or Plasma: 152 (milligram per deciliter)\n- Sodium [Moles/volume] in Serum or Plasma: 136 (millimole per liter)\n\n### Procedure\n- No procedures.\n\n### Condition\n- Malaise\n- Cough\n\n### Drug\n- albuterol 0.83 MG/ML Inhalation Solution, through Inhalation, started on 2009-03-12, presumably until 2009-03-12\n- albuterol 0.833 MG/ML / ipratropium bromide 0.167 MG/ML Inhalation Solution, through Inhalation, started on 2009-03-13, presumably until 2009-03-13\n- alprazolam 0.5 MG Oral Tablet, through Oral route, started on 2009-03-12, presumably until 2009-03-13\n- 1000 ML glucose 50 MG/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-03-12, presumably until 2009-03-12\n- azithromycin 250 MG Oral Tablet, through Oral route, started on 2009-03-13, presumably until 2009-03-13\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-16 14:17:31, ended at 2009-10-16 16:33:02\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- No procedures.\n\n### Condition\n- Primary diagnosis: Peripheral nerve disease\n\n### Drug\n- gabapentin 300 MG Oral Capsule, through Oral route, presumably until 2018-12-20. Instructions: take 300 mg by mouth 3 times a day. \n- lidocaine 0.05 MG/MG Medicated Patch, through Transdermal route, presumably until 2018-12-20. Instructions: 1 Patch by Transdermal route. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Office Visit, started at 2009-10-21 10:18:42, ended at 2009-10-21 13:38:21\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- No measurements.\n\n### Procedure\n- Psychiatric diagnostic interview examination\n- Psychological testing (includes psychodiagnostic assessment of emotionality, intellectual abilities, personality and psychopathology, eg, MMPI, Rorschach, WAIS), per hour of the psychologist's or physician's time, both face-to-face time administering test\n\n### Condition\n- Recurrent major depressive episodes, mild\n- Pain disorder with psychological factor\n- Anxiety state\n\n### Drug\n- No drugs.\n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-12-18 21:46:00, ended at 2009-12-19 03:53:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 30 (millimole per liter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.33 (million per microliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.82 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 14.6 (percent)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Platelets [#/volume] in Blood by Automated count: 150 (thousand per microliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Anion gap in Serum or Plasma: 6 (millimole per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 39.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 13.1 (gram per deciliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 12.3 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 123 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 5.6 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 104 (millimole per liter)\n- Neutrophils [#/volume] in Blood by Automated count: 4.02 (thousand per microliter)\n- Basophils [#/volume] in Blood by Automated count: 0.01 (thousand per microliter)\n- Calcium [Mass/volume] in Serum or Plasma: 9.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.0 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.69 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 71.8 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 4.2 (millimole per liter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 10 (milligram per deciliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.3 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.05 (thousand per microliter)\n- MCHC [Mass/volume] by Automated count: 33.5 (gram per deciliter)\n- MCV [Entitic volume] by Automated count: 90.2 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 140 (millimole per liter)\n\n### Procedure\n- Computed tomography, abdomen; with contrast material(s)\n- Computed tomography, pelvis; with contrast material(s)\n\n### Condition\n- Diverticulitis of colon\n- Nausea\n\n### Drug\n- ciprofloxacin 500 MG Oral Tablet, through Oral route, started on 2009-12-19, presumably until 2010-12-19, with quantity of 20.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 2 times a day. \n- docusate sodium 250 MG Oral Capsule, through Oral route, started on 2009-12-19, presumably until 2009-12-19, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Cap by mouth daily. \n- metronidazole 500 MG Oral Tablet, through Oral route, started on 2009-12-19, presumably until 2010-12-19, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth 3 times a day. \n- acetaminophen 500 MG / hydrocodone bitartrate 5 MG Oral Tablet, through Oral route, started on 2009-12-19, presumably until 2009-12-22, with quantity of 30.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 4 hours as needed \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Emergency Room Visit, started at 2009-12-19 09:47:00, ended at 2009-12-19 13:20:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 38 (unit per liter)\n- Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma: 16 (unit per liter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 26 (millimole per liter)\n- Calcium [Mass/volume] in Serum or Plasma: 8.9 (milligram per deciliter)\n- Erythrocyte distribution width [Ratio] by Automated count: 14.0 (percent)\n- Hemoglobin [Mass/volume] in Blood: 12.8 (gram per deciliter)\n- Lymphocytes [#/volume] in Blood by Automated count: 0.88 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Monocytes/100 leukocytes in Blood by Automated count: 10.4 (percent)\n- Platelets [#/volume] in Blood by Automated count: 147 (thousand per microliter)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Protein [Mass/volume] in Serum or Plasma: 7.0 (gram per deciliter)\n- Eosinophils [#/volume] in Blood by Automated count: 0.06 (thousand per microliter)\n- Monocytes [#/volume] in Blood by Automated count: 0.42 (thousand per microliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 11 (milligram per deciliter)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Glucose [Mass/volume] in Serum or Plasma: 147 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 4.0 (thousand per microliter)\n- MCV [Entitic volume] by Automated count: 89.8 (femtoliter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.00 (thousand per microliter)\n- Chloride [Moles/volume] in Serum or Plasma: 105 (millimole per liter)\n- Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma: 98 (unit per liter)\n- Creatinine [Mass/volume] in Serum or Plasma: 0.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.22 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 37.9 (percent)\n- INR in Platelet poor plasma by Coagulation assay: 1.2 (ratio)\n- Prothrombin time (PT): 15.1 (second)\n- Eosinophils/100 leukocytes in Blood by Automated count: 1.6 (percent)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 21.8 (percent)\n- Basophils/100 leukocytes in Blood by Automated count: 0.1 (percent)\n- Bilirubin.total [Mass/volume] in Serum or Plasma: 0.7 (milligram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.7 (gram per deciliter)\n- Albumin [Mass/volume] in Serum or Plasma: 3.3 (gram per deciliter)\n- Base excess in Blood by calculation: 0.0 (millimole per liter)\n- Globulin [Mass/volume] in Serum: 3.7 (gram per deciliter)\n- Neutrophils [#/volume] in Blood by Automated count: 2.66 (thousand per microliter)\n- Neutrophils/100 leukocytes in Blood by Automated count: 66.1 (percent)\n\n### Procedure\n- No procedures.\n\n### Condition\n- No conditions.\n\n### Drug\n- 500 ML glucose 50 MG/ML / sodium chloride 9 MG/ML Injection, through Intravenous route, started on 2009-12-19, presumably until 2009-12-19\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2009-12-19, presumably until 2010-12-19, with quantity of 25.0, with intended 0 refill(s). Instructions: take 1 Tab by mouth every 6 hours as needed for Pain. \n- 2 ML ondansetron 2 MG/ML Injection, started on 2009-12-19, presumably until 2009-12-19\n- oxazepam 15 MG Oral Capsule, through Oral route, presumably until 2014-11-29. Instructions: take 15 mg by mouth 3 times a day. \n\n<|VISIT_SEPARATOR|> \n\n## Visit\nThis visit record, was from Outpatient Visit, started at 2009-12-21 17:42:00, ended at 2009-12-22 17:04:00\nThe patient in this visit was 78 years old, White, Not Hispanic or Latino, FEMALE.\n\n### Measurement\n- Lymphocytes [#/volume] in Blood by Automated count: 1.30 (thousand per microliter)\n- Lymphocytes/100 leukocytes in Blood by Automated count: 44.3 (percent)\n- MCV [Entitic volume] by Automated count: 89.1 (femtoliter)\n- Creatinine [Mass/volume] in Serum or Plasma: 1.0 (milligram per deciliter)\n- Eosinophils/100 leukocytes in Blood by Automated count: 4.9 (percent)\n- Glucose [Mass/volume] in Serum or Plasma: 156 (milligram per deciliter)\n- Leukocytes [#/volume] in Specimen by Automated count: 2.9 (thousand per microliter)\n- MCH [Entitic mass] by Automated count: 30.2 (picogram)\n- Neutrophils/100 leukocytes in Blood by Automated count: 36.4 (percent)\n- Potassium [Moles/volume] in Serum or Plasma: 3.5 (millimole per liter)\n- Sodium [Moles/volume] in Serum or Plasma: 141 (millimole per liter)\n- Basophils [#/volume] in Blood by Automated count: 0.02 (thousand per microliter)\n- Basophils/100 leukocytes in Blood by Automated count: 0.7 (percent)\n- Anion gap in Serum or Plasma: 10 (millimole per liter)\n- Chloride [Moles/volume] in Serum or Plasma: 108 (millimole per liter)\n- Hemoglobin [Mass/volume] in Blood: 12.4 (gram per deciliter)\n- MCHC [Mass/volume] by Automated count: 33.9 (gram per deciliter)\n- Urea nitrogen [Mass/volume] in Serum or Plasma: 5 (milligram per deciliter)\n- Carbon dioxide, total [Moles/volume] in Serum or Plasma: 23 (millimole per liter)\n- Erythrocyte distribution width [Ratio] by Automated count: 13.9 (percent)\n- Monocytes [#/volume] in Blood by Automated count: 0.40 (thousand per microliter)\n- Monocytes/100 leukocytes in Blood by Automated count: 13.7 (percent)\n- Platelets [#/volume] in Blood by Automated count: 169 (thousand per microliter)\n- Body height: 5' 4.8\" (inch (US))\n- Calcium [Mass/volume] in Serum or Plasma: 7.9 (milligram per deciliter)\n- Erythrocytes [#/volume] in Blood by Automated count: 4.09 (million per microliter)\n- Hematocrit [Volume Fraction] of Blood by Automated count: 36.4 (percent)\n- Eosinophils [#/volume] in Blood by Automated count: 0.15 (thousand per microliter)\n- Neutrophils [#/volume] in Blood by Automated count: 1.07 (thousand per microliter)\n\n### Procedure\n- Therapeutic activities, direct (one-on-one) patient contact (use of dynamic activities to improve functional performance), each 15 minutes\n- Physical therapy evaluation\n- Self-care/home management training (eg, activities of daily living (ADL) and compensatory training, meal preparation, safety procedures, and instructions in use of assistive technology devices/adaptive equipment) direct one-on-one contact, each 15 minutes\n- Diagnostic interview and evaluation, not otherwise specified\n- Collection of venous blood by venipuncture\n\n### Condition\n- Gastroesophageal reflux disease\n- Spinal stenosis\n- Diverticulitis of colon\n- Anxiety state\n- Abdominal pain\n\n### Drug\n- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 4.5 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-22\n- pantoprazole 40 MG Delayed Release Oral Tablet, through Oral route, started on 2009-12-21, presumably until 2009-12-22\n- 0.4 ML enoxaparin sodium 100 MG/ML Prefilled Syringe, through Subcutaneous route, started on 2009-12-21, presumably until 2009-12-21\n- tramadol hydrochloride 50 MG Oral Tablet, through Oral route, started on 2009-12-22, presumably until 2009-12-22\n- gabapentin 300 MG Oral Capsule, through Oral route, started on 2009-12-21, presumably until 2009-12-22\n- 200 ML ciprofloxacin 2 MG/ML Injection, through Intravenous route, started on 2009-12-22, presumably until 2009-12-22\n- oxazepam 15 MG Oral Capsule, through Oral route, started on 2009-12-21, presumably until 2009-12-22\n- 100 ML metronidazole 5 MG/ML Injection, through Intravenous route, started on 2009-12-21, presumably until 2009-12-22\n\n\n\nAbove are the patient's recent EHR visit records (including the current visit) in chronological order.\n\nYou are a medical AI assistant analyzing patient data to predict future diagnoses given the patient's recent and current EHR visit records provided above.\n\nINSTRUCTIONS:\n- Predict if the patient will receive a recurrent diagnosis of Depressive disorder within the next year (we know this patient has had this condition in their medical records up to the current visit)\n- the condition of depressive_disorder means itself and any of its descendant conditions in the medical ontology hierarchy\n- Do not provide any explanation, reasoning, or additional text.\n- You must respond with exactly one word only: Yes or No\n\nAnswer:<|im_end|>\n<|im_start|>assistant\n", "arg_1": {"until": ["<im_end>"], "max_gen_toks": 2048, "do_sample": false, "temperature": 0.0}}}, "resps": [["No"]], "filtered_resps": ["No"], "filter": "binary_yn", "metrics": ["exact_match", "f1_gu_yn", "recall_gu_yn"], "doc_hash": "041169e56d336478cae525814edf61df09562fd1983e92918ad84208180cbd5f", "prompt_hash": "3e03f40ae3a8d682dce289ada47afe1f11e37d0945fa537425eae74cfd6c77f1", "target_hash": "1ea442a134b2a184bd5d40104401f2a37fbc09ccf3f4bc9da161c6099be3691d", "exact_match": 1.0, "f1_gu_yn": [0, 0], "recall_gu_yn": [0, 0]}
